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Introduction:  A brewery worker developed work-related asthma associated with exposure to malt 
and other grain dust allergens in a brewery over a period.  The aim of this study was to determine the 
prevalence of work-related respiratory symptoms and associated risk factors, within this brewery in 
South Africa 
 
Study method:  Use was made of a cross-sectional analytical study design.  Sample method:  A 
stratified opportunistic sampling method was used to select the study sample (n = 251) from a total 
population of 414 permanent workers in the brewery.  The workers were classified into three exposure 
groups based on a subjective visual assessment of exposure to dusts, chemicals, gases, vapors and 
fumes reported in different departments.  Study tool:  A previously validated interviewer-administered 
questionnaire of the European Community Respiratory Health Survey (ECRHS), adapted for local 
context, was used.  Almost all (251/252) workers selected eventually participated in the study.  
Analysis:  Univariate, bivariate and multivariate logistic regression models were used to investigate 
the association between upper and lower respiratory symptoms and outcomes, host factors and 
specific environmental exposures. 
 
Results:  The study population was predominantly male (n=95; 78%) with a mean age of 40 years and 
an average of 10 years employed in the current job.  Thirty-five percent (n=88; 35%) of the workforce 
were smokers, twenty-five percent (n=62; 25%) had a family history of allergy, hay fever and/or 
asthma and sixteen percent (n=39; 16%) reported doctor-diagnosed asthma.  The most common 
potentially hazardous agents reported included sodium hydroxide (n=123; 49%), carbon dioxide 
(n=108; 43%), ammonia (n=100; 40%), kieselguhr/silica dust (n=88; 35%) and malt dust (n=83; 
33%).  Upper respiratory symptoms (n=161; 64%) were more common than lower respiratory 
symptoms (3% – 28%).  Between 2% and 38% of workers reported possible work-related respiratory 
symptom experiences depending on the definition used.  The common respiratory disease phenotypes 
included general asthma (n=39; 16%), atopic asthma (n=18; 7%), work-related asthma (n=15; 6%), 
work aggravated asthma (n=7; 3%), possible allergic alveolitis/grain fever (n=63; 25%) and possible 
chronic bronchitis (n=7; 3%).  Host factors strongly associated with respiratory outcomes included 
age, male gender, previous hospitalization for a lung disease and a family history of allergy, hay fever 
or asthma.  In the adjusted multivariate logistic regression models, hazardous chemical agents such as 
sodium hydroxide (OR, 2.27: 95%CI, 1.09-4.73) and kiesselguhr/silica (OR, 2.58: 95%CI, 1.22-5.46) 













Workers in the high exposure group were ten times as likely (OR, 10.45: 95%CI 3.08–35.45), 
compared to the lower exposure group, to have reported a chest problem caused by peak exposures to 
a large amount of dusts, chemicals, gases, vapors or fumes.  Chemicals strongly associated with lower 
respiratory symptoms in general, and in excessive levels of either dusts, chemicals, gases, vapors or 
fumes causing a chest problem, included sodium hydroxide (OR, 2.79: 95%CI,1.48 - 5.28), carbon 
dioxide (OR, 3.92: 95%CI, 2.04 -7.56) and ammonia (OR,3.69: 95%CI, 2.01 – 6.78).  In addition, 
sodium hydroxide (OR, 7.28: 95%CI, 3.41-15.56), carbon dioxide (OR, 2.93: 95%CI, 1.53-5.62) and 
kiesselguhr/silica (OR, 2.40: 95%CI, 1.27- 4.53) were significantly associated with possible allergic 
alveolitis.  Only sodium hydroxide demonstrated strong associations with possible, probable or 
confirmed asthma.  Among the biological agents, grain dust (OR, 2.16: 95%CI, 1.08-4.33), hops (OR, 
2.05: 95%CI, 1.07-3.93) and malt dust (OR, 2.16: 95%CI, 1.17-4.04) were strongly associated with 
possible allergic alveolitis/grain fever.  Grain dust (OR, 13.28: 95%CI, 2.28-77.39), hops (OR, 7.21: 
95%CI, 1.33-39.18) and malt dust (OR, 5.83: 95%CI, 1.08-31.55) were significantly associated with 
possible chronic bronchitis. 
 
Conclusion:  Brewery workers exposed to high levels of dusts, chemicals, gases, vapors or fumes are 
at increased risk of developing work-related respiratory symptoms and developing work-related 
asthma, chronic bronchitis and possible allergic alveolitis/grain fever.  The symptoms are associated 
with exposure to once-off peak exposures of dusts, chemicals, gases, vapors or fumes.  Both 
hazardous chemical agents (sodium hydroxide, carbon dioxide, ammonia and kiesselguhr/silica) and 
biological agents (malt dust, hops and other grain dust) are implicated. 
 
Significance to clinical practice:  The high prevalence of work-related respiratory symptoms 
associated with chemical and biological exposures in a brewery were identified.  In addition, several 
host-related factors were also identified.  This survey points to the need for appropriate preventative 
strategies to be undertaken in order to reduce exposures and more targeted respiratory medical 
surveillance of exposed workers. This, in the long term will reduce the incidence of respiratory 
problems among brewery workers, and ensure the protection and promotion of the respiratory health 
of employees in the workplace. 
 
Key words:  Brewery workers; respiratory symptoms; asthma; work-related asthma; work-related 
rhinitis; risk factors; host; environmental; occupational exposure; work-exacerbated asthma; chronic 












OPERATIONAL DEFINITION OF TERMS 
 
Aeroallergen 




A chronic inflammatory disorder of the airways in which many cells and cellular elements 
play a role.  The chronic inflammation is associated with airway hyper-responsiveness that 
leads to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, 
particularly at night or in the early morning.  These episodes are usually associated with 
widespread, but variable, airflow obstruction within the lung, that is often reversible, either 
spontaneously or with treatment (Tarlo et al. 2008) 
 
Allergen 
A substance that causes the immune system to produce antibodies.  A non-parasitic antigen 
may be capable of stimulating a type-1 hypersensitivity reaction in atopic individuals.  In 
atopic individuals, non-parasitic antigens stimulate inappropriate IgE production, leading to 
type-1 hypersensitivity.  Sensitivities vary from one person to another and it is possible to be 
allergic to an extraordinary range of substances.  An antigen may be a foreign substance from 




Also known as immunoglobulins are gamma globulin proteins that are found in blood or 
other body fluids of vertebrates and are produced in response to an antigen by the immune 
system to identify and neutralize foreign agents 
 
Atopy 
Most humans mount significant Immunoglobulin E (IgE) responses only as a defense against 
parasitic infections. However, some individuals mount an IgE response against common 
environmental antigens. This hereditary predisposition is called atopy.  It is an allergic 
hypersensitivity reaction, affecting parts of the body not necessarily in direct contact with the 












Chronic obstructive pulmonary disease 
Chronic obstructive pulmonary disease is a disease characterized by airflow limitation, which 
is generally irreversible, with the presentation of symptoms of a productive cough, airway 
hyper-responsiveness and breathlessness to differing degrees 
 
Endotoxins 
Toxins associated with certain bacteria, secreted only during cell division 
 
Fibrosis (pulmonary) 
The formation or development of excess fibrous connective tissue in the lungs, commonly 
described as ‘scarring of the lungs’ 
 
Health risk 
A factor that raises the probability of adverse health outcomes (World Health Organisation) 
 
Healthy worker survivor effect 
This ‘effect’ occurs when workers who become ill are ‘selected out’ of employment, through 
either medical disability or resignation.  This would result in reduced risks estimates in a 
cross-sectional study assessing the relationship between the exposure and the outcome, such 
as asthma (Joubert & Ehrlich 2007) 
 
Hypersensitivity 
A state of altered reactivity in which the body reacts with an exaggerated immune response to 
what is perceived as a foreign substance 
 
Hypersensitivity (Type 1) 
Refers to immediate allergy, sensitivity, and is an allergic reaction provoked by re-exposure 
to a specific type of antigen referred to as an allergen.  Exposure may be by ingestion, 
inhalation, injection or direct contact 
 
Hypersensitivity Pneumonitis (HP) 
The group of diseases caused by pulmonary hypersensitivity to inhaled organic antigens, 
usually caused by a type-3 allergic reaction to microorganisms (e.g. aspergillus clevatus).  
Appears to affect the peripheral gas-exchanging tissues of the lung, and is characterized by 
dysnoea some hours after exposure, a pyrexial reaction, crepitations, diffuse micronodular 
opacities on radiological examination, and reduction in both forced vital capacity (FVC) and 
carbon monoxide (CO) transfer factor.  In most instances there is no clinical or physiological 













The study of all aspects of the immune system 
 
Immunoglobulin E (IgE) 
IgE is a type of protein called an antibody.  The body’s immune system produces antibodies 
in response to substances it perceives as threats to one’s health.  When one has allergic 
asthma one’s body is thought to make too much of a natural substance known as IgE in 
response to certain allergens such as pollen, dust mites, animal dander and cockroaches.  This 
extra IgE may lead to the development and persistence of airway inflammation, which results 
in asthma symptoms and asthma attack.  It is a class of antibody that has only been found in 
mammals, and plays an important role in allergy, is especially associated with type-1 
hypersensitivity and capable of triggering the most powerful immune reactions 
 
In vitro 
In an artificial environment outside the living organism, e.g. test done in a laboratory 
 
Irritant 
Many substances can aggravate or increase the severity of asthma symptoms in individuals 
who are sensitive to these allergens or irritants, such as cigarette smoke, ammonia gas 
 
Medical surveillance 
A periodic comprehensive review of a worker’s health status.  Acceptable elements of such 
surveillance program are listed in legislation pertaining to, for example, Occupational Health 
 
Mycotoxins 
The toxic chemical products produced by fungi e.g. mould.  One mould species may produce 
many different mycotoxins 
 
Occupational asthma (OA) 
Refers to de novo asthma or the recurrence of previously quiescent asthma (i.e, asthma as a 
child or in the distant past that has been in remission) induced by either sensitization to a 
specific substance (e.g. an inhaled protein [high-molecular-weight] protein of > 10 kd or a 
chemical at work [low-molecular-weight agent]), which is termed ‘sensitizer-induced OA’, 
and/or by exposure to an inhaled irritant at work, which is termed ‘irritant-induced OA’ 
(Tarlo et al. 2008) 
 
Occupational conjunctivitis 













Disease related to an occupation 
 
Organic dust 
Aerosols or particulate matter of microbial, plant or animal origin, that may consist of live or 




Total number of cases of a disease in the population at a given time, or the total number of 
cases in the population, divided by the number of individuals within that population.  It is 




Fever.  Elevated body temperature 
 
Reactive Airways Dysfunction Syndrome (RADS) 
The most definitive form of irritant-induced asthma which describes an acute onset of asthma 
after a single, very high irritant exposure (Tarlo et al. 2008) 
 
Rhinitis (occupational rhinitis)   
The episodic work-related occurrence of sneezing, nasal discharge, pruritis, and congestion 
which contribute to distress, discomfort and work inefficiency, and is two to three times more 
frequent than OA, and often co-exists with OA, frequently preceding development of OA but 
not developing subsequently to OR 
 
Sensitizer 
A chemical that causes a substantial proportion of exposed people or animals to develop an 
allergic reaction in normal tissue, after repeated exposure to the chemical 
 
Sentinel health event 
A sentinel event is defined as any unanticipated event in a healthcare setting, resulting in 
death or serious physical or psychological injury to a patient or patients not related to the 
natural course of the patient’s illness. Sentinel events specifically include loss of a limb or 















The measurement of the volume and /or flow rate of gas breathed in or out of the lungs under 
specific conditions of effort, namely maximum effort 
 
Toxins 
A poisonous substance produced by the living cells or organisms capable of causing disease 
 
Urticaria (Occupational contact urticaria)   
An erythematous, popular, pruritic rash seen in classic hives, specifically associated with 
occupational exposure.  The mechanism is usually an Immunoglobulin-E-mediated (IgE-
mediated) process 
 
Work-exacerbated Asthma (WEA) 
Asthma triggered by various work-related factors (e.g. aeroallergens, irritants or exercise) in 
workers who are known to have pre-existing or concurrent asthma.  Namely, asthma that is 
occurring at the same time but is not caused by workplace exposures (Tarlo et al. 2008) 
 
Work-related Asthma (WRA) 
A broad term encompassing both occupational asthma (OA) and work-exacerbated asthma 
















ACCP   American College of Chest Physicians 
ACGIH  American Conference of Industrial Hygienists  
 
CO   Carbon monoxide 
COID   Compensation for Occupational Injuries and Diseases Act 
COPD   Chronic obstructive pulmonary disease 
 
EAA   Extrinsic allergic alveolitis 
ECRHS  European Community Respiratory Health Survey 
 
FeNO   Fractional exhaled nitric oxide 
FEV1   Forced expiratory volume in one second 
FHS HREC  Faculty of Health Sciences Human Research Ethics Committee 
FVC   Forced vital capacity 
 
GDP   Gross Domestic Product 
 
Hazchem  Hazardous chemicals 
HMW   High molecular weight 
HP   Hypersensitivity pneumonitis 
 
IgE   Immunoglobulin-E 
IrIA   Irritant-induced asthma 
 
LoD   Limit of detection 
LMW   Low molecular weight 
 
MSDS   Material Safety Data Sheet 
 
NO   Nitrous oxide 
NIOH   National Institute of Occupational Health 
 
OA   Occupational asthma 
OC   Occupational conjunctivitis 
OCSA   Occupational Society of South Africa 
OD   Occupational dermatitis 
OHSA   Occupational Health and Safety Act 
OR   Occupational rhinitis 
 
PEFR   Peak expiratory flow rate 
PPE   Personal protective equipment 
 
RADS   Reactive airways dysfunction syndrome 
 
TLC   Total lung capacity 
 
WEA   Work-exacerbated asthma 
WHO   World Health Organisation 
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There have been very few studies that have investigated the prevalence of respiratory 
symptoms in brewery workers.  This study provides a description of the demographic profile 
of workers in a South African brewery with particular reference to personal and occupational 
characteristics.  The prevalence of work-related respiratory symptoms associated with 
allergic respiratory outcomes among the workers in different exposure groups are presented. 
A discussion of the relationship between these symptoms and host and work-related factors, 
followed by recommendations, concludes the study.  
 
Chapter 1  
Introduces the reader to the background to the study within its global, South African and 
industrial contexts.  The problem and scientific rationale are presented, aim and research 
question identified and research objectives stated.  
 
Chapter 2  
Presents the background and literature reviewed.  It describes the working population at risk. 
Properties, characteristics and health effects of malt dust, food dust particulates, chemicals, 
gases, vapors and fumes are related.  Respiratory outcomes, environmental and host risk 
factors are discussed.  An overview of previous studies is given.  Significance and relevance 
for health, and the purpose of the study concludes the chapter.  
 
Chapter 3  
Outlines the study design selected and considered most appropriate for this study. The 
rationale thereof, the study setting, study population, brewing process and methodology 
employed, is discussed.  The sampling approach and recruitment, including inclusion and 
exclusion criteria, are described.  Ethical considerations of the study are related.  The 













Chapter 4  
Presents the research analysis and findings that are derived from the specific research 
objectives that address the research question.  Univariate, bivariate and multivariate logistical 
regression models were used to investigate the association between upper and lower 
respiratory symptoms, host factors and specific chemical and biological agents, and 
respiratory outcomes.  Measures of disease association were evaluated by means of Chi2 test 
prior to regression models.  Results are presented by means of tables and statistical 
summaries including odds ratios (unadjusted and adjusted) and their confidence intervals. 
 
Chapter 5  
Presents a discussion of the findings.  Reference is made to relevant and available literature 
reviewed in Chapter 2, expanding on main trends.   
 
Chapter 6 
Concludes the study.  Limitations of the study, implications and recommendations will be 
included in this chapter.  A summary of findings and discussion concludes the study. 
 
1.2 Occupational Health:  The global context   
Work can be hazardous to one’s health and to ones safety.  Nearly half of the world’s 
population of 6 billion people are workers, of which an estimated 90% live and work in 
developing countries, contributing greatly to both economic and social development 
worldwide (WHO 2007).  Approximately 40% of these workers are employed in potentially 
hazardous sectors.  Global estimates focusing on the contribution of occupational exposures 
to ill health, indicates that selected risks at work resulted in the loss of 24 million years of 
healthy life and caused 850,000 deaths worldwide in 2000 (Adams, Morar, Kolbe-Alexander 
& Jeebhay 2007). 
 
Hazards in the workplace, together with social and individual factors, and access to health 
services, may impact on the health and safety of workers.  To address these issues, the World 
Health Organisation and other organisations have come together with strategies, policies and 
programs to target, in particular, developing countries with occupational initiatives.  This is in 
order to prevent occupational hazards and to protect and promote health at the workplace 












National policies and plans for the implementation, monitoring and evaluation of a ‘Global 
Plan of Action on Workers health 2008 – 2017’, together with appropriate mechanisms and 
legal frameworks, is being promoted at both national and international levels. This is in 
collaboration with workers, employers and their organizations (World Health Organisation 
2007).  It includes the incorporation of workers health into national policy, the establishment 
of appropriate evidenced-based health programs, services and surveillance systems in the 
primary prevention of work-related hazards and diseases, and the development of 
comprehensive health and non-health strategies to ensure reintegration of sick and injured 
workers into the mainstream of society (World Health Organisation 2007). 
   
1.3 Occupational health: The South African context 
Workers accounted for 17 million of the economically active population in 2006.  This figure 
represented a marked growth and was particularly observed in both the informal sector and 
women applicants, with women accounting for six in ten of all new labour force entrants 
(Adams et al. 2007).  
  
Occupational illness and disease pose an enormous cost to the South African economy.  A 
study commissioned by the Department of Labour in 1997 estimated the cost to equate to 
R17 billion which translated to 3.5% of the Gross Domestic Product (Adams et al. 2007).  As 
Public health care provision in South Africa is influenced by legislative requirements, so too 
is health care provision in the workplace.  There are statutes that govern occupational health 













Table 1: South African legislation pertaining to occupational health and safety, health service provision 




As far as health care financing is concerned, the government, financing 44% of health care, 
has been identified as the largest source thereof.  Other sources include household (making 
contributions to medical schemes, private insurance or direct out-of-pocket payments for 
health care services), donors and non-governmental organizations (Adams et al. 2007).  
Health care in the workplace may be provided by means of contributions to private health 
insurance companies and employer-funded occupational health services.  There is, however, 
no obligation on employers to do so.  As a result thereof, employer-funded workplace-based 
clinics only service a fraction of workplaces and are limited to the services they offer.  This is 
influenced by legislative requirements, employment patterns, the nature of the industry, 
associated hazards and availability of and access to health care outside of the workplace 













1.4 The food and beverage industry in South Africa 
The total income generated by the food and beverage industry over the three months ended 
April 2010 increased by 4.6% to R8.6 billion, compared with the three months ended April 
2009 (Statistics South Africa 2010).  
 
Central to this study, is that of the liquor industry which has developed into a major force 
worldwide.  In an independent study, ‘The Econex Report 2010’ (Econex 2010), it was 
determined that in the South African economy, this industry and its suppliers provided 
employment to about 87 000 workers and generated tax revenue in excess of R19-billion 
during 2009.  This study estimated that, including all multiplier impacts (in process of 
manufacturing, packaging, marketing and delivering alcoholic beverages), the liquor industry 
contributed R94.2-billion or 4.4% to GDP in 2009, generating in excess of R41-billion in 
government revenue, and sustained close to 550,000 jobs (Econex 2010).  
 
1.5 The brewing process   
 
Figure 1: Adapted from ‘Stellman, J.M. 1998. Encyclopaedia of occupational health and safety.fourth 












Brewing is the production of beer through steeping a starch source, commonly cereal grains 
such as barley or wheat, in water, and then fermenting the yeast.  The basic ingredients of 
beer include water, malt, maize and hops.  As beer is composed mostly of water, and mineral 
content of regions differ, different regions are suited to make different beers (Nelson 2005).  
Although brewing can be viewed as an art, there are also several fundamental steps in the 
brewing process. 
 
Raw materials are received, unloaded and stored.  These may include starches (including 
maize and barley), malt (including malted barley and black malt), hops, liquid adjunct 
(consisting of maltose, dextrose and sucrose), yeast, calcium sulphate, calcium chloride, 
oxygen and carbon dioxide. 
 
Malting, the first step in beer making, is a process whereby grain is steeped in water and 
allowed to soak, allowing it to begin germinating in order to develop enzymes to convert the 
starch in the grain to sugar.  This process is stopped by heating and the drying of the cereal, 
often in a kiln, the degree of which influences both flavor and colour of the beer.  Dust and 
husks are removed.  Milling is the process whereby malt is crushed in order to break open the 
grain kernels, allowing easier absorption of water which extracts sugar from the malt.  A 
small amount of lactic acid is added to adjust the PH.  The milled grain is then dropped into 
hot water  in a large vessel called a ‘mash tun’ and, by a process known as mashing,  mixed 
to a ‘porridge’, with time and temperature according to brew.  In the Lauter Tun this mixture 
is laid to rest on a false bottom, and, whilst water sprayed over it, slowly moved with large 
rakes, in order to remove as much sweet wort as possible.   
 
The wort is then boiled in the Wort Kettle at a specific temperature for a specific time 
according to the brand.  Hops that is responsible for the bitterness and distinct aroma of the 
beer, is added.  Calcium Sulphate is dosed automatically, and Calcium Chloride, salt and 
liquid adjunct also added.  It is within the Whirlpool that the wort is separated from the solid 
particles, leaving through the sides, the remaining solid particles used for cattle feed.  Wort, 
heated and rapidly cooled in the heat exchanger, passes to the cellars where yeast, added to 
produce fermentation, converts the fermentable sugars into alcohol and carbon dioxide.  After 
about 2 weeks the ‘fermentation’ is sent to maturation, where the cold conditioning process, 












particles, and, following the testing of carbon dioxide content, colour, aroma and taste, the 
final product is packaged for distribution far and wide (Stellman et al. 1998). 
It is within the context of the food and beverage industrial setting, that of a brewery in South 
Africa, that this study takes place. 
 
1.6 Background to the study 
A brewery worker developed work-related asthma following exposure to inhalable malt dust, 
despite all precautionary measures taken to remove him from highly exposed areas at the time 
of his first episode six years previously.  Patterns of sensitization to malt dust and other 
allergens were subsequently identified and occupational asthma diagnosed, for which he was 
compensated.  Due to more frequent episodes of bronchospasm to malt dust and other 
allergens or irritants, at work and at home, he was granted permanent disability.  
 
A number of the brewery workers in this factory are exposed to various irritants and 
allergens, including that of malt dust.  Annual dust monitoring has revealed varying exposure 
levels to malt dust these past few years.  Exposure levels have been, at times, over the 
legislated recommended limit of 10 mg/m3, with some malt intakes more ‘dusty’ than others.  
Occasional distribution of malt dust is dispersed all over the plant, such as on a very windy 
day.  Engineering control measures to contain the dust and limit the number of employees 
exposed to this dust, by means of the use of an extractor system and curtains to enclose malt 
intake area, have been, at times, dysfunctional.  This has resulted in greater dispersion of, and 
over-exposure of employees, to this dust.  Although grain is normally emptied into the silos 
by means of an extractor system from base of the train carts, grain is not always transported 
to the brewery by train.  Tipper trucks are also used.  The emptying of grain from tipper 
trucks generates far more dust than that from the train.  Of note, however, is the subsequent 
enclosure of sides of the malt intake area with metal plates a few months ago.  This, together 
with the re-institution of the extractor system, when in use, has had a positive impact on 
reducing the dust levels. 
 
1.7 Statement of Problem  
The level of exposure to a causative agent at work is the major determinant of risk for the 
development of occupational asthma (Nicholson, Cullinan, Burge & Boyle 2010).  Evidence-












cornerstones of patient management for patients with immunological occupational asthma 
(OA) (Nicholson et al. 2010).   
 
A regular health surveillance program consisting of annual medical, various questionnaires 
and specified tests are conducted on an annual basis on workers in the brewery exposed to 
known sensitizers, irritants or allergens in the workplace.  Those employees identified as 
exposed to noise, to certain dusts, chemicals, gases, vapors and fumes, as legislated, are 
included in this program.  
 
Despite the present surveillance program in place, a sentinel health event resulted in 
subsequent granting of permanent disability to an employee with asthma exposed to malt dust 
and other allergens over time.  The prevalence of respiratory problems in this brewery setting 
is, largely, unknown.   
 
1.8 Rationale for the study 
Although there have been significant contributions to the knowledge base around asthma and 
allergens, what will be revealed in the literature review is the paucity of both international 
and national literature on respiratory health of brewery workers.  Whilst a number of studies 
have described the harmful effects of exposure to grain dust on lung function, namely the 
development of respiratory disease amongst grain workers, only a few studies have 
investigated the respiratory health of brewery workers, particularly in relation to malt dust 
and other chemical agents used in the production process.  No studies have documented the 
prevalence of work-related respiratory problems and associated risk factors within a brewery 
in South Africa. 
 
1.9 Aim of Study 
To conduct a respiratory health survey within a brewery in South Africa in order to document 
the prevalence of work-related respiratory problems and associated risk factors.   
 
1.10 Research question identified 
What is the prevalence of work-related respiratory problems and associated risk factors 












1.11 Research objectives 
i. To describe the demographic profile of the workforce in relation to personal and 
occupational characteristics.  
 
ii. To classify the subjects into 3 exposure groups based on subjective levels of exposure 
to dusts, chemicals, gases, vapors and fumes in different departments.  This was based 
on the principle investigators prior knowledge and assessment of departmental levels 
of exposure to chemical and biological dusts, chemicals, gases, vapors and fumes.  
Prior knowledge of the principle investigator to the levels of these exposures was built 
on current risk assessments and level of medical surveillance to which each 
department was currently subjected to, at the brewery.  Exposure levels included: 
• High exposure: Brewing (Including Utilities), Logistics.  
• Medium exposure:  Packaging, Warehouse, Laboratory (Including QAQC). 
• Low exposure:  Administration (Including Sales and Distribution).    
 
iii. To determine the prevalence of work-related respiratory symptoms associated with 
allergic respiratory outcomes (rhino-conjunctivitis, asthma, extrinsic allergic alveolitis 
and chronic bronchitis) among workers in these different exposure groups. 
 
iv. To document the relationship between work-related respiratory symptoms reported 
and potential risk factors for disease with specific reference to: 
• Host factors:  Age, gender, smoking status, atopy (allergic tendency), previous 
family history (of allergy, hay fever or asthma); 
• Work-related factors:  Exposure group category (to dusts, chemicals, gases, 
vapors or fumes) 
 
1.12 Conclusion 
The background to this study within its global, South African and industrial contexts has been 
presented.  The problem has been described, aim and research question identified, and 














LITERATURE REVIEW  
 
2.1 Introduction 
This chapter will present the background and literature reviewed, with particular reference to 
the prevalence of respiratory problems, including asthma and allergy.  Particular emphasis 
will be placed on these health outcomes within the brewery setting, and the working 
population at risk.  Properties, characteristics and health effects of malt dust, food dust 
particulates, chemicals, gases, vapors and fumes will be related.  Respiratory outcomes, 
environmental and host risk factors will be discussed.  An overview of previous studies will 
be given.  Significance and relevance for health, and the purpose of the study will conclude 
the chapter.  
 
2.1.1 Background and review of the literature 
A worker developed work-related asthma associated with exposure to malt dust and other 
grain dust allergens in a brewery over a period.  The prevalence of respiratory problems in 
this brewery setting is unknown.  
 
The aim of the study was to determine the prevalence of respiratory problems, including 
asthma and allergy, as well as patterns and factors associated with these outcomes, within a 
brewery setting, in order to identify groups of workers that may be potentially at risk of 
developing respiratory outcomes.  The purpose of this review was to gain a better 
understanding and insight into respiratory health and risk factors associated with this industry 
and workforce.  The ultimate aim would be the protection and promotion of respiratory health 
in the workplace. 
 
The literature review included internet searches of both Google and Google Scholar, and 
electronic databases of CINAHL and Pub Med.  Other sources included government gazettes, 
books, journal articles and articles of interest.  All articles that were considered relevant and 












The search was limited to the keywords which included: Brewery workers; respiratory 
symptoms; asthma; work-related asthma; rhinitis, work-related rhinitis; occupational asthma; 
occupational rhinitis; work-related chest symptoms; immunological sensitization; 
occupational exposure; occupational allergens; occupational irritants; work-exacerbated 
asthma; chronic obstructive pulmonary disease; chronic bronchitis; respiratory health; malt 
dust; food; plants; barley; insects; rhodents; pests; dusts; chemicals; gases; vapours; fumes. 
 
Incidence studies appeared to be uncommon, with prevalence studies remaining the most 
widely done investigations. 
 
2.1.2 Working population at risk 
The food industry employs a large proportion of workers, many of which are exposed to 
potential allergens capable of occupational allergy and asthma (Van der Walt, Lopata, 
Nieuwenhuizen & Jeebhay 2010).  A variety of food, food additives and food contaminants 
have been identified as associated with these outcomes. 
 
The primary risk of exposure to food allergens is by means of the inhalation of dust, steam 
and vapors of aerolized proteins.  Those at risk would, therefore, include those involved in 
the cutting, scrubbing, cleaning, cooking, boiling and drying activities of these products 
(Cartier 2010). 
 
As in the food industry, the South African liquor industry has developed into a major force in 
the South African economy, supporting thousands of jobs related to these sectors.  Workers 
are exposed to various products in the production process.  Of particular note, is the reporting 
of exposure, although not excessive, to grains and to malt dust, in the brewing industry, as an 
important risk factor for the development of respiratory disease amongst brewery workers 
(Godnic-Cvar, Zuskin, Mustajbegovic, Schachter, Kanceljak, Macan, Ilic, & Ebling 1999).  
Resultant symptoms may vary from mild local to severe systemic allergic reactions.  
 
As far as breweries and grain dust is concerned, the exact numbers of workers exposed to 
grain dust is unknown since so many occupations are involved (Chan-Yeung, Ashley, & 
Grzybowski 1978).  Occupational exposure to malt dust, however, occurs mainly at the malt 












Working populations at risk include farmers, industrial workers exposed to the grain, workers 
employed in the storing and packing of the grain,  malt workers and brewery workers that are 
involved in malt intake, and workers involved in raw material handling and in the transferring 
of grain or malt to silos for storage, logistics, maintenance and repairs (Riddle 1974; Grant, 
Blackadder, Greenberg & Blyth 1976; Chan-Yeung et al. 1978; Ellis & Friend 1981; 
Stellman et al. 1998; Heaney, McCrea, Buick & MacMahon 1997; Godnic-Cvar et al. 1999 & 
Bernstein, Bernstein, Chan-Yeung & Malo 2006). 
 
2.2 Grain dust and its characteristics 
Grain dust is generated by the abrasive action of the kernels when the grain is being handled  
(Bernstein et al. 2006) whether whilst harvesting, receiving, grading, weighing, milling, 
baking, storage, cleaning, transport, loading or offloading.  The levels of grain dust is 
influenced by the type of grain handled, the degree of activity, the extent of enclosure, the 
efficiency and upkeep of exhaust ventilation provided at transfer points, and work and 
housekeeping practices (Bernstein et al. 2006). 
 
The physical and chemical composition of grain dust varies according to the geographic site, 
the type of grain, the wetness of the area, storage temperature and other factors.  Grain has 
variable components including fractured grain kernels, fractured weed seeds, storage mites, 
insects, bacteria, moulds, silica and chemicals such as pesticides and insecticides, many 
particles of which are respirable (Bernstein et al. 2006).  Certain grains may precipitate 
certain symptoms in individuals.  Barley and oats contain many needle-like fragments 
compared to other types of grains and many grain workers complain that their symptoms are 
worse when they handle these grains (Bernstein et al. 2006).  The allergenicity of grains are 
not always comparable.  The allergenicity of milled grain, according to Baatjies & Jeebhay 
(2002), may be greater than unmilled grain (Baatjies & Jeebhay 2002).     
 
The microflora of grain dust also changes during various processes.  During harvesting many 
fungi produce spores which become airborne in large quantities such as Cladasporium and 
Alternaria.  This production of spores, however, changes during storage, depending on water 
content, the degree of spontaneous heating and the aeration of the grain bulk, where fungi 












Storage mites, the number of which is directly related to the water content of the dust, are 
also found in grain dust, together with particles from weevils, insects, rodents, birds, and their 
excreta (Bernstein et al. 2006).  According to Jeebhay, Baatjies & Lopata (2005), allergens 
from the storage pests, mealworm and cockroach, in grain-mill dust, is a significant predictor 
of work-related asthma symptoms, particularly evident in atopic workers who demonstrated 
increased IgE reactivity to mealworm and cockroach associated with work-related asthma 
symptoms (Jeebhay, Baatjies & Lopata 2005).  Other components such as herbicides, 
aluminium phosphide and other types of pesticides, and chemicals such as fumigants, 
commonly used in agriculture and storage, can be absorbed through the skin, swallowed, or, 
more frequently, inhaled. The pathogenicity of all these components, on the respiratory health 
of workers, is not known (Bernstein et al. 2006). 
 
2.3 Biochemical/Immunological properties of malt dust and allergens 
Exposure to malt dust or other types of allergens may lead to the development of acute and 
chronic respiratory symptoms accompanied by lung function and immunological changes.  
The routes of exposure to, for example, malt dust, a food-derived protein allergen, are 
primarily through inhalation and occasionally cross-reactivity through ingestion, inducing 
allergic or immunologic diseases, that include occupational rhinitis (OR), occupational 
conjunctivitis (OC), extrinsic allergic alveolitis (EAA), hypersensitivity pneumonitis (HP) or 
occupational asthma (OA) (Sikora, Cartier, Aresery, Wild & Lehrer 2008).  
 
Malt dust is allergenic and capable of eliciting a type-1, IgE-mediated reaction in sensitive 
individuals.  A worker’s initial contact with the antigen, e.g. malted barley, is followed by a 
latent sensitization period of weeks or years between first exposure and development of 
symptoms, depending on the allergen type, followed by the development of symptoms on 
exposure to even very low doses of the allergen and the onset of clinical disease, for example, 
occupational asthma (Jeebhay 2010). At this stage, exposure to non-specific irritants may 
even trigger a reaction.  It is noted, however, that whilst the latent interval can extend to 
many years, the risk of occupational asthma appears to be highest in the first few years of 













Figure 2: Natural history of occupational asthma, risk factors for disease onset and  progression (Source: 
http://www.asthma-workplace.com/en/information/modelused) 
 
2.4 Health effects of food dust particulates (e.g. grain and malt dust), 
chemicals, vapors, fumes and gases 
Occupational lung diseases, such as asthma, extrinsic allergic alveolitis and chronic 
obstructive pulmonary disease (COPD) are caused by exposure to airborne particles.  These 
diseases  present major health challenges, with significant potential for acute morbidity, long-
term disability, and adverse social and economic impacts (Tarlo, Balmes, Balkissoon, Beach, 
Beckett, Bernstein, Blanc, Brooks, Cowl & Daroowalla 2008) on workers and society as a 
whole (Malo & Chan-Yeung 2007).  Although occupational asthma is the most common 
occupational lung disease in industrialized countries and the second most common 
occupational lung disease after pneumoconiosis in developing countries (Table 2), 
occupational asthma remains under-recognised, poorly managed and inadequately 













Table 2: Occupational diseases reported to the Compensation Fund for the non-mining sector in South 




2.5 Work-related asthma 
World- wide, an estimated 300 million people of all ages and ethnicities, suffer from asthma, 
the prevalence of which range from 1% to 18% in various populations (Dykewicz  2009).  
Estimates of the incidence and prevalence of occupational asthma vary, due partly to 
inconsistent definitions, diagnostic criteria, and variable work settings as well as limited 
surveillance data.  Although the true frequency of the disease is not known, occupational 
factors are estimated to account for about one in six cases of asthma in adults of working age.  
This includes new onset or recurrent disease.  The annual population incidence of 
occupational or work-related asthma ranges from an estimated 12 to 300 cases per million 
workers (Nicholson et al. 2010).  Occupational asthma occurred in 3% to 10% of workers 
exposed to green coffee beans (Sikora et al. 2008) and in 16% of snow crab processing 
workers (Cartier, Malo, Forest, Lafrance, Pineau, St-Aubin & Dubois 1984).  In a cross-
sectional study of 517 supermarket bakery workers in 31 bakeries in South Africa, the 
presence of probable occupational asthma was 13% (Baatjies, Lopata, Sander, Raulf-













It is generally accepted that between 9% to 16% (Blanc & Toren 1999, Balmes et al. 2003, 
Henneberger 2007, Tarlo et al. 2008, Dykewicz 2009; & Cartier 2010) of adult onset asthma 
can be attributed to workplace exposures or occupational factors.  This figure is rising, with 
recent data indicating that 25% or more of de nova asthma may have an occupational basis 
(Dykewicz  2009).  According to Henneberger (2007), 45% of all work-related asthma cases 
attributable to asthma, is not caused by, but exacerbated by work (Henneberger 2007).   
 
Several hundred agents have been reported to cause occupational asthma, and new cases are 
being reported regularly (Nicholson et al. 2010).  Cartier (2010) states that, in food industries 
in which the prevalence of occupational asthma is available, rates of occupational asthma do 
not differ significantly from those found in non-food industries, that both individual and 
industrial factors are associated with asthma (Cartier 2010).  Most frequently reported agents 
include isocyanates, flour and grain dust, colophony and fluxes, animals, aldehydes, 
adhesives, metals, resins and wood dust (Nicholson et al. 2010).  The workers most 
commonly reported include animal handlers, bakers and pastry makers, chemical workers, 
food processing workers, hairdressers, paint sprayers, nurses and other health professionals, 
timber workers and welders (Nicholson et al. 2010). 
 
Whilst occupational asthma is the most common occupational lung disease in industrialized 
countries, it is the second most common occupational lung disease reported, after 
pneumoconiosis, in developing countries (Jeebhay & Quirce 2007). The reported mean 
annual incidence of occupational asthma in developing countries is less than two per 100 000 
population, compared to very high rates of up to 18 per 100 000 population in Scandinavian 
countries. There are, however, also regional differences in existence in South Africa, with a 
much higher incidence reported in the highly urbanized Western Cape Province of 2.5 per 
100 000 population compared to that of 1.8 per 100 000 population in South Africa (Jeebhay 
& Quirce 2007). 
 
Work-related asthma (WRA) can be generally defined as, and includes, occupational asthma 
(OA) or asthma caused by conditions or specific agents in the workplace and work 
exacerbated asthma (WEA) or pre-existing asthma exacerbated or worsened by work.  There 
are two main forms of OA:  Sensitizer-induced OA, caused by sensitizers at work, such as 
malt dust, is characterized by a latency period required for developing allergic sensitization 












of occupational asthma are of the allergic type (Nicholson et al. 2010).  According to 
Douwes, Gibson, Pekkanen & Pearce (2002), however, a substantial proportion of work-
related asthma is non-allergic, one type of which is frequently referred to as irritant-induced 
asthma (Douwes et al. 2002) and relatively common in occupational populations.  Causal 
exposures are diverse, and often present in the general environment. In contrast to allergic 
asthma, previously unexposed subjects can develop symptoms and reversible airflow 
obstruction without any prior sensitization or latency period.    
 
Non-allergic occupational asthma is mediated by an acute inflammatory response and the 
subsequent massive infiltration and activation of neutrophils in the lower and upper airway.  
This is very similar to the inflammatory response observed in non-eosinophilic asthma in the 
general population (Douwes et al. 2002).  This may follow single or multiple exposures to 
irritant compounds such as forms of dusts, vapors, fumes or gases (Henneberger 2007).  
 
Most low molecular weight chemicals encountered in the workplace can induce airways 
disease.  Most low molecular weight (LMW) chemicals are irritants.  If exposure levels are 
high enough or if there is extended exposure, these chemicals can cause inflammation of the 
eyes, respiratory tract and alveolar membrane without antibody production or involvement of 
cellular mechanisms.  Reflex or inflammatory bronchoconstriction may result (O’Neil 1990) 
At lower concentrations, some of these LMW chemicals are hapenic and induce respiratory 
symptoms by immune mechanisms.  Dose, duration of exposure, physiochemical properties 
of the agent and host factors influence the effect that a given agent may have on the 
individual (O’Neil 1990).  According to Douwes et al. (2002), the primary agent inducing 
these inflammatory responses in workers exposed to organic dust is believed to be bacterial 
endotoxin.  Macrophages carry specific endotoxin binding receptors, namely CD14 or TLR4, 
that play a crucial role in the activation of these cells and the subsequent inflammatory 
reactions (Douwes et al. 2002). Irritant occupational asthma includes Reactive Airways 
Dysfunction Syndrome (RADS) which is a syndrome which develops within 24 hours after a 
single, high dose exposure to high levels of an irritating vapor, fume or smoke.  Chemicals 
involved in this type of asthma, amongst others, include chlorine, sulfur dioxide and 
ammonia.  Due to the initial injury the bronchial epithelium becomes denuded and loses its 













Work-exacerbated asthma, on the other hand, is the worsening of asthma due to workplace 
conditions and can be triggered by physical factors (e.g. extreme temperature and exercise), 
behavioral states (e.g. strong emotions, stress), odors (e.g. perfume), general irritants and 
dust, and second hand cigarette smoke (Henneberger 2007) (Fig.3:  Classification of work-
related asthma).   
 
 
Figure 3: Classification of work-related asthma (Jeebhay 2010) 
 
It has been suggested, generally, that OA has a poor prognosis and is likely to persist and 
deteriorate unless identified early and managed effectively (Nicholson et al. 2010).  The 
likelihood of improvement or resolution of symptoms, or of preventing deterioration, is 
greater in workers who avoid further exposure to the causative agent, and who have relatively 
normal lung function and shorter duration of symptoms at the time of diagnosis (Nicholson et 
al. 2010). 
 
Reducing airborne exposure by means of substituting the agent with a less harmful agent, 
engineering and hygiene measures, including use of respiratory protection and worker 
education and training, can prevent the onset of OA and the numbers of workers who become 
sensitized, later developing asthma.  Redeployment to a low exposure area may lead to 
improvement or resolution of symptoms or prevent deterioration in some workers, but is, 












protective equipment may reduce but not completely prevent occupational asthma, which 
should be considered in all workers with symptoms of airflow limitation (Nicholson et al. 
2010).   
 
In order to detect sensitized individuals or cases of asthma at the very early, reversible stage 
of the occupational asthma, an adequate health surveillance program, including the use of a 
respiratory questionnaire, spirometry, and where appropriate, identification of specific 
Immunoglobulin-E (IgE) by skin prick test or serology, may be used.  It has been suggested, 
however, that screening questionnaires may underestimate the prevalence of occupational 
asthma, that questionnaires are insensitive.  As far as other tests are concerned, depending on 
the quality of recorded series, the sensitivity and specificity of serial peak flow measurements 
can be high for the diagnosis of occupational asthma (Nicholson et al. 2010).  Both skin prick 
and serological tests are sensitive for detecting specific IgE and occupational asthma caused 
by most high molecular weight (HMW) agents but are not specific for diagnosing asthma 
(Nicholson et al. 2010).  Overall, both skin prick and serological tests are less sensitive for 
detecting specific IgE and occupational asthma caused by low molecular weight (LMW) 
agents and while specificity may be higher, they are not specific for diagnosing asthma 
(Nicholson et al. 2010).  Carefully controlled specific challenges come closest to a gold 
standard test for some agents causing occupational asthma (Nicholson et al. 2010).  As with a 
normal exhaled nitric oxide test not excluding the diagnosis of occupational asthma, in the 
clinical setting the absence of sputum eosinophilia does not exclude a diagnosis of asthma 
(Nicholson et al. 2010).   
 
It has been related that workers with occupational asthma suffer financially, that 
approximately one third of workers with occupational asthma are unemployed up to six years 
after diagnosis (Jeebhay 2010).  It has, therefore, been suggested, that in cases of established 
disease, adequate management including timely reporting and compensation thereof where 
necessary, is essential, in order to minimize the effects thereof (Nicholson et al. 2010).   
 
2.6 Extrinsic Allergic Alveolitus (Hypersensitivy  Pneumonitis) 
Extrinsic allergic alveolitis (EAA) is an immunologically mediated inflammatory disease 
involving the terminal airways of the lung associated with intense or repeated exposure to 












followed by granuloma formation and eventually irreversible pulmonary fibrosis in the 
untreated patient (Sikora et al. 2008).  This disease can progress to a disabling or even fatal 
end-stage lung disease. 
 
According to Sikora et al. (2008), the incidence of EAA, as compared to WRA, is difficult to 
determine because of the disease’s general low occurrence, problems with differential 
diagnosis, and the lack of prospective epidemiologic studies.  Incidence depends on exposure 
levels of the offending antigen and varies widely in different industries or even in areas of the 
same plant.  Both industrial and individual factor, such as atopy, genetic predisposition, 
cigarette smoking and possible pre-existing non-specific bronchial responsiveness, are 
associated with an increased risk of developing occupational hypersensitivity (Sikora et al. 
2008). 
 
2.7 Chronic Obstructive Pulmonary Disease 
Cigarette smoking has been identified as the most commonly encountered risk factor for the 
development of Chronic Obstructive Pulmonary Disease (COPD), accounting for over 75% 
of the cases of the disease (Naidoo 2010).  According to Rabe, Hurd, Anzueto, Barnes, Buist, 
Calverley, Fukuchi, Jenkins, Rodriquez-Roisin & van Weel (2007), a wide variety of 
occupational exposures, including that of organic and inorganic dusts such as grain dust, 
chemical agents and fumes, have the potential to cause COPD if exposure is high and over a 
long period of time, and account for 10% to 20% of either symptoms or functional 
impairment consistent with this disease (Rabe et al. 2007, Naidoo 2010).  If not the cause, 
one’s occupation, directly or in combination with tobacco smoke, may result in greater 
severity of the disease, greater disability and acceleration of loss of lung function among 
those with the disease (Naidoo 2010).  However, not all who have similar exposures to 
smoking, environmental or occupational agents develop the disease.  Consideration needs to 
be taken of other factors in a working population.  Genetic components highly implicated in 
COPD pathogenesis include that of a severe hereditary genetic deficiency of α-1antitrypsin 
(Naidoo 2010).  Other risk factors are ageing, gender, respiratory infections (including 
Tuberculosis and childhood infections), socio-economic status, and indoor air pollution, such 
as the use of biomass as a source of energy which has been strongly linked to the 













Chronic obstructive pulmonary disease globally, both in developed and developing countries, 
is associated with increased morbidity and mortality worldwide and is largely preventable 
(Naidoo 2010).  This disease is characterized by airflow limitation associated with abnormal 
inflammatory response of the lung to exposures such as noxious particles and gases, that is 
usually progressive and not fully reversible.  Other symptoms include the presentation of a 
chronic productive cough, airway hyper-responsiveness and breathlessness to differing 
degrees (Naidoo 2010).  The pathogenesis of COPD is related to the inflammatory response 
to noxious inhalants, resulting in the release of destructive proteolytic enzymes from 
inflammatory cells, eventually resulting in airway remodeling (Rabe et al. 2007).   
 
This multi-factorial and progressive respiratory disease is strongly associated with both 
occupational and non-occupational exposures.  Chronic obstructive pulmonary disease is the 
sixth leading cause of death in developing countries.  This disease is responsible, according to 
the 2001 World Bank/World Health Organization Global Burden of Disease Report:  2004 
update, in 2001, for 4.9% of deaths (Naidoo 2010). It has been predicted, according to the 
World Health Organisation, Global Burden of disease report:  2004 update, that the non 
communicable disease burden, which includes COPD, will increase to 66% by the year 2030.  
This is due to factors such as the increase in an ageing population and increase in cigarette 
smoking (World Health Organisation 2009).   
 
2.8. Environmental risk factors for work-related asthma: Sensitizing power 
of the allergen, work processes, dust exposure concentration and duration 
of exposure 
Other than the intrinsic physicochemical and immunogenic properties of agents, and route of 
exposure, the most important risk for developing OA is the level and duration of exposure to 
agents capable of causing OA.  Industrial hygiene and engineering practices also influence 
the potential of occupational agents to induce allergic disease (Sikora et al. 2008).   
 
According to Cartier (2010), it is difficult to distinguish between roles of the sensitizing 
powers of the various foods or allergens and that of certain processes and exposure levels 
regarding level of exposure and risk afforded to the worker (Cartier 2010).  Literature has 
revealed the high allergenicity of grain dust, with some grains, such as barley and oats, 












10mg/m3 TWA of total inhalable dust (Government Gazette 2005). This standard is, 
however, less conservative than international standards and not always applicable and 
acceptable.  A 4mg/m3 TWA has been recommended by the American Conference of 
Industrial Hygienists (ACGIH). 
 
Dust concentration can vary considerably, and can depend on factors such as to whether a 
ventilation and extractor system is in place and is functional.  It is likely that the effect on the 
respiratory system and/or development of sensitization varies with the concentration, and is 
dose-dependent (Chan-Yeung et al. 1978; Jeebhay 2010; Nicholson et al. 2010).  This has 
been demonstrated in a number of occupational settings (Nicholson et al. 2010), such as those 
in bakery, crab, prawn and pilchard (Jeebhay 2010). The quality of the grains too, differs.  
Some grain has been partly cleaned during its transport which may account for low frequency 
of effects, such as grain fever, on the grain workers.  Whilst a positive correlation between 
the frequency of respiratory symptoms and the number of years of exposure in non smoking 
workers in grain elevators has been found, in other studies such a correlation was difficult to 
establish (Chan-Yeung et al. 1978). 
 
2.9 Host risk factors for work-related asthma 
While the concentration and the quality of dust influence the frequency and type of clinical 
syndrome in grain workers, host factors are also important, as only a small proportion of 
exposed workers develop occupational reactions (Sikora et al. 2008).  These factors may 
include atopy, genetic predisposition, cigarette smoking, socio-economic and educational 
factors and the presence of occupational rhinitis or occupational conjunctivitis (Sikora et al. 
2008).  According to Cartier (2010), the pre-existence of asthma is not a risk factor for the 
development of Occupational Asthma, unless the individual is atopic (Cartier 2010). 
 
2.9.1 Atopy 
Atopy is a state whereby the subject tends to produce specific immunoglobulin IgE on 
ordinary exposure to common allergens in the subject’s environment (Nicholson et al. 2010).   
Nicholson (2005) states that, as most food allergens are high molecular weight chemicals, 
atopy is the most important risk factor for the development of occupational asthma 
(Nicholson 2005).  Sikora et al. (2008) confirms that, in general, the association, although not 












individuals may often have a personal or family history of hay fever, asthma or atopic 
dermatitis, and exhibit a greater tendency to develop sensitivity to environmental agents than 
do normal subjects.  Although atopic individuals frequently show elevated total IgE levels, 
atopy is not always associated with an increased incidence of OA.  Skin prick testing is often 
used along with a suggestive history to establish a diagnosis thereof (Sikora et al. 2008).  A 
number of studies have reported atopy as increasing the risk of developing occupational 
asthma caused by exposure to many high molecular weight agents that induce the production 
of specific IgE antibodies (Nicholson et al. 2010).  For example, atopy has been found to be 
associated with an increased risk of developing occupational asthma in workers exposed to 
flour (Baatjies et al. 2009).  However, this association was not confirmed in two snow crab-
processing industries (Cartier et al. 1984).  
 
According to Chan-Yeung et al. (1978) the proportion of individuals with atopy in grain 
workers, as judged from positive reactions to SPT with common antigens, appeared to be 
about the same in this working population as in the general population (Chan-Yeung et al. 
1978).  And similarly, atopy was not a major studied factor responsible for the high 
prevalence of chronic respiratory symptoms in male workers employed in a brewery plant 
(Godnic-Cvar et al. 1999)  
 
2.9.2 Genetics 
It has been suggested that grain workers with intermediate serum concentrations of alpha-1 
Antitrypsin (heterozygotes with the MZ phenotype), appear to have, although not confirmed, 
a greater frequency of lung function abnormalities (Chan-Yeung et al. 1978).  He added that, 
if this were to be established, alpha-antitrypsin phenotyping would be able to be 
recommended as a pre-employment screening procedure.  Individuals with the ZZ phenotype 
can be expected to experience severe lung function abnormalities.  However, the frequency of 
this phenotype in the general population is so low (approximately 1:2000) that costly 
screening for the purpose of discovering these individuals would not be justified (Chan-
Yeung et al. 1978).  According to Sikora et al. (2008), certain genetic factors have recently 
been identified that may alter risk for OA (Sikora et al. 2008), although very little data exists, 














Although the role of cigarette smoke, including exposure to second-hand smoke, in the 
development, exacerbation, or pathogenesis of OA is not clear, cigarette smoking can 
increase the risk of developing occupational asthma with some sensitizing agents (Nicholson 
et al. 2010).  Tobacco use has been associated with, according to the report of Global Health 
Risks of exposure to cigarette smoke, globally causing about 71% of lung cancer, 42% of 
chronic respiratory disease and nearly 10% of cardiovascular disease.  It is responsible for 
12% of male deaths and 6% of female deaths in the world and estimated to cause 
approximately 5.1 million deaths globally in 2004 among adults aged 30 years and over 
(World Health Organisation 2009).  
 
As far as occupational asthma is concerned, conflicting evidence is available regarding the 
role of cigarette smoking (Nicholson et al. 2010). Cigarette smoke has been found to increase 
bronchial epithelial permeability.  This might potentially allow inhaled antigens increased 
access to immune-competent cells and an immune respons  (Sikora et al. 2008).  Although 
tobacco smoking has not been found to be consistently associated with increased risk for OA, 
reports of an association between smoking and OA from certain agents suggest that the 
absence or presence of such an association may vary depending on the agent (Dykewicz et al. 
2009).  According to Chan-Yeung et al. (1978), the effects of cigarette smoking has an 
additive effect on grain dust exposure and is the most important factor influencing the 
frequency of chronic bronchitis (Chan-Yeung et al. 1978).   
 
2.9.4 Occupational rhinitis/Occupational conjunctivitis 
There is epidemiological evidence from the general population that rhinitis and asthma 
frequently occur together, possibly as clinical manifestations of a single disorder (Nicholson 
et al. 2010).  Rates of co-morbid rhinitis or rhino-conjunctivitis of between 45% and 100% 
have been reported in subjects suffering from occupational asthma attributed to various 
agents (Nicholson et al. 2010).   
 
Occupational rhinitis and/or occupational conjunctivitis is characterized by ocular symptoms, 
reduced airway caliber and hyper-responsiveness as well as inflammation, and is caused by 
agents in the workplace (Gautrin & Malo 2010).  It has been found that these symptoms are 












1997; Gautrin & Malo 2010; Nicholson et al. 2010).  It is the presence of OR and OC in a 
sensitized individual that may identify patients at greater risk for developing OA (Nicholson 
et al. 2005; Dykewicz et al. 2009).  This risk is highest in the year after the onset of 
occupational rhinitis (Nicholson et al. 2010).   
 
As with OA there are two main forms of OR:  Sensitizer-induced OR, caused by sensitizers at 
work.  These sensitizers are usually HMW agents or LMW agents.  Sensitization by HMW 
agents such as malt dust, is characterized by a latency period required for developing allergic 
sensitization prior to the development of symptoms.  Irritant-induced OR is usually caused by 
LMW agents, without latency, characterized by the onset of rhinitis following exposures to 
irritant compounds, such as chemicals (Gautrin & Malo 2010).  As so far as prevalence and 
intensity of rhino-conjunctivitis is concerned in relation to agents, Malo, Lemiere, Desjardins 
& Cartier (1997) reported the prevalence of symptoms were not different for HMW and 
LMW agents, although rhinitis was more intense for HMW than for LMW agents (Malo et al. 
1997).   
 
2.10 Previous studies of respiratory health in brewery workers 
It was Ramazzini, in 1713, who, observing that workers in granaries and barns, sifting and 
measuring grain, almost all developed shortness of breath and rarely reached old age, 
initiated the clinical diagnosis of the occupational nature of asthma (Breathnach 2000).   
 
Many years later the term ‘extrinsic allergic alveolitis’, was collectively used to describe the 
diffuse pulmonary hypersensitivity to inhaled organic antigens or spores.  This term included 
diseases such as farmer’s lung, bird fancier’s lung, bagossis, and many more.  Although the 
prevalence of extrinsic alveolitis in the brewing industry was not large, malt men were 
potentially at risk.  They would be very ill, often leaving the industry on a voluntary basis 
because they were physically unable to work (Riddle, Channell, blyth, Weir, Lloyd, Amos & 
Grant 1968).  In a study amongst Scottish malt workers, more than half of the malt workers 
were found to have precipitating antibodies in their serum against antigens from mould 
spores of Aspergillus Clavatus, Penicillin Citrinum or Rhizopus Stolonifer.  No correlation, 
however, was found, in that study, between sensitization to these and the presence of chronic 
respiratory disease (Grant et al. 1976).  It was the concentration of the spores more than the 












amongst Hungarian malt workers respiratory illness was attributed to the physical properties 
of the dust inhaled rather than to the many mould spores present (Mickolczy 1958 cited in 
Riddle 1974). It was subsequently suggested that, when conditions were not favorable for 
malting barley at high ambient temperatures, due to damaged or split corns, or grain 
contaminated with mould, the malting should be stopped until conditions improve and 
personal protective equipment (PPE) worn (Riddle 1974).  According to Riddle (1974), high 
quality barley is less liable to fungal contamination than the inferior imported, and often 
damaged, grain which is more likely to cause respiratory disease (Riddle 1974).   
 
Episodes of bronchospasm in non-atopic subjects having precipitins, with a delay in onset 
after exposure to antigens, similar to that in allergic alveolitis, is what Pepys drew attention to 
in industry (Pepys 1969 cited in Riddle 1974).  Although, according to Riddle (1974), illness 
of this nature was not revealed in his present survey (Riddle 1974), many of the workers, 
complaining of symptoms after work, mentioned wheezing (Riddle 1974).  Riddle (1974) 
suggested that, in addition to the men continuing to work in the malting, a large scale survey 
would be justified to investigate the reasons that men leave, and the state of their health 
before and after working in the malting industry (Pepys & Bernstein 1969; Riddle 1974).  
Riddle (1974) suggested they were leaving the industry on a voluntary basis because they 
were physically unsuitable (Riddle 1974).  This was confirmed in a study of Scottish malt 
workers and allergic alveolitis, where Grant (1976) noted most cases were mild, as men with 
more severe disease had possibly left the industry.  He also recommended the replacement of 
old methods by new mechanical processes in order to reduce, if not eliminate altogether, this 
form of extrinsic allergic alveolitis (Grant et al. 1976).  
 
Chan-Yeung et al. (1978) reported grain dust to be composed of a large number of materials.  
These included various types of grain and their disintegration products.  These included 
silica, fungi , insects and mites, hairs and excreta of rodents and pigeons, and chemicals used 
in agriculture and pest control that could be absorbed through skin, swallowed or inhaled 
(Chan-Yeung et al. 1978).  Both acute and chronic respiratory affects of grain dust exposure 
in grain elevator workers, including chronic bronchitis, grain dust asthma, extrinsic allergic 
alveolitis, grain fever, silo-fillers lung, rhinitis and conjunctivitis, has been reported.  Lung 
destruction in a malt worker, initially thought to be extrinsic allergic alveolitis, was found to 
be a cavitating lung disease as a result of Aspergillus Fumigatous infection.  This resulted in 












reticulonodular shadowing, fibrosis and bullae formation.  The lung function revealed a 
restrictive defect and reduction of transfer factor, resulting in progressive breathlessness on 
exertion in the affected worker (Ellis & Friend 1981). 
As suggested by Chan-Yeung et al. (1978), it was not only the type, quantity (concentration) 
and quality (some washed and not so dusty) of grain that influenced the frequency, duration 
and the type of clinical syndrome in grain workers, but also host factors, including smoking, 
atopy and genetic factors.  Chan-Yeung et al. (1978) recommended that studies should 
provide the scientific background for the determination of appropriate threshold limit 
concentration for grain dust.  What was borne in mind, however, was that allergic reactions 
such as asthma and alveolitis may occur with exposure to lower concentrations (Chan-Yeung 
et al. 1978).  It was also recognized that respiratory impairment, continuing into the 
retirement years, was linked with chronic disability (Chan-Yeung et al. 1993). 
 
Although, as far as smoking is concerned, the presence of chronic respiratory symptoms 
increased with the number of cigarettes smoked, the differences, while suggestive, were not 
conclusive in earlier studies (Riddle et al. 1974).  Cause and effect were not apparent 
(Channell et al. 1969), quite unlike data in a later study.  The suggestion that exposure to 
agents in the brewery environment may lead to the development of acute and chronic 
respiratory symptoms accompanied by lung function and immunological changes was made 
as early as 1999 by Godnic-Cvar et al.1999.  Among the 97 male workers employed in a 
brewery plant, occupational asthma was recorded in 2.1% of the brewery workers exposed to 
organic dusts such as hops, barley and brewer’s yeast.  The prevalence of most of chronic 
respiratory symptoms was also significantly higher (P < 0.01) compared to a group of 
unexposed brewery workers.  Suggestive of obstructive changes in smaller airways was the 
evidence in the decreased lung function compared to predicted reference values.  This was 
thought to be possibly due to workplace exposures (Godnic-Cvar et al. 1999).   
 
Immunological changes were evident in the increased prevalence of positive skin prick tests 
of brewery workers exposed to tested allergens, including organic dusts such as hops, barley 
and brewery yeast, compared to controls (P<0.05).  Indicative, also, of a correlation of 
immunologic changes with the work environment, was the increased total IgE serum levels 
(p<0.01) found in 45.1% of brewery workers, compared to only 2.7% of control workers 
(Godnic-Cvar et al. 1999).  Exposures were considered multi-factorial.  It was smoking 












responsible for the high prevalence of respiratory impairment and immunological reactions in 
workers in the brewing industry (Godnic-Cvar et al. 1999).   
 
Schwartz, Thorne, Yagla, Burmeister, Olenchock, Watt & Quinn (1995) suggested the 
concentration of endotoxin in grain dust bio-aerosols may be particularly important in the 
development of grain dust induced airway disease (Schwartz et al. 1995).  Deetz, Jagielo, 
Quinn, Thorne, Bleuer & Schwartz (1997) supported the notion that exposure to malt dust 
could cause airflow obstruction and lower respiratory tract inflammation in human subjects 
(Deetz et al. 1997).  Pepys & Bernstein (2006) maintained that different types of organic 
dusts, such as barley and malt, and various other components had the potential to change 
respiratory function and immunologic status of those exposed (Pepys & Bernstein 2006). 
In another study individuals exposed to hops, barley and yeast, and with potential to develop 
both acute and chronic respiratory problems, were investigated.  The effects of brewery dust 
on guinea pig tracheal smooth muscle were studied.  It was suggested that brewery dust 
extracts cause a dose-related airway smooth muscle constriction by non-immunologic 
mechanisms involving a variety of airway mediators and, possibly, cholinergic receptors 
(Schachter, Zuskin, Rienzi, Goswami, Castranova, Whitmer & Siegel 2001).  Miedinger, 
Malo, Cartier, Labrecque & duSacre-Coeur (2009) emphasized that, following a case of 
occupational asthma to malt and a case of allergic alveolitis in a subject who was initially 
referred for possible occupational asthma,  in workers with respiratory symptoms who were 
exposed to malt, both occupational asthma as well as allergic alveolitis must be considered 
(Miedinger et al. 2009).  
 
According to Bernstein (2006), the agent in grain dust mainly responsible for grain dust 
asthma is unknown, and no information on the true overall prevalence of allergic grain dust-
induced asthma is available, as asthmatics are likely to seek alternative employment and 
leave the industry shortly after starting employment, resulting in a ‘healthy worker effect’.  It 
has also been suggested that a cross-shift decline of lung function observed in grain workers, 
is directly related to the level of dust exposure or endotoxin, and not due to age, smoking 
habit, duration of employment, or atopic status skin reactivity to grain dust antigens.  Grain 
dust-induced asthma may possibly be due to a non-allergic response to some constituents in 
the grain that is not IgE-mediated.  It  has also been suggested that the prevalence of grain 
dust-induced asthma is likely to be low, that atopic status does not appear to be an important 












primarily mediated by an acute inflammatory response and airway obstruction in the 
respiratory tract, in a dose-dependent manner.  This is thought to be primarily due to bacterial 
endotoxin in the grain dust releasing chemical mediators directly in the airways.  This acute 
illness, identified as Grain Fever, was reported in 6% - 32% of exposed workers in different 
studies (Bernstein et al. 2006)  Studies suggest, however, that workers exposed to levels of 
dust less than 1mg/m3 are not at risk of developing rapid decline in lung function (Bernstein 
et al. 2006).  
 
2.11 Significance and relevance for health and purpose of this study 
A review of the literature has revealed that a number of studies have described the harmful 
effects of exposure to grain dust on lung function, namely the development of respiratory 
disease amongst grain workers or workers handling grain products (Williams, Skoulas & 
Merriman 1964; Chan-Yeung et al. 1978; Yap, Chan & Wang 1994; Schwartz et al. 1995; 
Vidal & Gonzalez-Quintela 1995; Deetz et al. 1997; Jeebhay, Stark, Fourie, Robins & 
Ehrlich 2000;  Sigsgaard & Schlunssen 2004; Jeebhay, Baatjies & Lopata et al. 2005; Sikora 
et al. 2008; Baatjies et al. 2009;).  Only a few studies, (Riddle et al. 1968; Riddle 1974; Grant 
et al. 1976; Ellis et al. 1981; Heaney et al. 1997; Godnic-Cvar et al. 1999; Schachter et al. 
2001 & Miedinger et al. 2009), have investigated the respiratory health of brewery workers,  
particularly in relation to dusts, chemicals, gases, vapors and fumes.  No studies have 
documented the prevalence of work-related respiratory problems and associated risk factors 
within a brewery in South Africa.   
 
Central to this study is the recent identification of an individual with the diagnosis of OA, 
which represents a potential sentinel health event.  Evaluation of the workforce, in order to 
identify and prevent other cases of OA in the same setting, is considered best practice to 
follow (Tarlo et al. 2008).  Despite dust exposures in this brewery recently being below 
threshold limit values for non-specific dust, this does not take into account the fact that 
allergic reactions such as occupational asthma and extrinsic allergic alveolitis may occur with 
exposure to lower concentrations (Chan-Yeung et al. 1978).  This survey was to assist in 
determining the prevalence of work-related respiratory health problems within this brewery 
setting, identify groups of workers that are potentially at risk of developing respiratory health 
problems and provide greater insight into the risk factors for respiratory health problems 












knowledge base of respiratory problems and associated risk factors among brewery workers, 
informing policy so as to develop effective intervention and preventative strategies, as health 
of workers is an important consideration for both economical and ethical reasons (Chan-
Yeung et al. 1978).  The implementation of appropriate preventative strategies to be 
undertaken in order to reduce exposures and more targeted medical surveillance of exposed 
workers could reduce the incidence of respiratory health problems among brewery workers, 
improve health and lower the cost to the individual, to business and to society as a whole 
(Tarlo et al. 2008). 
 
2.12 Summary 
An overview of the literature with particular reference to the prevalence of respiratory 
problems, including asthma and allergy, and patterns and associated factors has been 
provided. 
 
Significance and relevance for health and purpose of this study concluded this chapter. 
Chapter three will describe the research design and methodology chosen including details of 
the research process. 
 
















3.1.1 Study setting and population 
The study took place within a South African brewery.  This brewery was centrally situated 
and conveniently accessible by both rail and road.  Over 500 brewery workers, including 414 
permanent employees were responsible for the brewing, packaging, distribution, security, 
administration and marketing of its products.  The brewing process necessitated 24 hour 
coverage, and a worker’s ability to acclimatize to shift work and tight schedules, and to noisy, 
hot, humid, wet conditions.  Hard work was encouraged and driven by incentives to perform 
and meet demands of this progressive, multi-ethnic, multi-cultural company.   
 
3.2 Study design and rationale 
A cross-sectional, analytical study design was used.  A comparative rather than a simple 
survey design was chosen as three groups were being compared to see if there were any 
similarities or differences on selected variables (Brink 2002; de Vos, Strydom, Fouche & 
Delport 2005).   
 
3.3 Study frame and sample size 
The study population size (n=414) was determined by means of lists generated of all current 
permanent, full-time brewery workers.  These lists constituted the study frame.  This included 
358 permanently employed brewery workers involved in the production process and a further 
56 employees responsible for the administration, sales and distribution of the product.   
 
An accurate sample size calculation using the Raosoft statistical calculator, based on the 
prevalence and required precision of the estimate was done.  This was based on the study 
population size, included a measure of error one can accept of 5%, an aim of a confidence 
level of 95% and a minimal response distribution of 50%.  Based on previous studies of the 
literature (Godnic-cvar 1999), a 38-45% prevalence of IgE reactivity, a 30% prevalence of 
asthma-related symptoms and 2% prevalence of occupational asthma was found in brewery 












resources (including money, time available to conduct the research and personnel available), 
and the number of variables in which the data were grouped, a sample size of at least 200 was 
proposed.  This sample was to be drawn from the sample frame. 
 
3.4 Inclusion criteria 
Workers, male and female, aged 18-65 years and employed by the brewery in a permanent, 
full time capacity, at the time of the study, were invited to participate.  This was on a 
voluntary, informed basis only and independent of the length of employment at the brewery. 
 
3.5 Exclusion criteria 
All contract workers were excluded from the study.  No permanent, full-time brewery 
workers were excluded from the study.  This was to minimize the introduction of bias into the 
study and accommodate findings, such as the prevalence of work-aggravated asthma. 
 
3.6 Recruitment 
The nature, procedure and importance of the proposed study was related to the manager of 
the brewery in relevant meetings by the Occupational Health Nurse that headed the brewery 
clinic, and related to Department Heads on a one-to-one basis by the principal researcher.  
This was supported by a written explanation, a ‘Memorandum of Understanding’ between the 
principal investigator and the brewery, of the proposed study.  It included an introduction to 
and purpose of the study, the proposed sample frame and size, and an explanation of the 
procedure.  Emphasis was placed, in this ‘memorandum of understanding,’ on the granting of 
ethical approval by the Faculty of Health Sciences Human Research Ethics Committee in 
order for the study to take place (Addendum 1:  Ethical approval).  This included rights and 
confidentiality of employer and employees.  Implications including expected risks and 
benefits, costs or compensation related to participation in the study were explained.  
Commitment of the researcher to the brewery ensuring protection of information collected 
and the objective and accurate interpretation and dissemination of findings according to 
academic practice was related.  Thereafter, both permission and co-operation were obtained 
from the management of the brewery, signified by the signing of this agreement, the 
‘Memorandum of Understanding’, by both principal investigator and the brewery manager 












Notification of the study, describing and explaining the aim, purpose and objectives of the 
study to the potential study participants, within the identified population, was communicated 
via meetings and emails, or on an individual basis, inviting them to participate. 
 
Those workers who, at the time of the study, were employed by the brewery in a permanent, 
full time capacity, were invited to participate in the study.  Participation was to be 
independent of length of employment at the brewery.  No worker was excluded from the 
study.  This was to ensure bias was not introduced and all findings were accommodated, such 
as that of the prevalence of work-aggravated asthma. 
 
Participation was entirely voluntary and on an informed basis only.  If a worker did not wish 
to take part in the study, the researcher would not have access to their information.  In order 
to prevent selection bias, however, full participation was encouraged by means of 
communication of the study verbally and by email, and on a personal basis.  Benefits to 
employees, to business and to society as a whole, was related to the workers, as too the 
availability of the researcher to explain any queries that may have arisen.  These were 
possible contributing factors to such a high participation rate in this voluntary study.  
Maximum participation was encouraged.  One worker declined the opportunity to participate 
in the study.  All remaining workers selected agreed to participate in the study. 
 
3.7 Sampling technique 
An opportunistic stratified sampling method was used.  This was linked to annual medicals in 
order to ensure all workers in the 3 exposure groups were represented.  The study population 
was classified into 3 exposure groups based on subjective levels of exposure to dusts, 
chemicals, gases, vapors and fumes in different departments.  This was based on the principle 
investigators prior knowledge and assessment of departmental level of exposure to chemical 
and biological dusts, gases, vapors and fumes. Prior knowledge of the principle investigator, 
to the level of exposure, was built on current risk assessments and level of medical 












In order to ensure adequate representation of each exposure group, which was of unequal 
size, an attempt was made to include all subjects in the high exposure group and a proportion 
of subjects in the medium and low exposure group, in the study: 
• High exposure: Brewing (Including Utilities), Brewing Engineering, Logistics.   
• Medium exposure:  Packaging, Warehouse, Laboratory (Including QAQC). 
• Low exposure:  Administration, Sales and Distribution.     
 
Data collection was linked to the routine annual medical examinations and/or surveillance 
program that was currently in place.  All employees in the medium exposure groups and high 
exposure groups who presented to the clinic for their annual medicals, for follow-up 
procedures linked to their annual medicals, or for administrative purposes, were included in 
the study.  The study was not linked to the presentation of the worker to the clinic for other 
reasons, such as  pertaining to primary health care matters, as it was thought that this may 
introduce bias towards workers who were unwell.  Although the principal investigator 
completed the routine annual medicals, it was the supervisor and not the principal 
investigator who scheduled who would be attending the medicals.  All persons whose 
medicals where scheduled with the principal investigator were, therefore, invited to 
participate in the study.  Those whose medicals were not scheduled with the principal 
investigator did not participate in the study.  The principal investigator was ‘blinded’ as to 
who would be scheduled to arrive for a medical, and who would not be scheduled to arrive 
for a medical. 
 
As far as the lower exposure group is concerned, as no medicals were performed, data 
collection was linked to clinic visits, other than clinic visits for primary health care purposes, 
or by phone call if necessary.  Each employee in this group received either an email or phone 
call inviting them, on a voluntary, informed basis, to participate during normal working 
hours.  The principal investigator would, as per other exposure groups, interview the 
participants upon arrival at clinic or by means of phone call if necessary.   
 
3.8 Method of data collection:  Interview-administered questionnaire 
The study took the form of an interviewer-administered questionnaire, either face-to-face or 
by means of a phone call if necessary, which took no longer than 15 minutes of the subjects 












administered questionnaire of the European Community Respiratory Health Survey 
(ECRHS), specifically designed for the investigation of work-related asthma and respiratory 
problems.  This would be adapted for local context and the brewing industry.  Prior to use 
thereof, coding of the proposed questionnaire took place (Addendum 3:  Coding of 
questionnaire). 
 
Permission was sought from authors of the European Community Respiratory Health Survey 
(ECRHS) (Burney et al. 1993) to use and adapt their questionnaire to the brewery setting.  
Affirmative response was received (Addendum 4:  Covering letter requesting use of ECRHS 
questionnaire & response received).  Of the two hundred and fifty two workers invited to 
participate in the study, two hundred and fifty one workers consented to participate verbally 
and in writing (Addendum 5:  Consent form).   
 
Thereafter, it was requested of each participant to respond to a standard questionnaire.  A 
previously validated interview-administered questionnaire  of the European Community 
Respiratory Health Survey (ECRHS) (Burney et al. 1993) specifically designed for the 
investigation of work-related asthma and respiratory problems, and adapted for local context 
and the brewing industry, was used (Addendum 6).  The questionnaire addressed acute and 
chronic work-related respiratory symptoms, current and previous employment, prevalence of 
exposure to dusts (including that of malt dust), gases, vapors and fumes, and to tobacco 
smoke.  All questionnaires were administered by the principal investigator herself as she was 
an experienced occupational health nurse.  The questionnaire was administered in English.   
 
The questionnaire was administered in privacy, face-to-face, on a one-to-one basis, or by 
telephone if necessary, and was ideally linked to the annual medical examination or clinic 
visits or appointment.  It took approximately 15 minutes to complete, and was administered 
during normal working hours.  Smoking status was classified into three categories viz. non-
smoker as lifelong abstinence from smoking; ex-smoker if ceased smoking more than a 
month before the survey; and current smoker.  A worker’s description of job (Addendum 7:  
job descriptions) in a specific work area, including subjective exposure to dusts, gasses, 
vapors and fumes, use of personal protective equipment (PPE) e.g. respirators, goggles and 
gloves, in the questionnaire, assisted in assessing environmental exposure and temporal 












order to determine whether there could have been previous exposures to agents similar to 
those in the current workplace.   
Past medical history, with regard to respiratory problems, prior to and after employment in 
the brewing industry, was assessed by the presence of any one of the following: history of 
allergy, hay fever, asthma, tuberculosis of the lungs or hospitalization for a serious lung 
problem. Acute and chronic upper and lower respiratory symptoms were evaluated for 
prevalence of rhino-conjunctivitis, asthma, extrinsic allergic alveolitis and chronic bronchitis 
and for temporal relation to work.  Specific symptoms related to the clinical endpoints, 
namely, those pertaining to asthma (wheeze, tight chest, cough and shortness of breath); those 
pertaining to allergic alveolitis (dysnoea, cough, feverish, night sweats, pyrexial reaction 
occurring some hours after exposure to malt dust); those pertaining to chronic bronchitis 
(coughing most days or nights for as much as three or more months in each of the last 2 
years), and those pertaining to rhino-conjunctivitis (itchy watery red eyes, hay fever, runny 
nose, blocked nose, stuffy nose), were addressed.  
 
The medical history detailed any precipitating events, including whether there was a personal 
history of allergies or a family history of asthma and allergies.  The characterization of 
asthma symptoms (e.g. shortness of breath, chest tightness, cough, and/or wheezing), triggers 
in the work environment, and, for example, whether condition worsened by exercise, or at 
night, in support of the diagnosis of asthma was included.  In addition to providing 
information on respiratory symptoms present in work-related asthma patients, and whether it 
did accompany or was preceded by symptoms of rhinitis and/or conjunctivitis, specific 
inquiry was made to determine any relationship between the workplace and symptoms.  The 
use of protective devices or equipment, the onset and timing of symptoms, reported 
medication needs, and temporal relationship to periods at and away from work, were also 
included in the history (Addendum 8:  Operational definitions of respiratory symptoms).   
 
3.9 Ethical considerations 
3.9.1 Institutional approvals 
Ethical approval for the study was sought from the Faculty of Health Sciences Human 
Research Ethics Committee, University of Cape Town.  Upon ethical approval (Addendum 
1), permission was sought from the manager of the brewery.  A Memorandum of 












office, University of Cape Town, was signed by the manager of the brewery and the principal 
investigator.  
3.9.2 Autonomy 
As individuals are autonomous, and have the right to self-determination and the right to be 
respected (Brink 2002), participation in the study was entirely voluntary, on an informed 
basis. All physiological, psychological, social, political, religious, cultural and economic 
consequences were considered throughout the study.   
 
All participants had the right to fair selection and treatment and the right to decide whether 
they would participate in the study.  They had the right to refuse to answer a question and the 
right to withdraw from the study at any time, without any negative consequences to the 
participant. 
 
3.9.3 Beneficence and non-maleficence 
Beneficence obliges the researcher to do good.  Non-maleficence refers to the obligation of 
the researcher not to cause harm (Brink 2002).  In order to secure the wellbeing of the person 
in this study, effort was made to protect participants from discomfort and harm by ensuring 
every possible precaution was taken to apply good ethical principles throughout the research 
process.  Any possible risks as a result of completing the questionnaire were explained to the 
participant.   That there would be no compensation or remuneration and no costs as a result of 
participating in the study was also emphasized to the participant. 
 
It was explained that what was hoped to be gained from this study would be the prevalence of 
brewery workers that suffer from respiratory problems and associated risk factors. It was 
hoped that this would assist in the identification of appropriate preventative strategies that 
could be used in order to reduce the incidence of respiratory problems among brewery 
workers, with ultimate aim of the protection and promotion of the respiratory health of 
employees in the workplace.  It was emphasized though, that although the study would 
recommend changes, it could not implement changes, as the principal researcher could not 














The principle of justice includes the right to fair selection and treatment and the right to 
privacy and confidentiality (Brink 2002).  Selection of participants was directly linked to 
routine annual medicals in both medium and high exposure groups. All were invited to 
participate in low exposure group.  Care was taken to ensure the interview took place on a 
one-to-one basis in a private room.  Only appropriate questions and no invasive questions 
were asked in the study. 
 
In order to ensure confidentiality, referring to the researcher’s responsibility to protect all 
data gathered within the scope of the project from being divulged or made available to any 
other person (Brink 2002), all information collected during the course of the study was kept 
strictly confidential to the extent permitted by law, and was safely stored in a locked 
cupboard accessible only to the Principal Investigator or research team. 
 
Anonymity refers to the act of keeping participants nameless in relation to their participation 
in the research (Brink 2002).  Information relating to the participants was not linked to the 
participants personally and individual names were not included in the analysis of the findings. 
No identifying information, such as name, was included on the questionnaire.  Each 
individual who agreed to participate was assigned a unique 3-digit code.  The data collection 
instruments reflected this. All questionnaires were stored in confidential files, in a locked 
cupboard, until the completion of the study  (All questionnaires will be retained in a locked, 
fireproof cupboard for 24 months post study for reference purposes.  Thereafter, the research 
co-ordinator will ensure that all questionnaires be suitably destroyed, in order to protect 
confidentiality of participants). 
 
Individual results were treated as confidential and personal information was only released 
with the worker’s consent as the need arose.  Anonymity was assured.  All workers with 
abnormal outcomes were to be, upon written consent, referred to their own general 
practitioner, their local clinic or the brewery occupational health clinic, for further evaluation 
and management, or to the Occupational Medicine Clinic at the relevant hospital, if indicated.  
It was also emphasized that should it be recommended that a participant be referred for 













3.9.5 Informed consent 
Verbal consent was initially sought from recruited participants.   Voluntary, informed written 
consent was sought from each participant prior to administration of the questionnaire.   This 
was achieved by means of a covering letter and consent (Addendum 5: English consent 
form), explaining the purpose of the research, the requirements of the research project, ethical 
considerations, and expected completion time resulting from participation in the study.      
 
To voluntarily agree to take part in the study, it was requested of the participant to sign a 
consent form (Addendum 5:  English consent form).  It was emphasized that the participant 
would not be giving up any of his/her legal rights by signing this form.  The signature would 
indicate that the participant had read, or had read to him/her, the entire consent form, 
including the risks and benefits, and had all questions answered.  The participant was given a 
copy thereof. 
 
3.9.6 Management of data 
The questionnaire was administered free of charge on an informed, voluntary basis during 
working hours.  Good faith was expected of the researcher to ensure the findings were  
interpreted objectively and as accurately as possible, and presented as such, ensuring the 
importance of scientific honesty in disclosing sufficient, correct and understandable 
information, disclosing shortcomings and acknowledging input, was ensured.   It was related 
to management that a draft final report would be presented to the brewery management upon 
completion of the study. 
 
3.10 Validity and reliability 
Validity refers to the ability of an instrument to measure the variable that it is intended to 
measure (Brink 2002).  Reliability refers to the consistency and dependability of a research 
instrument to measure a variable, including stability, equivalence and internal consistency 
(Brink 2002). 
 
3.10.1 The pilot study 
In order to test the research design for the prospective study, prior to the study, a pilot study 
(small-scale study), and a second pilot study, was carried out on a small population who had 












interview-administered questionnaire was administered to a total of 30 brewery contractors 
working in similar environments as those of the proposed study participants.  Errors were 
identified and controlled where necessary.  An opportunistic stratified sampling method was 
used, in order to ensure all workers in the three exposure groups were represented.   
The purpose of the pilot study was to identify and control any errors, such as instrument 
errors, and reduce it to its lowest possible level.  This would ensure data would be as 
meaningful and as accurate as possible.  This would increase the precision of the instrument, 
the questionnaire (de Vos 2005). 
 
3.10.2 Content stability 
The questionnaire to be used was compiled from the ECRHS, the reliability of which had 
already been tested (Burney et al. 1994). 
 
3.10.3 Bias 
It was suggested that certain bias may be present:  Data in this study applied only to the 
brewery being studied and was not representative of any other brewery or form of private 
home brewing practice.  It was felt that effects of selection may bias results of this study, as 
misclassification of subjects could be operative.  Close linkage of interviews with annual 
medicals was a possible drawback and could have resulted in some degree of ‘over-
reporting’.  There could be information bias introduced as data collected at one point in time 
does not necessarily reflect the symptoms experienced throughout the year, which may vary.  
There may have been potential recall bias, as information collected may have resulted in 
inaccuracies arising due to information having to be recalled over a period of time.  
Furthermore, only permanent, full time employees, who may have been healthier than non 
permanent employees, participated in this study.  This may have represented the ‘healthy 
worker effect’.  As this study was a cross-sectional analyses of the current workforce, this 
study may have reflected the resulting survivor effects.  Workers who had recently left the 
company or changed jobs in order to safeguard their health may also have contributed to the 
‘healthy worker effect’.  Attempts were made to account for this latter effect by collecting 













3.10.4 Generalization   
It was thought that the results of this study, although applicable to the brewery studied, would 
be able to be generalized to other brewery settings.  It was also thought that the possibility 
existed that results may suggest that further studies may be required. 
 
3.11 Data analysis 
3.11.1 Statistical analysis 
STATA statistical package was utilized for data management and analysis.  The entire 
database and questionnaire responses were analysed using STATA version 10.  Independent 
checks of range, validity, consistency and missing data were performed.  Logic check 
programs were run to ensure that each value found in the data fell within the expected range 
or corresponded to possible values in the codebook.  All discrepancies were addressed.  
Descriptive statistics such as means and proportions were used to summarize the data. Key 
associations of interest involved investigating relationships between exposure groups (low, 
medium and high), occupational agents (chemical, and biological), host factor attributes (e.g 
age, gender, family history of allergy, hay fever or asthma, smoking, or history of a lung 
problem for which the participant had to be hospitalized) and respiratory health outcomes 
(e.g. work-related upper and lower respiratory symptoms).   Univariate, bivariate and 
multivariate logistic regression models were used to investigate the association between 
upper and lower respiratory symptoms, host factors and specific chemical and biological 
agents, and respiratory outcomes (Tredoux & Durrheim 2002).  Measures of disease 
association were evaluated by means of chi-squared test prior to the development of 
regression models (Tredoux & Durrheim 2002).  Strength of association was expressed as an 
odds ratio (OR) or p-value, with a p-value of ≤ 0.05 considered significant.  Results were 
presented by means of tables and statistical summaries (Katzenellenbogen 2004). 
 
3.11.2 Outcome variables 
The key outcome variables of interest (Please refer to definitions below) included: 
Self-reported upper respiratory symptoms, general and work-related, suggestive of 
rhinoconjunctivitis   
• Self-reported lower respiratory symptoms, general and work-related 












• Self-reported work-aggravated asthma 
• Self-reported atopic asthma 
• Self-reported work-related asthma 
• Possible extrinsic allergic alveolitis symptom complex 
• Possible chronic bronchitis symptom complex  
 




symptoms suggestive of 
Rhino-conjunctivitis 
Nasal allergies in the last 12 months 
Nasal allergies worse with work 
Nasal allergies after starting at the brewery 
Asthma Doctor-diagnosed asthma 
Asthma attack in past 12 months  
OR Use of asthma medication in past 12 months 
Work-aggravated asthma Asthma attack in last 12 months 
OR asthma medicine in last 12 months 
AND work-related chest symptoms, 
OR job change due to work-related symptoms, 
OR increase in medication use 
Atopic asthma Family history of asthma, allergy or hay fever 
AND definition of Asthma 
Work-related asthma Definition of Asthma 
AND one or more work-related chest symptoms, as follows: 
Chest symptoms after starting at the brewery 
Change of work processes preceding onset of chest symptoms 
Change of job because of chest problems 
Increase in medication use 
Symptoms worse when working in current job 
Symptoms improve after changing job or during extended 
     time away from job   
 
Possible extrinsic allergic 
alveolitis 
Fever, chills, cough, difficulty in breathing following 
exposure to product or certain work activity  














3.11.4 Exposure variables 
The primary measures of exposure included: 
Exposure group:  Subjects were classified into 3 exposure groups.  This was based on the 
principle investigators prior knowledge and assessment of departmental levels of exposure to 
chemical and biological dusts, gases, vapors and fumes.  Prior knowledge of the principle 
investigator to the levels of these exposures, was built on current risk assessments and level 
of medical surveillance to which each department was currently subjected to, at the brewery. 
Exposure levels included: 
• High exposure: Brewing (Including Utilities), Logistics.  
• Medium exposure:  Packaging, Warehouse, Laboratory (Including QAQC). 
• Low exposure: Administration (Including Sales and Distribution) based on visual 
inspection of levels of exposure to dusts, gases, vapours and fumes in different 
departments. 
 
Chemical agents: The most important chemical agents used in the analysis were sodium 
hydroxide, carbon dioxide, ammonia and kiesselguhr/silica (Addenda 10 and 11). 
 
Biological agents: The most important biological agents used in the analysis were grain dust, 






Family history of allergy, hay fever or asthma 
Current smoking status 
Previous history of a serious lung problem for which participant had to be hospitalized.   
 
3.12 Chapter summary 
Use was made of a cross-sectional analytical study design, using a stratified opportunistic 
sampling method to select the study sample (n = 251) from a total population of 414 
permanent workers in the brewery. A previously validated interview-administered 












local context, was used to interview workers divided in 3 exposure groups. Ethical principals 
were considered throughout the study in the collection and management of data and data 
analysis.  This included the use of univariate, bivariate and multivariate logistic regression 
models to investigate the association between respiratory symptoms and outcomes, host 
















A cross sectional analytical study was conducted within a brewery in South Africa in order to 
document the prevalence of work-related respiratory problems and associated risk factors.   
This chapter presents the research analysis and findings that were derived from the specific 
research objectives that addressed the research question. Univariate, bivariate and 
multivariate analyses used to investigate the association between upper and lower respiratory 
symptoms and outcomes, and host factors and specific chemical and biological agents, is 
presented. Measures of disease association are evaluated by means of Chi-squared test prior 
to the development of regression models. Strength of association is expressed by means of 
odds ratio or p-value.  Results are presented by means of tables, and statistical summaries. 
 
4.2 Demographic, employment and health-related characteristics 
A total of two hundred and fifty-one (n=251; 61%) permanently employed brewery workers 
(n=414) were selected to participate in the survey.  The mean age of this study sample was 40 
years, and ranged from 20 years to 62 years of age.  The majority of the participants were 
male 195 (78%).  Only thirty-five percent (n=88; 35%) of the study population reported to be 
smoking at the time of the study, the majority of which smoked less than 10 cigarettes per 
day. Of those currently smoking, eight percent (n=7; 8%) reported smoking more than 20 
cigarettes per day (Table 3). 
 
The years of service in current jobs of participants averaged 10 years.  Job categories varied 
quite substantially (Addendum 7).  Of interest, twenty-five percent (n=62; 25%) of 
participants reported a family history of allergy, hay fever or asthma.  A total of five percent 
(n=13; 5%) of workers reported a past history of a serious lung problem for which the 
participant had to be hospitalized.  These included hospitalization for asthma, pneumonia, 
tuberculosis, a viral lung infection, a collapsed lung, pulmonary embolism and pleural 
effusion.  Only two percent (n=5; 2%) of participants reported a history of tuberculosis for 












Table 3: Demographic, employment and health-related characteristics of workers in a South African 





Prevalence n (%) 
 
 
Age ( years) 
 
40 ± 10 
Age < 30 years 55 (22%) 
Age 31 - 40 years 78 (31%) 
Age 41 - 50 years 77 (31%) 
Age > 50 years 41 (16%) 
  
Gender:  Female: Male (%) 22 : 78 
  
Smoking status  
Current smokers 88 (35%) 
Number of cigarettes smoked per day:  currently  
1 – 10 cigarettes 57 (65%) 
11-20 cigarettes 24 (27%) 
More than 20 cigarettes 7 (8%) 
  
Employment History  
Duration of employment in brewery (years)  12 ± 9 
Duration of employment in current job (years) 10 ± 8 
  
Past History of allergy  
Family history of allergy, hay fever, asthma 62 (25%)                                                   
Past history of serious lung problem for which had to be hospitalized 13 (5%) 
Past history of Tuberculosis of the lung (not hospitalized)  5 (2%) 
  













4.3 Self-reported exposure to particulate dust agents 
A large proportion of workers were exposed to various hazardous agents.  Table 4 lists 
common hazardous particulate dust agents identified through self-reported exposure histories 
of the brewery workers interviewed.  A high proportion of workers were exposed to 
kieselguhr and silica dust (n=88; 35%), and to malt dust (n=83; 33%).  (Addendum 9:  Self-
reported exposure to particulate dust agents. 
 
Table 4: Top 10 hazardous particulate dust agents identified through self-reported exposure histories of 













Malt dust 83 (33%) 
  
Hops  67 (27%) 
 
Grain dust( maize) 52 (21%) 
 




Diesel particulates 38 (15%) 
  
Calcium sulphate /calcium chloride 33 (13%) 
 
Activated carbon 28 (11%) 
 
Lucilite (silica aerogels) 20 (8%) 
 
Glass dust (bottle washer; empty bottle inspection; glass crusher; depallitizer; glass 



















4.4 Self-reported hazardous chemical agents  
Table 5 lists the more common hazardous chemical agents, including gases, vapors and 
fumes, identified through self-reported exposure histories of workers in this brewery.  The 
most common hazardous chemical agent to which the brewery workers reported to have been 
exposed to was sodium hydroxide (n=123; 49%), followed by carbon dioxide (n=108; 43%) 
and ammonia (n=100; 40%).  Please refer to Addendum 10:  Self-reported hazardous 
chemical agents.  (Addendum 11: Self-Reported Exposure to Gases, Vapors, fumes). 
 
Table 5: Top 10 hazardous chemical (including gases, vapors and fumes) agents identified through self-








Caustic soda (sodium hydroxide) 
 
123 (49%) 
Carbon dioxide 108 (43%)  
Ammonia 100 (40%) 
Sterilant (hydrogen peroxide aqueous solution) 55 (22%) 
Carbon monoxide 48 (19%) 
Fumes from welding, soldering, cutting 30 (12%) 
Videojet make-up fluid (2-Butanone, methanol,  
Propylene glycolmonomethylether  
 
25 (10%) 
Chlorine dioxide 23 (9%) 
Lactic acid  20 (8%) 
Sulphurs (sulphur; sulphuric acid; sulphur dioxide)  17 (7%) 
  
Note: Data are presented as number (%), unless otherwise stated 
 
Those chemicals cited as causing respiratory problems as a result of peak exposure 
experiences included ammonia (n=45; 18%), carbon dioxide (n=19; 8%), malt dust (n=16;  












4.5 Self-reported respiratory symptom history  
4.5.1 Upper respiratory symptoms 
A high prevalence of upper respiratory symptoms was reported with sixty-four percent 
(n=161; 64%) of participants reporting nasal allergies including ocular-nasal symptoms in the 
last 12 months.  Up to half of those reporting these symptoms, reported ocular-nasal 
symptoms commencing after starting at the brewery and twenty-three percent (n=58; 23%) 
reported these symptoms worse at work (Table 6). 
 
4.5.2 Lower respiratory symptoms 
A range of between three percent (n=8; 3%) and twenty-eight percent (n=71; 28%) of 
workers reported lower respiratory symptoms which could be indicative of possible, probable 
or confirmed asthma.  A prevalence of sixteen percent (n=39; 16%) reported doctor-
diagnosed asthma.  Of those participants reporting doctor-diagnosed asthma, only one third 
(n=12; 5%) were currently using asthma medication (Table 6).   
 
4.5.3 Work-related respiratory symptoms 
A range of between two (n=4; 2%) and thirty-eight percent (n=95; 38%) of workers reported 
possible work-related respiratory symptom experiences.   Just over one third of the 
participants (n=95; 38%) reported experiencing chest symptoms after starting at the brewery.  
Almost a third (n=69; 27%) reported peak exposure experiences, namely exposure to a large 
amount  of  a dust, chemical, gas, vapor or fume, causing a chest problem.  A total of four 
percent (n=11; 4%) reported changing a job because of a chest problem.  Reasons cited for 
changing of job as a result of exposure to either dusts, chemicals, gases, vapors or fumes 
causing a respiratory problem included exposures to dust,  malt, kieselguhr, caustic, carbon 
















SYMPTOM   
 
PREVALENCE(%)  
(n = 251) 
 
  
UPPER RESPIRATORY SYMPTOMS  
Ocular-Nasal symptoms:  
Ocular-nasal symptoms in the last 12 months 161 (64%) 
  
Work-related ocular -nasal symptoms: 
Ocular-nasal symptoms after starting at the brewery 
 
75 (30%) 
Ocular-nasal symptoms worse at work 58 (23%) 
  
LOWER RESPIRATORY SYMPTOMS  
Possible/probable/confirmed asthma:  
Wheezing or whistling within the last 12 months 71 (28%) 
Wheeze or whistling in chest and breathlessness past 12 months 36 (14%) 
Wheeze or whistling without a cold  31 (12%) 
Woken up with tight chest in past 12 months 39 (16%)   
Attack of shortness of breath at rest in past 12 months 21 (8%) 
Shortness of breath at night or woken by shortness of breath past 24 (10%) 
Doctor-diagnosed asthma 39 (16%) 
Attack of asthma in last 12 months 8 (3%) 
Current use of asthma medication in past 12 months 12 (5%)      
  
Possible work-related respiratory symptom experiences  
Chest symptoms present after starting at the brewery 95 (38%) 
Changes in work processes preceding onset of chest symptoms 25 (10%) 
Chest symptoms worse when working in current job 8 (3%) 
Chest symptoms improve during extended times away from work 12 (5%) 
Increase in medicine while working in current job 4 (2%) 
Change in job because of chest problem 11 (4%) 
Large amount of dust, chemical, gas, vapor, fume causing chest problem 69 (27%) 
 













4.6 Respiratory disease and asthma phenotypes   
Referring to Table 7, possible allergic alveolitis was the most common respiratory disease 
phenotype (n=63; 25%)   Among asthma phenotypes, almost half of asthmatics (n=39; 16%) 
had atopic asthma, (n=18; 7%), suggesting a larger proportion with non-atopic asthma.   
 
Table 7: Prevalence of respiratory disease and asthma phenotypes among brewery workers (n = 251)  in a 






Prevalence n (%) 
 
  
Asthma  39 (16%) 
Probable atopic asthma 18 (7%) 
Work-related asthma  15 (6%) 
Work-aggravated asthma 7 (3%) 
Possible allergic alveolitis 63 (25%) 
Possible chronic bronchitis 7 (3%) 
  
Note: Data are presented as number (%) unless otherwise stated 
 
4.7 Demographic, employment and health-related characteristics in 
relation to exposure  
In relation to exposure category, males were more likely to be employed in the medium and 
high exposure category jobs (p<0.001).  No other demographic and health-related 
characteristics (age, smoking, employment duration, past history of allergy, previous 
hospitalization for a lung disease) appeared to be significantly different over exposure 












Table 8: Demographic, employment and health-related characteristics of workers in a South African 





























(n = 65)  
 






p-value   
                                                 
 
      
Age ( years) 40 ± 10 37±9 42±11 37±9 0.648 
Age category      
Age < 30 years 55 (22%) 17 (30%) 19 (15%) 19 (29%)  
Age 31 -40 years 78 (31%) 19 (33%) 33 (26%) 26 (40%)  
Age 41 -50 years 77 (31%) 15 (26%) 46 (36%) 16 (25%)  
Age > 50 years 41 (16%) 6 (11%) 6 (11%) 4 (6%)  
      
Gender: Female: Male (%) 22 : 78 61:39 10:90 10:90 <0.001 
      
Smoking status      
Current smokers 88 (35%) 17 (30%) 45 (35%) 26 (40%) 0.240 
Number cigarettes smoked/day      
1 – 10 cigarettes 57 (23%) 14 (25%) 28 (22%) 15 (23%)  
11-20 cigarettes 24(10%) 3 (5%) 12 (9%) 9 (14%)  
More than 20 cigarettes 7 (3%) - 5 (4%) 2 (3%)  
      
Employment History      
Permanent employee 251 (100%) 57 (23%) 129 (51%) 65 (26%) - 
Duration of employment in brewery (yrs) 12 ± 9 9±7 15±9 10±8 0.787 
Duration of employment in current job 10 ± 8 8±6 12±8 8±7 0.842 
      
Past History of allergy      
Family history of allergy, hay fever, asthma 62 (25%) 13 (23%) 37 (29%) 12 (18%) 0.497 
      
Past history of serious lung problem for 




      
Past history of Tuberculosis of the lung 




Note: Categorical values – chi-squared test for trend 
Low exposure group = Administration, Sales and Distribution departments 
Medium exposure group= Packaging, Warehouse, Laboratory and QAQC departments 












4.8 Respiratory symptoms in relation to exposure group using bivariate 
analysis 
Self-reported upper and lower respiratory symptom history in relation to exposure group 
(Table 9) demonstrated an association of upper airway symptoms in relation to work.  The 
reporting of ocular-nasal symptoms after starting at the brewery was associated (P=0.036), 
and the reporting of ocular-nasal symptoms worse with work was strongly associated 
(P<0.001) with exposure category.   
 
For lower airway symptoms, doctor-diagnosed asthma demonstrated association (P=0.011), 
and varied across the exposure groups with a higher prevalence in the lower group, (n=17; 
30%). 
 
Chest symptoms significantly  associated with work-relatedness included the experiencing of 
chest symptoms after starting at the brewery  (p=0.001), changes in work processes preceding 
the onset of chest symptoms (p= 0.001), and the reporting of inhaling a large amount of dust, 
chemical, gas, vapor or fume causing a chest problem (P<0.001).  Less strongly associated 
was the reporting of chest symptoms worse when working in current job (p=0.079) and chest 
symptoms improving during extended times away from work (p=0.085).  Among the 
respiratory disease phenotypes, the increasing prevalence of possible allergic alveolitis across 
exposure groups demonstrated a strong association (P<0.001).  Less strongly associated was 































(n = 65)     
 




        
      
UPPER RESPIRATORY SYMPTOMS      
Ocular-Nasal symptoms:      
Ocular-nasal symptoms in the last 12 months 161 (64%) 34 (60%) 4 (65%) 43 (66%) 0.466 
      
Work-related ocular -nasal symptoms:      
Ocular-nasal symptoms after starting at the brewery 75 (30%) 5 (9%)  51 (40%) 19 (29%) 0.036 
Ocular-nasal symptoms worse with work  58 (23%)  1 (2%)  36 (28%) 21 (32%) <0.001 
      
LOWER RESPIRATORY SYMPTOMS      
Possible/probable/confirmed asthma:      
Wheezing or whistling within the last 12 months 71 (28%) 14 (25%) 37 (29%) 20 (31%) 0.453 
Wheeze or whistling in chest and breathlessness past 12 months 36 (14%)  8 (14%) 19 (15%) 9 (14%) 0.483 
Wheeze or whistling when no cold  31 (12%) 6 (11%) 15 (12%) 10 (15%) 0.633 
Woken up with tight chest in past 12 months 39 (16%) 9 (16%) 16 (12%) 14 (22%) 0.348 
Attack of shortness of breath at rest in past 12 months 21 (8%) 5 (9%) 10 (8%) 6 (9%) 0.914 
Short of breath at night/woken by shortness of breath past 12 months 24 (10%) 4 (7%) 14 (11%) 6 (9%) 0.704 
Doctor-diagnosed asthma in past 12 months 39 (16%) 17 (30%) 14 (11%) 8 (12%) 0.011 
Attack of Asthma in last 12 months 8 (3%) 3 (5%) 3 (2%) 2 (3%) 0.666 
Current use of asthma medication in past 12 months 12 (5%) 6 (11%) 3 (2%) 3 (5%) 0.918 
      
Possible work-related respiratory symptom experiences      
Chest symptoms after starting at the brewery 95 (38%) 7 (12%) 58 (45%) 30 (46%) 0.001 
Changes in work processes preceding onset of chest symptoms 25 (10%) 1 (2%) 10 (8%) 14 (22%) 0.001 
Chest symptoms worse when working in current job  8 (3%) -  4 (3%)  4 (6%) 0.079 
Chest symptoms improve during extended times away from work 12(5%)  - 7 (5%)  5 (8%)  0.085 
      
      












      
      


















(n = 65)     
 




        
      
Possible work-related respiratory symptom experiences (continued)      
Increase in medicine while working in this job 4 (2%)   1 (2%)  2 (2%)  1 (2%)  0.480 
Change in job because of chest problem 11 (4%) 1 (2%)  6 (5%)  4 (6%)  0.242 
Large amount of dust, chemical, gas, vapor, fume causing a chest problem   69 (27%) 5 (9%)  31 (24%) 33 (51%) <0.001 
      
RESPIRATORY DISEASE PHENOTYPES       
Asthma 39 (16%) 17 (31%) 14 (11%) 8 (12%) 0.011 
Work-aggravated asthma 7 (3%)  2 (4%)  3 (2%) 2 (3%)  0.902 
Atopic asthma 18 (7%) 9 (16%) 6 (6%) 3 (5%)  0.021 
Work-related asthma 15 (6%) 3 (5%)  5 (4%)  7 (11%) 0.179 
Possible allergic alveolitis  63 (25%)  2 (4%)  35 (27%) 26 (40%) <0.001 
Possible chronic bronchitis 7 (3%)  1 (2%)  3 (2%)  3(5%)  0.329 
      
Note: Categorical values – chi-squared test for trend  
Low exposure group = Administration, Sales and Distribution departments 
Medium exposure group= Packaging, Warehouse, Laboratory and QAQC departments 
High exposure group= Brewing (including Utilities) and Logistics departments 
   














4.9 Host factors associated with respiratory symptoms using unadjusted 
models. 
In the unadjusted logistic regression models (Table 10), increasing age was significantly 
associated with chest symptoms after starting at the brewery (OR,1.06; 95%CI, 1.02-1.10) 
and inhaling a large amount of dust, chemical, gas, vapor, fume causing a chest problem 
(OR,1.82; 95%CI, 1.00-1.05).   
 
Male gender was significantly associated with work-related ocular nasal symptoms (OR, 
5.46; 95%CI, 2.00-14.88), experiencing chest symptoms after starting at the brewery (OR, 
4.80; 95%CI, 2.11-10.94) and the reporting of a large amount of dust, chemical, gas, vapor, 
fume causing a chest problem (OR, 3.98, 95%CI,1.62 – 9.77) (Table 10). 
 
Similarly a family history of allergy, hay fever and asthma was strongly and positively 
associated with both upper and lower respiratory symptoms, and in relation to work, the 
association being strong for reporting of ocular-nasal symptoms in the past 12 months (OR, 
3.85; 95%CI, 1.85-8.04) and doctor-diagnosed asthma (OR, 3.25; CI, 1.60-6.63).  Those 
reporting lower respiratory chest symptoms were between 2 and 4 times more likely to have 
reported a family history of allergy, hay fever or asthma (OR, 2.18, 95%CI, 1.06-4.49 to OR, 
3.52; 95%CI, 1.28-9.65).  The strongest association was that of reporting current use of 
medication in the past 12 months.  These workers were 12 times more likely to have reported 
a family history of allergy (OR, 11.80; 95%CI, 2.11-66.87).  In relation to work, those who 
reported a change of job because of a chest problem were almost 6 times more likely to have 
reported a family history of allergy, hay fever or asthma (OR, 5.86; 95%CI, 1.65-20.74) 
(Table 10).   
 
Hospitalization for a serious lung problem in the past was strongly and significantly 
associated with doctor-diagnosed asthma (OR, 5.32; 95%CI, 1.68-16.83) and change in job 
because of a chest problem (OR, 8.63; 95%CI, 1.98-37.52).  Of borderline significance, was 
improvement of chest symptoms during extended times away from work (OR, 5.4; 95%CI, 
0.93-31.42).  There was no significant association between ‘currently smoking’ and any of 













Host factors strongly associated with the general asthma phenotypes was family history of 
allergy (OR, 3.25; 95%CI 1.60-6.63), and hospitalization for a serious lung problem (OR, 
5.32; 95% CI 1.68-16.83).  Hospitalization for a serious lung problem was significantly 
associated with atopic asthma (OR, 7.11; 95%CI, 1.95-25.98) and work-related asthma 
(OR,9.17; 95%CI, 2.44-34.48), but not positively associated with possible allergic alveolitis 
or possible chronic bronchitis.  Other factors strongly associated with work-aggravated 
asthma was the reporting of a family history of allergy (OR,8.16, 95%CI 1.54-43.18) and 













Table 10: Unadjusted logistical regression models for host factors associated with upper and lower respiratory symptoms of brewery workers (n = 251) in a South 
African brewery 
 






















     
   Odds ratio (Confidence Interval)  
     
 
UPPER RESPIRATORY SYMPTOMS 
     
Ocular-Nasal symptoms:                                                                                                 
Ocular-nasal symptoms in the last 12 months 0.96 (0.93 – 0.98) 0.65 (0.34 – 1.25) 3.85 (1.85 – 8.04) 0.90 (0.49 – 1.67) 0.63 (0.21 – 1.95) 
      
Work-related ocular -nasal symptoms:      
Ocular-nasal symptoms after starting at the brewery 0.95 (0.92 – 0.98) 0.34 (0.15 – 0.74) 1.80 (0.91 – 3.55) 0.94 (0.46 – 1.93) 1.17 (0.25 – 5.41)   
Ocular-nasal symptoms worse with work 1.03 (0.99 – 1.06) 5.46 (2.00 – 14.88) 0.79 (0.40 – 1.59) 0.77 (0.37 – 1.61) 0.28 (0.03 – 2.42)    
      
LOWER RESPIRATORY SYMPTOMS      
Possible/probable/confirmed asthma:      
Wheezing or whistling within the last 12 months 1.01 (0.99 – 1.04) 0.71 (0.37 – 1.34) 2.60 (1.42 – 4.77) 1.30 (0.74 – 2.30) 1.13 (0.34 – 3.80) 
Wheeze or whistling in chest and breathlessness 
last 12 months 
1.01 (0.99 – 1.04) 0.71 (0.37 – 1.34) 2.60 (1.42 – 4.77) 1.29 (0.68 – 2.44) 3.09 (0.31 – 31.24)   
Wheeze or whistling without a cold  0.99 (0.94 – 1.04) 81 (0.28 – 2.34) 3.52 (1.28 – 9.65) 0.74 (0.28 – 1.96) 1.31 (0.17 – 9.86) 
Woken up with tight chest in past 12 months 0.99 (0.96 – 1.02 0.69 (0.32 – 1.48) 2.18 (1.06 – 4.49) 2.18 (1.06 – 4.49) 1.68 (0.44 – 6.42)    
Attack of shortness of breath at rest in past 12 months 0.98 (0.94 – 1.03) 0.34 (0.14 – 0.86) 3.09 (1.24– 7.69) 0.41 (0.14 – 1.22) 2.10 (0.43 – 10.15)    
Short of breath at night or woken by shortness of 
breath past 12 months 
1.01 (0.97 –1.06) 1.49 (0.49 – 4.54) 1.28 (0.50 – 3.25) 0.73 (0.26 – 2.00) 0.78 (0.10 – 6.27)     
Doctor-diagnosed asthma in past 12 month 0.97 (0.94 – 1.01) 0.33 (0.16 – 0.69) 3.25 (1.60– 6.63) 0.49 (0.20 – 1.20) 5.32 (1.68 – 16.83) 
Attack of Asthma in last 12 months  0.97 (0.89 –1.05) 0.33 (0.07 – 1.65) 4.75 (0.82 – 27.50) 1.8 (0.29 – 11.16) 2.25 (0.33 – 15.26) 
Current use of asthma medication in last 12 months 1.03 (0.96 – 1.10) 0.36 (0.09 – 1.45) 11.80 (2.11 – 66.87) 1.32 (0.22 – 7.82) 2.67 (0.45 – 15.72)    
      
      




































      
   Odds ratio (Confidence Interval)  
      
      
Possible work-related respiratory symptom 
experiences 
     
Chest symptoms after starting at the brewery 1.06 (1.02 – 1.10) 4.80 (2.11 – 10.94) 0.83 (0.40 – 1.70) 0.74 (0.34 – 1.60) 0.79 (0.17 – 3.67)    
Changes in work processes preceding onset of  
chest symptoms 
1.00 (0.96 – 1.05) 1.55 (0.49 – 4.89) 1.18 (0.47 – 2.97) 0.53 (0.21 – 1.36) 2.12 (0.39 – 11.61) 
Chest symptoms worse when working in current job 1.03 (0.96 – 1.10) 2.00 (0.24 –16.86) 1.49 (0.34 – 6.53) 0.13 (0.02 – 1.12) 0.30 (0.03 – 2.89) 
Chest symptoms improve during extended times away 
from work 
0.96 (0.90 – 1.02) 3.26 (0.41 – 26.21) 2.66 (0.81 – 8.75) 0.28 (0.06 – 1.34) 5.4 (0.93 – 31.42) 
Increase in medicine while working in this job 0.10 (0.90 – 1.11) 0.33 (0.02 – 4.74) 0.43 (0.02 – 9.36) - 1.0 (0.06 – 15.99) 
Change in job because of chest problem  1.01 (0.95 – 1.07) 0.76 (0.19 – 2.95) 5.86 (1.65 – 20.74) 0.70 (0.19– 2.56) 8.63 (1.98 – 37.52) 
Large amount of dust, chemical, gas, vapor, fume 
causing chest problem 
1.82 (1.00 – 1.05) 3.98 (1.62 – 9.77) 0.64 (0.32 – 1.28) 1.37 (0.71 – 2.63) 0.78 (0.21 – 2.93) 
      
RESPIRATORY DISEASE PHENOTYPES       
Asthma 0.97 (0.94 – 1.01) 0.33 (0.16 – 0.69) 3.25 (1.60 – 6.63) 0.43 (0.19 – 0.97 5.32 (1.68 – 16.83) 
Work-aggravated asthma 1.02 (0.95 – 1.10) 0.11 (0.02 – 0.56) 8.16 (1.54 – 43.18) 0.73 (0.14 – 3.87) 17.55 (3.45 – 89.15) 
Atopic asthma 0.96 (0.91 – 1.01) 0.20 (0.07 – 0.53 - 0.51 (0.16 – 1.59) 7.11 (1.95 – 25.98) 
Work-related asthma 1.02 (0.97 – 1.07) 0.40 (0.14 – 1.19) 2.86 (0.99 – 8.5) 0.44 (0.12 – 1.62) 9.17 (2.44 – 34.48) 
Possible allergic alveolitis 1.01 (0.98 – 1.04) 2.82 (1.20 – 6.60) 1.78 (0.95 – 3.34) 1.56 (0.87 – 2.80) 0.53 (0.11 – 2.45 
Possible chronic bronchitis 0.97 (0.90 – 1.05) 0.71 (0.13 – 3.76) 1.22 (0.23 – 6.45) 0.30 ( 0.04 – 2.54) 3.20 (0.36 – 28.94) 
      
Each OR represents a separate logistic regression model 
OR not determinable where dash 
 
Table 10: Unadjusted logistical regression models for host factors associated with upper and lower respiratory symptoms of brewery workers (n = 251) in a South 













4.10 Environmental exposure group categories in relation to respiratory 
symptoms. 
In the unadjusted logistic regression models with exposure group as a predictor of self-
reported upper and lower respiratory symptoms of brewery workers (Table 11), a strong 
association was observed between exposure status and ocular nasal symptoms.  A very strong 
association was also observed between work-related ocular-nasal symptoms for medium 
versus low (OR, 24.75: 95%CI, 3.23-189.54) and high versus low (OR, 31.50; 95%CI 3.95-
251.46) exposure categories in a dose-dependant manner.   
 
Similarly, a strong association was also observed between exposure category and increased 
asthma medication usage while working in this job, in a dose-dependant manner:  Workers in 
the high exposure group was 11 times more likely to have reported having an increase in 
medicine usage while working in the job, in a dose-dependant manner [medium versus low 
(OR,3.29; 95%CI, 1.21-8.97) and high versus low (OR, 10.73; 95%CI, 3.80-30.30)].   
 
The association with exposure status was generally stronger for work-related upper than for 
lower respiratory outcomes.  Positive associations included the reporting of chest symptoms 
after starting at the brewery, changes in work processes preceding the onset of symptoms and 
peak exposure (the reporting of a large amount of dust, chemical, gas, vapor or fume causing 
a chest problem). A very strong association was also observed between exposure groups of 
possible allergic alveolitis [medium versus low (OR, 10.24: 95%CI, 2.37-44.24) and high 












Table 11: Adjusted logistical regression with exposure group as a predictor of self-reported upper and lower respiratory symptoms of brewery workers (n = 251) in 














(n = 129) 
 
High 
Exposure   









       
       
 Prevalence (%)                                                                           Odd ratio (Confidence Interval) 
 
  
UPPER RESPIRATORY SYMPTOMS       
Ocular-Nasal symptoms:       
Ocular-nasal symptoms in the last 12 months 161 (64%) 34 (60%) 84 (65%) 43 (66%) 1.26 (0.67 – 2.40) 1.32 (0.63 – 2.76) 
       
Work-related ocular -nasal symptoms:       
Ocular-nasal symptoms after starting at the brewery 75 (30%) 5 (9%)  51 (40%) 19 (29%) 0.11 (0.04 – 0.32) 0.22 (0.07 – 0.67) 
Ocular-nasal symptoms worse with work 58 (23%) 1 (2%)  36 (28%) 21 (32%) 24.75(3.23–189.54) 31.50(3.95-251.46) 
       
LOWER RESPIRATORY SYMPTOMS       
Possible/probable/confirmed asthma:       
Wheezing or whistling within the last 12 months 71 (28%) 14 (25%) 37 (29%) 20 (31%) 1.24 (0.61 – 2.52) 1.37 (0.61 – 2.52) 
Wheeze or whistling in chest and breathlessness past  
12 months 
36 (14%) 8 (14%) 19 (15%) 9 (14%) 0.79 (0.23 – 2.73) 0.61 (0.15 – 2.43) 
Wheeze or whistling when no cold 31 (12%) 6 (11%)  15 (12%) 10 (15%) 0.91 (0.26 – 3.16) 1.33 (0.34 – 5.27) 
Woken up with tight chest in past 12 months 39 (16%) 9 (16%) 16 (12%) 14 (22%) 0.76 (0.31 – 1.83) 1.46 (0.58 – 3.69)   
Attack of shortness of breath at rest in past 12 months 21 (8%) 5 (9%) 10 (8%) 6 (9%) 0.87 (0.28 – 2.68) 1.06 (0.30 – 3.67) 
Short of breath at night or woken by shortness of  
breath past 12 months 
24 (10%) 4 (7%) 14 (11%)    6 (9%) 1.61 (0.51 – 5.13) 1.35 (0.36 – 5.04)        
Doctor-diagnosed asthma in past 12 months 39 (16%) 17 (30%) 14 (11%) 8 (12%)    0.29 (0.13 – 0.63) 0.33 (0.13 – 0.84)      
Attack of Asthma in last 12 months  8 (3%) 3 (5%) 3 (2%) 2 (3%) 1.27 (0.21 – 7.58) 1.56 (0.20– 11.83)       
Current use of asthma medication in past 12 months 12 (5%) 6 (11%)  3 (2%)  3 (5%)  0.50 (0.10 – 2.52) 1.10 (0.19 - 6.29) 
       
       
       












       













(n = 129) 
 
High 
Exposure   









       
       
 Prevalence (%)                                                                           Odd ratio (Confidence Interval) 
       
       
Possible work-related respiratory symptom 
experiences 
      
Chest symptoms after starting at the brewery 95 (38%) 95 (38%) 7 (12%)  58 (45%) 30 (46%) 5.33 (1.99 – 14.23) 7.01(2.30–21.35) 
 
Changes in work processes preceding onset of chest  
symptoms    
25 (10%) 1 (2%) 10 (8%) 14 (22%) 3.16 (0.38 – 25.95) 12.44(1.52–1.82) 
 
Chest symptoms worse when working in current job  8 (3%) - 4 (3%) 4 (6%) - - 
Chest symptoms improve during extended times   
away from work     
12(5%) - 7 (5%) 5 (8%) - - 
 
Increase in medicine while working in this job 4 (2%) 1 (2%) 2 (2%) 1 (2%) 3.29 (1.21 -8.97) 10.73 (3.80– 30.30)      
Change in job because of chest problem 11 (4%) 1 (2%) 6 (5%) 4 (6%) 2.73 (0.32 – 23.23) 3.67 (0.40 – 33.85)         
Large amount of dust, chemical, gas, vapor, fume 
causing chest problem 
69 (27%) 5 (9%) 31 (24%) 33 (51%) 3.29 (1.21 – 8.97) 10.73 (3.80 –30.30) 
       
PHENOTYPES OF ASTHMA:       
Asthma  39 (16%) 17 (31%) 14 (11%) 8 (12%)  0.29 (0.13 – 0.63) 0.33 (0.13 – 0.84) 
Work-aggravated asthma 7 (3%) 2 (4%)  3 (2%) 2 (3%) 0.65 (0.11 – 4.03) 0.87 (0.19 – 6.41) 
Atopic asthma 18 (7%) 9 (16%)  6 (6%)  3 (5%) 0.26 (0.88 – 0.77)       0.26 (0.07 – 1.00) 
Work-related asthma 15 (6%) 3 (5%)  5 (4%)  7 (11%) 0.73 (0.17 – 3.15) 2.17 (0.53 – 8.83) 
Possible allergic alveolitis 63 (25%) 2 (4%) 35 (27%) 26 (40%) 10.24 (2.37 – 44.24) 18.33(4.11 –81.80)   
Possible chronic bronchitis 7 (3%) 1 (2%) 3 (2%)  3(5%) 1.33 (0.14 – 13.10) 2.71(0.27 – 26.81) 
       
Each OR represents a separate logistic regression model adjusted for age, gender, smoking, family history of allergy and past history of hospitalisation for lung problems 
OR not determinable where dash  
Low exposure = Administration, Sales and Distribution departments 
Medium exposure = Packaging, Warehouse, Laboratory and QAQC departments 
High exposure = Brewing (including Utilities) and Logistics departments 
 
Table 11: Adjusted logistical regression with exposure group as a predictor of self-reported upper and lower respiratory symptoms of brewery workers (n = 251) in a 













4.11. Adjusted logistical regression:  Exposure group and respiratory 
symptoms 
After adjusting for potential confounders (Age, gender, family history of allergy, hay fever or 
asthma, smoking and past history of hospitalization for a lung problem) the association 
between exposure categories and respiratory outcomes was generally stronger for upper than 
for lower respiratory outcomes (Table 12).  There was a strong association between exposure 
status and work-related ocular nasal symptoms (Medium versus low (OR, 15.89: 95%CI, 
1.95-129.87) and high versus low (OR, 21.42; 95%CI 2.53-181.04).  Positive associations 
were also observed with reporting of chest symptoms after starting at the brewery [medium 
versus low (OR, 3.93: 95%CI, 1.03-15.01) and high versus low (OR, 8.28; 95%CI 2.00-
34.12)], and changes in work processes preceding the onset of symptoms, high versus low 
(OR, 15.12; 95%CI 1.42-161.52).  Similarly, positive associations were also observed for 
peak exposure, high versus low (OR, 10.45; 95%CI 3.08-35.45), work-related asthma, high 
versus low (OR, 10.88; 95%CI 1.50-76.76), and possible allergic alveolitis [(Medium versus 













Table 12: Adjusted logistical regression with exposure group as a predictor of self-reported upper and lower respiratory symptoms of brewery workers (n = 251) in 
a South African Brewery 
____________________________________________________________________________________________________________________ 
       
SYMPTOM Overall  Low Medium High Medium High 
 (n = 251) Exposure Exposure Exposure vs vs 
  (n = 57)  
 









      
Ocular-Nasal symptoms:       
Ocular-nasal symptoms in the 
last 12 months 
161 (64%) 34 (60%) 84 (65%) 43 (66%) 2.03 (0.88-4.69) 1.82 (0.74 – 4.47) 
 
       
Work-related ocular -nasal 
symptoms: 
      
Ocular-nasal symptoms after 
starting at the brewery 
75 (30%) 5 (9%)  51 (40%) 19 (29%) 0.09 (0.02 – 0.31) 0.17 (0.04 - 0.68) 
 
Ocular-nasal symptoms worse 
with work 
58 (23%) 1 (2%)  36 (28%) 21 (32%) 15.89(1.95–129.87) 21.42(2.53-181.04) 





      
Wheezing or whistling within 
the last 12 months 
71 (28%) 14 (25%) 37 (29%) 20 (31%) 1.65 (0.66 – 4.10) 2.28 (0.86 – 6.10) 
Wheeze or whistling in chest 
and breathlessness past  
12 months  
36 (14%) 8 (14%) 19 (15%) 9 (14%)  0.90 (0.16 – 5.04) 0.78 (0.14 – 4.46) 
Wheeze or whistling when no 
cold 
 
31 (12%) 6 (11%)  15 (12%) 10 (15%) 0.94 (0.16 – 5.36) 1.64 (0.27 – 9.79) 
 












       
SYMPTOM Overall  Low Medium High Medium High 
 (n = 251) Exposure Exposure Exposure vs vs 
  (n = 57)  
 
(n = 129) (n = 65)  
 
Low Low 
       
 Prevalence (%)                                                                                                                              Odds Ratio (Confidence Interval) 
       
       
Possible/probable/confirmed 
asthma (continued) 
      
Woken up with tight chest in 
past 12 months 
39 (16%) 9 (16%) 16 (12%) 14 (22%) 0.82 (0.29 – 2.36) 1.84 (0.63 – 5.39)   
Short of breath at night or 
woken by shortness of  
breath past 12 months 
24 (10%) 4 (7%) 14 (11%) 6 (9%) 1.28 (0.33 – 4.93) 1.21 (0.28 – 5.22)       
Doctor-diagnosed asthma in 
past 12 months 
39 (16%) 17 (30%) 14 (11%) 8 (12% ) 0.31 (0.12 – 0.85) 0.42 (0.14 – 1.25)      
Attack of Asthma in last 12 
months  
8 (3%) 3 (5%) 3 (2%)  2 (3%) 1.57 (0.14 – 17.12) 3.12 (0.19 – 51.17)      
Current use of asthma 
medication in past 12 months 
12 (5%)  6 (11%)  3 (2%) 3 (5%) 0.79 (0.08 – 7.87) 4.13 (0.31 – 54.83) 




95 (38%) 7 (12%)  58 (45%) 30 (46%) 3.93 (1.03 – 15.01) 8.28 (2.00 – 34.12) 
Changes in work processes 
preceding onset of chest 
symptoms 
25 (10%) 1 (2%) 10 (8%) 14 (22%) 2.94 (0.27 – 32.04) 15.12(1.42–161.52) 
 
Chest symptoms worse when 
working in current job 
8 (3%) - 4 (3%) 4 (6%) 2.48 (0.13 – 45.74) 0.31 (0.02 – 4.34) 
Increase in medicine while 
working in this job 
 
4 (2%)  1 (2%) 2 (2%) 2 (2%) - - 
       
       
       
       
Table 12: Adjusted logistical regression with exposure group as a predictor of self-reported upper and lower respiratory symptoms of brewery workers (n = 251) in a 













       
       
SYMPTOM Overall  Low Medium High Medium High 
 (n = 251) Exposure Exposure Exposure vs vs 
  (n = 57)  
 
(n = 129) (n = 65)  
 
Low Low 
       
 Prevalence (%)                                                                                                                              Odds Ratio (Confidence Interval) 
       




      
Change in job because of 
chest problem 
11 (4%) 1 (2%)  6 (5%) 4 (6%) 5.23 (0.36 – 75.23) 11.71(0.36 – 75.43) 
Large amount of dust, 
chemical, gas, vapor, fume 
causing chest problem 
69 (27%) 5 (9%) 31 (24%) 33 (51%) 2.57 (0.77 – 8.60) 10.45(3.08 – 35.45) 
       
RESPIRATORY DISEASE 
PHENOTYPES: 
      
Asthma  39 (16%) 17 (31%) 14 (11)  8 (12) 0.31 (0.12 – 0.85) 0.42 (0.14 – 1.25) 
Work-aggravated asthma 7 (3%) 2 (4)  3 (2) 2 (3) 5.42 (0.35 – 82.79) 13.17(0.70–247.82) 
Atopic asthma 18 (7%)  9 (16) 6 (6) 3 (5) 0.05 (0.01 – 0.40) 0.07 (0.01 – 0.76) 
Work-related asthma 15 (6%)  3 (5)  5 (4)  7(11) 1.86 (0.27 – 12.67) 10.88 (1.5 – 76.76) 
Possible allergic alveolitis 63 (25%) 2 (4%)  35 (27%) 26 (40%) 7.63 (1.60 – 36.32) 16.64 (3.39– 81.65) 
Possible chronic bronchitis 7 (3%) 1 (2%)  3 (2%) 3(5%) 2.64 (0.19 – 36.37) 5.19 (0.36 – 73.92) 
 
Each OR represents a separate logistic regression model adjusted for age, gender, smoking, family history of allergy and past history of hospitalisation for lung problems 
OR not determinable where dash  
Low exposure = Administration, Sales and Distribution departments 
Medium exposure = Packaging, Warehouse, Laboratory and QAQC departments 
High exposure = Brewing (including Utilities) and Logistics departments 
 
Table 12: Adjusted logistical regression with exposure group as a predictor of self-reported upper and lower respiratory symptoms of brewery workers (n = 251) in a 













4.12 Multivariate logistic regression models for chemical agents associated 
with respiratory symptoms   
In the adjusted multivariate logistic regression models for chemical agents associated with 
upper and lower respiratory symptoms (Table 13), chemical agents associated with work-
related upper airway ocular-nasal symptoms included sodium hydroxide (OR, 2.27: 95%CI, 
1.09-4.73) and kiesselguhr/silica (OR, 2.58: 95%CI, 1.22-5.46).  The main chemicals 
associated with lower respiratory symptoms included sodium hydroxide, carbon dioxide, 
ammonia and kiesselguhr/silica.  Among the four chemicals, only sodium hydroxide 
appeared to be significantly associated with possible, probable or confirmed asthma, with 
experiencing an attack of shortness of breath (OR,3.83;95%CI, 1.22 - 12.00), and short of 
breath at night or woken by shortness of breath (OR, 2.88; 95%CI, 1.07 – 7.77).  All these 
chemicals however, and in particular sodium hydroxide, were significantly associated with 
possible work-related respiratory experiences, such as inhaling a large amount of dust, 
chemical, gas, vapor or fume causing a chest problem.  In addition, sodium hydroxide (OR, 
7.28: 95%CI, 3.41-15.56), carbon dioxide (OR, 2.93: 95%CI, 1.53-5.62) and 
kiesselguhr/silica (OR, 2.40: 95%CI, 1.27-4.53) were significantly associated with possible 












Table 13: Adjusted multivariate logistic regression models for specific chemical agents associated with upper and lower respiratory symptoms among workers  
(n = 251) in a South African brewery 
 
     
SYMPTOM SODIUM CARBON AMMONIA KIESSELGUHR/ 
 HYDROXIDE DIOXIDE  SILICA  
 
  
Odds Ratio (Confidence interval) 
 
     
UPPER RESPIRATORY SYMPTOMS     
Ocular-Nasal symptoms:     
Ocular-nasal symptoms in the last 12 months 1.34 (0.75 – 2.40) 1.42 (0.78 – 2.56) 1.17 (0.67 – 2.06) 0.61 (0.34 – 1.12) 
     
Work-related ocular -nasal symptoms:     
Ocular-nasal symptoms after starting at the brewery 0.69 (0.34 – 1.39) 0.79 (0.39 – 1.56) 0.44 (0.22 – 0.86) 0.53 (0.26 – 1.08) 
Ocular-nasal symptoms worse with work 2.27 (1.09 – 4.73) 1.66 (0.82 – 3.36) 1.27 (0.64 – 2.53) 2.58 (1.22 – 5.46) 
     
LOWER RESPIRATORY SYMPTOMS 
Possible/probable/confirmed asthma: 
    
Wheezing or whistling within the last 12 months  1.47 (0.79 – 2.74) 1.28 (0.69 – 2.39) 1.41 (0.79 – 2.55) 0.99 (0.53 – 1.84) 
Wheeze or whistling in chest and breathlessness last 12 months 1.94 (0.61 – 6.15) 1.19 (0.41 – 3.41) 2.39 (0.81 – 7.00) 1.05 (0.35 – 3.11)   
Wheeze or whistling when no cold 1.37 (0.44 – 4.32) 1.72 (0.60 – 5.00) 1.26 (0.44 – 3.60) 0.59 (0.19 – 1.82) 
Woken up with tight chest in past 12 months 2.12 (0.97 – 4.64) 1.44 (0.67 – 3.07) 1.51 (0.75 – 3.07) 1.06 (0.50 – 2.24) 
Attack of shortness of breath at rest in past 12 months 3.83 (1.22 – 12.00) 1.74 (0.61 – 4.91) 1.78 (0.69 – 4.56) 1.54 (0.58 – 4.07)    
Short of breath at night or woken by shortness of breath  
past 12 months 
2.88 (1.07 – 7.77) 0.70 (0.28 – 1.75) 2.02 (0.85 – 5.54) 1.00 (0.40 – 2.50)                                                                                         
Doctor-diagnosed asthma in past 12 month 0.78 (0.35 – 1.73) 0.58 (0.25 – 1.34) 0.84 (0.39 – 1.81) 1.09 (0.49 – 2.38      
Attack of Asthma in last 12 months 1.03 (0.14 – 7.47) 3.94 (0.34 – 46.37 2.18 (0.30 – 15.59) 1.46 (0.20 – 10.45)      
Current use of asthma medication in last 12 months 0.85 (0.14 – 5.30) 6.23 (0.56 – 69.75) 1.87 (0.27 – 12.86) 2.64 (0.41 – 17.20)     














     
SYMPTOM SODIUM CARBON AMMONIA KIESSELGUHR/ 
 HYDROXIDE DIOXIDE  SILICA  
 
  
Odds Ratio (Confidence Interval) 
 
 
Possible work-related respiratory symptom experiences 
    
Chest symptoms after starting at the brewery 2.46 (1.12 – 5.39) 2.31 (1.04 – 5.14) 2.81 (1.25 – 6.31) 1.93 (0.85 – 4.41) 
Changes in work processes preceding onset of  
chest symptoms 
3.77 (1.27 – 11.19) 2.98 (1.12 – 11.19) 3.40 (0.97 – 5.94) 2.63 (1.03 – 6.71)    
Chest symptoms worse when working in current job - 1.26 (0.27 – 5.80) 1.11 (0.24  - 5.20) 2.98 (0.64 – 13.97)     
Chest symptoms improve during extended times  
away from work  
13.67 (1.10 – 169.63) 3.79 (0.85 – 16.90) 1.10 (0.29 – 4.19) 1.24 (0.31 – 4.98) 
Increase in medicine while working in this job - - - 0.09 (0.00 – 95.20)                
Change in job because of chest problem 2.68 (0.58 – 12.31) 0.80 (0.19 – 3.31) 1.10 (0.29 – 4.20) 1.45 (0.36 – 5.82)    
Large amount of dust, chemical, gas, vapor, fume 
 causing chest problem 
2.79 (1.48 – 5.28) 3.92 (2.04 – 7.56) 3.69 (2.01 – 6.78) 4.04 (2.12 – 7.67) 
     
RESPIRATORY DISEASE PHENOTYPES:     
Asthma 0.78 (0.35 – 1.73) 0.58 (0.25 – 1.34) 0.84 (0.39 – 1.81) 1.09 (0.49 - 2.38 
Work-aggravated asthma 3.72 (0.43 – 32.43) 7.41 (0.70 – 78.45) 2.76 (0.44 – 17.30) 1.52 (0.20 – 11.57) 
Atopic Asthma 0.50 (0.13 – 1.86) 0.64 (0.17 – 2.48) 1.32 (0.35 – 4.90) 0.79 (0.20 – 3.06) 
Work-related asthma 2.26 (0.62 – 8.20) 1.57 (0.44 – 5.56) 1.28 (0.41 – 4.00) 2.97 (0.87 – 10.17) 
Possible allergic alveolitis 7.28 (3.41 – 15.56) 2.93 (1.53 – 5.62) 1.65 (0.90 – 3.03) 2.40 (1.27 – 4.53) 
Possible chronic bronchitis 3.54 (0.54 - 23.27)
  
3.54 (0.54 - 23.27)
  
2.15 (0.45 – 10.26)
  
2.67 (0.52 – 13.58) 
Each OR represents a separate logistic regression model adjusted for age, gender, smoking, family history of allergy and past history of hospitalisation for lung problems 
OR not determined where dash 
 
Table 13: Adjusted multivariate logistic regression models for specific chemical agents associated with upper and lower respiratory symptoms among workers  













4.13 Multivariate logistic regression models for specific biological agents 
associated with respiratory symptoms 
It is evident that malt dust is associated with work-related ocular-nasal symptoms (OR, 2.06: 
95%CI, 1.00-4.25) (Table 14).  This was not evident in the unadjusted logistic regression 
models (data not shown).  Grain dust was also associated with lower respiratory symptoms 
after joining the brewery (OR, 3.16: 95%CI, 1.15 – 8.63).  Both hops and malt dust 
demonstrated borderline association with development of chest symptoms after starting at the 
brewery.  Grain dust, hops and malt were all significantly associated with changes in work 
processes preceding onset of symptoms and peak exposure causing a chest problem (Table 
14).  Furthermore, grain dust (OR, 2.16: 95%CI, 1.08-4.33), hops (OR, 2.05: 95%CI, 1.07-
3.93) and malt dust (OR, 2.16: 95%CI, 1.17-4.01) were positively associated with possible 
allergic alveolitis.  In addition, grain dust (OR, 13.28: 95%CI, 2.28-77.39), hops (OR, 7.21: 
95%CI, 1.33-39.18) and malt dust (OR, 5.83: 95%CI, 1.08-31.55) were significantly 












Table 14: Adjusted multivariate logistic regression models for specific biological agents associated with upper and lower respiratory symptoms among workers  
(n = 251) in a South African brewery  
____________________________________________________________________________________________________________________ 










Odds ratio (Confidence interval) 
 
 
UPPER RESPIRATORY SYMPTOMS 
   
    
Ocular-Nasal symptoms:    
Ocular-nasal symptoms in the last 12 months 1.42 (0.71 – 2.85) 1.15 (0.61 – 2.16) 1.31 (0.73 – 2.35) 
    
Work-related ocular -nasal symptoms:    
Ocular-nasal symptoms after starting at the brewery 0.44 (0.19 – 1.01) 0.42 (0.20 -0.89) 0.61 (0.30 – 1.22) 
Ocular-nasal symptoms worse with work 1.67 (0.73 – 3.81) 2.06 (0.96 – 4.40) 2.06 (1.00 – 4.25)  
    
LOWER RESPIRATORY SYMPTOMS    
Possible/probable/confirmed asthma:    
Wheezing or whistling within the last 12 months  1.21 (0.60 – 2.47) 1.27 (0.67 – 2.43) 1.17 (0.64 – 2.14) 
Wheeze or whistling in chest and breathlessness last 12 months         1.54 (0.44 – 5.38) 1.06 (0.35 – 3.18) 0.88 (0.31 – 2.56)   
Wheeze or whistling when no cold 0.88 (0.25 – 3.08) 1.23 (0.40 – 3.76) 1.05 (0.36 – 3.08) 
Woken up with tight chest in past 12 months 1.54 (0.67 – 3.52) 1.11 (0.51 – 2.43) 1.20 (0.58 – 2.49)   
Attack of shortness of breath at rest in past 12 months 3.79 (1.34 – 10.67)  1.98 (0.75 – 5.26) 1.47 (0.85 – 5.54)  
Short of breath at night or woken by shortness of breath                                 
past 12 months      
1.38 (0.51 – 3.73) 1.88 (0.77 – 4.60) 1.61 (0.67  - 3.82) 
Doctor-diagnosed asthma in past 12 month 1.70 (0.71 – 4.13) 1.26 (0.57 – 2.86) 1.06(0.48 – 2.30) 
Attack of Asthma in last 12 months 2.89 (0.32 – 26.29)  3.51 (0.39 – 31.59)  4.87 (0.52 – 45.24) 
Current use of asthma medication in last 12 months 5.94 (0.64 – 55.08)  4.35 (0.49 – 3.43) 5.64 (0.62 – 51.67)  
    
Possible work-related respiratory symptom experiences    
Chest symptoms after starting at the brewery 3.16 (1.15 – 8.63) 2.16 (0.91 – 5.12) 2.11 (0.92 – 4.87)    
Changes in work processes preceding onset of  
chest symptoms   
3.17 (1.22 – 8.26) 3.96 (1.58 – 9.96) 4.09 (1.61 – 10.39) 
 












    
SYMPTOM GRAIN DUST HOPS MALT DUST 
    
    
 Odds ratio (Confidence Interval) 
    
    
Possible work-related respiratory symptom experiences (continued)    
Chest symptoms worse when working in current job 1.58 (0.28 – 9.02) 3.79 (0.82 – 17.51)  3.41 (0.74 – 15.85) 
Chest symptoms improve during extended times away from work 1.74 (0.42 – 7.11) 1.36 (0.34 – 5.36) 1.23 (0.31 – 4.86) 
Increase in medicine while working in this job 0.46 (0.01 – 14.33)  0.46 (0.01 – 14.33)  0.46 (0.01 – 14.33)  
Change in job because of chest problem 1.21 (0.26 – 5.64) 2.21 (0.59 – 8.25) 2.72 (0.75 – 9.96) 
Large amount of dust, chemical, gas, vapor, fume 
 causing chest problem 
3.41 (1.74 – 6.67) 2.52 (1.34 – 4.74) 4.04 (2.18 – 7.47) 
    
RESPIRATORY DISEASE PHENOTYPES:    
Asthma  1.71 (0.71 – 4.13) 1.26 (0.56 – 2.86) 1.06 (0.48 – 2.30)  
Work-aggravated asthma      
Atopic asthma 2.06 (0.25 – 16.65) 0.99 (0.13 – 7.54) 1.94 (0.32 – 11.61) 
Work-related asthma 2.35 (0.68 – 8.07) 1.94 (0.60 – 6.25) 2.20 (0.71 – 6.80) 
Possible allergic alveolitis 2.16 (1.08 – 4.33) 2.05 (1.07 – 3.93) 2.16 (1.17 – 4.01) 
Possible chronic bronchitis 13.28 (2.28 – 77.39) 7.21 (1.33 – 39.18)  5.83 (1.08 – 31.55) 
    
Each OR represents a separate logistic regression model adjusted for age, gender, smoking, family history of allergy and past history of hospitalisation for lung problems 
OR not determined where dash 
 
Table 14: Adjusted multivariate logistic regression models for specific biological agents associated with upper and lower respiratory symptoms among workers  














The reporting of upper respiratory symptoms (n=161; 64%) were more common than the 
reporting of lower respiratory symptoms which ranged between three percent (n=8; 3%) and 
twenty-eight percent (n=71; 28%). Between two percent (n=4; 2%) and thirty-eight percent 
(n=95; 38%) of workers reported possible work-related respiratory symptom experiences 
depending on the definition used. The common respiratory disease phenotypes included 
general asthma (n=39; 16%), atopic asthma (n=18; 7%), work-related asthma (n=15; 6%), 
work aggravated asthma (n=7; 3%), possible allergic alveolitis / grain fever (n=63; 25%) and 
possible chronic bronchitis (n=7; 3%). Both hazardous chemical agents (sodium hydroxide, 
carbon dioxide, ammonia and kiesselguhr/silica) and biological agents (malt dust, hops and 


















This epidemiological study allowed for the determination of the prevalence of work-related 
respiratory problems and associated risk factors within a brewery in South Africa, using self-
reported symptoms and self-reported exposures obtained from a questionnaire.  
 
Although there have been significant contributions to the knowledge base around asthma and 
allergens, there was the paucity of both international and national literature on respiratory 
health of brewery workers. Whilst a number of studies had described the harmful effects of 
exposure to grain dust on lung function, namely the development of respiratory 
disease amongst grain workers, only a few studies had investigated the respiratory health of 
brewery workers, particularly in relation to malt dust and other chemical agents used in the 
production process.  No studies had documented the prevalence of work-related respiratory 
problems and associated risk factors within a brewery in South Africa. 
 
The demographic profile of the workforce (n=251) in relation to personal and occupational 
characteristics has been described.  The prevalence of work-related respiratory symptoms 
associated with respiratory outcomes amongst workers in different exposure groups has been  
determined.  The relationship between symptoms reported and potential risk factors for 
disease, with specific reference to host and work-related factors, documented.  In order to 
gain greater insight into the risk factors for respiratory health, problems amongst the various 
exposure groups will be discussed.  It is hoped that these findings may contribute to enriching 
the knowledge base of respiratory problems and associated risk factors among these brewery  
workers.  
 
5.2  Discussion of findings 
In this study a higher prevalence of upper respiratory symptoms (n=161, 64%), compared to 
lower respiratory symptoms [within a range of between three percent (n=8, 3%) and twenty-
eight percent (n=71, 28%)], was reported.  Work-related exposure was specifically shown to 












ocular-nasal symptoms, namely rhino-conjunctivitis, could be attributed to other non-
occupational factors in addition to work exposures,  almost half of the participants reporting 
prevalence of upper respiratory symptoms (n=161, 64%), reported ocular-nasal symptoms 
after starting at the brewery (n=75, 30%) and ocular-nasal symptoms worse with work (n=58, 
23%). This was reported in a dose-dependent manner, in that the odds of ocular-nasal 
symptoms being worse with work was higher (OR, 31.50: 95%CI, 3.95 – 251.46) in the high 
versus low exposure group, compared to the medium versus low exposure group (OR, 24.75: 
95%CI 3.23 – 189.54).  
 
Occupational rhinitis and/or occupational conjunctivitis are characterized by ocular 
symptoms, reduced airway caliber, hyper-responsiveness and inflammation, and is caused by 
agents in the workplace (Gautrin & Malo 2010).  These symptoms are common, and often 
precede and co-exist with the onset of occupational asthma (Malo et al. 1997; Gautrin & 
Malo 2010; Nicholson et al. 2010).  It is the presence of occupational rhinitis (OR) and 
occupational conjunctivitis (OC) in a sensitized individual that may identify patients at 
greater risk for developing OA (Nicholson et al. 2005; Dykewicz et al. 2009).  The risk of 
developing this respiratory outcome is highest in the year after the onset of occupational 
rhinitis (Nicholson et al. 2010).   
 
As with OA there are two main forms of occupational rhinitis (OR).  Sensitizer-induced OR 
is caused by sensitizers (usually HMW agents) at work, such as malt dust, and is 
characterized by a latency period required for developing allergic senisitization prior to the 
development of symptoms.  Irritant-induced OR (usually LMW agents), without latency, is  
characterized by the onset of rhinitis following exposures to irritant compounds, such as 
chemicals (Gautrin & Malo 2010).  It has been well documented that symptoms of rhino-
conjunctivitis are often associated with high molecular weight agents such as grain dust 
(Chan-Yeung et al. 1978, Malo et al. 1997).   In this study malt dust was associated with 
ocular-nasal symptoms being worse with work (OR, 2.06: 95%CI, 1.00-4.25).  According to 
Malo et al. (1997), the prevalence of ocular-nasal symptoms was found to be no different for 
high molecular weight than for low molecular weight agents (Malo et al. 1997).  In the case 
of exposure to high molecular weight agents, however, rhino-conjunctivitis was often more 
pronounced, often appearing before occupational asthma  (Malo et al. 1997), compared to 












conjunctivitis of between 45% and 100% in subjects suffering from occupational asthma 
attributed to various agents (Nicholson et al. 2010).   
 
It has been reported that the primary risk of occupational exposure to food allergens, such as 
grain dust, hops and malt dust, is by means of the inhalation of dust, steam and vapor of 
aerolised proteins (Cartier 2010), which may cause occupational lung diseases, such as 
asthma, extrinsic allergic alveolitis and chronic obstructive pulmonary disease (Tarlo et al. 
2008).    
 
The common respiratory disease phenotypes that were identified in this study included 
possible allergic alveolitis/grain fever (n=63; 25%), general asthma (n=39; 16%), atopic 
asthma (n=18; 7%), work-related asthma (n=15; 6%), work-aggravated asthma (n=7; 3%) and 
possible chronic bronchitis (n=7; 3%).  
  
This implies that a large proportion of workers (n=63; 25%) had possible allergic alveolitis 
(grain fever).  This is consistent with the literature that reveals that this acute illness was 
reported in 6% - 32% of exposed workers in different studies (Bernstein et al. 2006).   
 
In this study, the prevalence of lower respiratory symptoms associated with asthma ranged 
between 3%-28%. The high prevalence of doctor diagnosed asthma (n=39, 16%) is consistent 
with previous reports of prevalence of asthma ranging from 1% to 18% in various 
populations (Dykewicz et al. 2009). However, of those participants reporting doctor-
diagnosed asthma, only one third were currently using asthma medication. Interestingly, the 
prevalence of doctor-diagnosed asthma varied across exposure groups with a significantly 
higher prevalence (p=0.011) in the lower exposure group (n=8, 30%) compared to the high 
exposure group (n=8, 12%).  The relatively low prevalence of asthma in the higher exposure 
groups, and lower proportion of older workers in the higher exposure group suggests that 
asthmatics are likely to change jobs and seek alternative employment in lowly exposed jobs, 
or leave the industry shortly after starting employment (Chan-Yeung 2006). This would result 
in the ‘healthy worker survivor effect’.  This ‘effect’ occurs when workers become ill are 
‘selected out’ of employment, through either medical disability or resignation.  This would 
result in reduced risks estimates in a cross-sectional study assessing the relationship between 
the exposure and the outcome, such as asthma (Joubert & Ehrlich 2007).  The ‘healthy 












middle-aged. Most exposed workers are generally healthy, at least when they start working. 
This could indicate that the working population has a lower total morbidity and mortality than 
the population as a whole (Beaglehole, Bonita, Kjellstrom 2005). 
 
Lower respiratory symptoms reported in this study, were often related to work, with over a 
third of the participants (n=95, 38%) reporting possible work-related respiratory symptoms.  
Interestingly, aside from a large proportion of participants reporting exposure to high 
molecular weight protein allergens, such as malt (n=83, 33%), hops (n=67, 27%) and grain 
dust (n=52, 21%), a large proportion of participants also reported exposure to low molecular 
weight chemicals capable of causing allergic as well as irritant induced asthma.  These 
reported chemical exposures included sodium hydroxide (n=123, 49%), carbon dioxide 
(n=108, 43%) and ammonia (n=100, 40%). 
 
As far as the possible relation of respiratory symptoms to work is concerned, unlike doctor 
diagnosed asthma, respiratory symptoms were strongly associated with work-related asthma 
in the high exposure group.  A range of between two percent (n=4, 2%) and thirty-eight 
percent (n=95, 38%) of participants reported possible work-related respiratory symptom 
experiences.  Thirty-eight percent (n=95, 38%) of workers reported experiencing chest 
symptoms after starting at the brewery.   
 
This study reported that a slightly larger proportion of brewery workers with probable asthma 
(56%) had non-atopic (irritant induced) asthma (n=21; 9%), compared to the proportion of 
workers with probable asthma (44%) who had atopic (sensitizer-induced) asthma (n=18, 7%). 
This is consistent with the literature that shows that at least fifty percent (50%) of asthma is 
of non atopic nature (Douwes et al. 2002).     The overall prevalence of work-related asthma 
was six percent (n=15; 6%) and that of work-aggravated asthma three percent (n=7; 3%). 
This suggests that the 37.5% proportion of work-related asthma in this population (n=15; 6%) 
with a sixteen percent (n=39; 16%) overall prevalence of general asthma is quite high.  In 
previous studies it has generally been accepted that between 9% - 15% of adult onset asthma 
could be attributed to workplace exposures or occupational factors (Balmes et al. 2003, 
Henneberger et al. 2007, Tarlo et al. 2008 &  Dykewicz et al. 2009).  
 
With regard to the prevalence of possible chronic bronchitis (n=7; 3%), inconsistencies with 












prevalence of COPD, however, which  includes the definition adopted in this study for 
bronchitis, varies between 5% and 22% globally, 10% - 20% of which can be attributed to 
workplace exposures such as vapors, gases, dusts and fumes, by itself and through interaction 
with other risk factors (Naidoo 2009).   
 
It is well-known that the level of exposure to a causative agent at work is the major 
determinant of risk for the development of occupational asthma (Nicholson, Cullinan, Burge 
& Boyle 2010). Almost a third of this workforce (n=69, 27%) reported peak exposure 
experiences, namely exposure to a large amount of a dust, chemical, gas, vapor or fume, 
causing a chest problem.   
 
It has been stated that reduced airway caliber and hyper responsiveness, as well as an 
inflammatory response is caused by agents in the workplace (Gautrin & Malo 2010).  This is 
followed by subsequent massive infiltration and activation of neutrophils in the upper and 
lower airway which is very similar to the inflammatory response observed in non-
eosinophilic asthma in the general population (Douwes et al. 2002).  This may follow single 
or multiple exposures to irritant compounds such as forms of dusts, vapors, fumes or gases 
(Henneberger 2007). 
 
This was evident in the adjusted multivariate logistic regression models, where hazardous 
chemical agents such as sodium hydroxide (OR, 2.27: 95%CI, 1.09-4.73) and 
kiesselguhr/silica (OR, 2.58: 95%CI, 1.22-5.46) were strongly associated with work-related 
upper airway symptoms and possible rhinitis.   In the form of a liquid or a spray mist, sodium 
hydroxide is a hazardous corrosive and irritant chemical.  It may produce tissue damage 
particularly with regard to mucous membranes of eyes, nose, mouth and respiratory tract, 
with subsequent redness, watering and itching thereof.  According to Shakeri, Dick & Ayres 
(2008), sodium hydroxide is one of the many chemical agents identified and reported as 
being associated with RADS (Shakeri, Dick & Ayres 2008). This chemical, when present in 
very high concentrations, has irritant qualities to its nature.  Linked to RADS, sudden onset of 
respiratory symptoms may simulate asthma, with coughing, wheezing, chest tightness and 













A respirable dust, Kieselguhr/silica contains quartz and crystalline silica, and is an irritant to 
the eyes, nose and throat. Following exposure, congestion and an inflammatory response of 
the upper airway may occur.  Kieselguhr/silica is also a human carcinogen, may cause 
silicosis, a non-cancerous lung disease, bronchitis, emphysema and asthma. Silicosis, a 
chronic lung disease initiated by cellular mechanisms that initiate and propagate a process of 
inflammation and scarring of lung tissue, continues to be a common cause of chronic lung 
diseases (Rimal, Greenberg & Rom 2005).  The variability of pathogenic potential of 
different varieties of silica has been well recognized, such as potential of silica quartz to 
cause Silicosis (Rimal et al. 2005).  These diseases can be prevented by environmental dust 
control.   
 
In the adjusted multivariate logistic regression models, a hazardous biological agent strongly 
associated with work-related upper airway symptoms and possible rhinitis, was malt dust.  
According to Douwes et al. (2002), the primary agent inducing these inflammatory responses 
in workers exposed to organic dust is believed to be bacterial endotoxin. Macrophages carry 
specific endotoxin binding receptors (CD14, TLR4) that play a crucial role in the activation 
of these cells and the subsequent inflammatory reactions (Douwes et al. 2002).  
 
In order to avoid contamination, one essential factor in the food and beverage industry is the 
cleaning and disinfection of the equipment used in processing of the product it produces.  
Sodium hydroxide, a cleaner, disinfectant and a sterilant, is widely used in the brewing 
industry.  An irritant and corrosive, this chemical may produce severe burns or irritation to 
eyes, and, upon inhalation, to the respiratory system. Following severe overexposure, the 
subsequent inflammatory response, characterized by coughing, choking, or shortness of 
breath, may ultimately result in death.  
 
Carbon dioxide is the fourth most common gas in the earth’s atmosphere and the most 
common by-product of living organisms. As a result, many individuals who have an 
occupational exposure to carbon dioxide, believe it to be harmless.  While this is true that 
carbon dioxide is harmless at normal atmospheric levels, it can be absolutely deadly at high 
concentrations (Scott, Kraemar and Keller 2009).  Carbon dioxide is produced and used by 
many industries in its solid, liquid or gaseous states.  In addition to its cooling properties, the 
brewery encounters carbon dioxide during the fermentation process, when it is produced from 












the bottom of enclosed spaces, where, in sufficient concentration, it can act as an asphyxiant 
due to oxygen displacement.  Carbon dioxide is extremely soluble in tissue fluid.  It is carried 
by the blood, either in solution or in combination with haemoglobin.  An increase in carbon 
dioxide levels in the blood results in a decreased affinity of haemoglobin for oxygen.  At 
lower levels, carbon dioxide is a simple asphyxiant, an irritant and a powerful cerebral 
vasodilator  (Scott et al. 2009).  
 
Ammonia, widely used in the brewing industry is an extremely irritating and noxious gas.  
Injury may be thermal as well as chemical to skin, eyes, airways and lungs.  When inhaled, 
ammonia is capable of producing severe damage to all levels of the respiratory tract, 
including laryngotracheitis, pulmonary edema and haemorrhage, bronchopneumonia, 
bronchiectasis and fibrous obliteration of small airways (Montague & Macneil 1980).  
Present in high concentrations, ammonia is one of the chemicals linked to RADS, symptoms 
of which may simulate asthma, including cough, wheeze, tight chest and dysnoea (Shakeri et 
al. 2008). 
 
Both airway inflammation and constriction of the smooth muscles of the airway are known to 
be part of the pathophysiologic events that accompany occupational airway disease (Schacter 
et al.  2000).   In this study, a dose-dependant association was found between self-reported 
level of exposure and lower respiratory symptoms triggered by excessive/peak exposure to a 
dust or chemicals. Workers in the high exposure group were 10 times as likely (OR, 10.45: 
95%CI 3.08–35.45), compared to the lower exposure group, to have reported a chest problem 
caused by peak exposures to a large amount of dust, chemical, dust or fumes (Table 11).  
Chemicals strongly associated with peak exposures included sodium hydroxide (OR, 
2.79:95%CI,1.48 - 5.28), carbon dioxide (OR, 3.92:95%CI, 2.04 -7.56), ammonia 
(OR,3.69:95%CI, 2.01 – 6.78) and kiesselguhr/silica (OR, 4.04:95%CI 2.12 – 7.67) (Table 
13).  Only sodium hydroxide demonstrated strong associations with possible, probable or 
confirmed asthma (Table 13).  Although not strongly associated with the reporting of a 
change of job because of chest problems, chemical work processes cited as the reason for 
necessitating a change of job because of a chest or nasal problem included a need to change 
from processes such as the filler, washer, empty bottle inspection, depallitiser, the kieselguhr 













Relatively strong associations were found between chemicals and dusts and the development 
of possible allergic alveolitis/grain fever. 
 
Reasons cited for the development of fever, chills, following exposure to a product or process 
included exposures to ammonia, carbon dioxide (bright beer tank room, filler, cellars), malt 
dust, kieselguhr/silica and carbon monoxide from forklifts.  Among the biological agents, 
grain dust (OR, 2.16: 95%CI, 1.08-4.33), hops (OR, 2.05: 95%CI, 1.07-3.93) and malt dust 
(OR, 2.16: 95%CI, 1.17-4.04) were strongly associated with possible allergic alveolitis/grain 
fever (Table 14).  Among the chemical agents, sodium hydroxide (OR,7.28; 95%CI, 3.41-
15.56), carbon dioxide (OR, 2.93; 95%CI, 1.53-5.62) and silica (OR, 2.40; 95%CI, 1.27-4.53) 
were strongly associated with this respiratory outcome. 
 
Ventilation in these areas were reported by participants to be either inadequate, non-
operational, ineffective or reduced as a result of an energy-saving initiative at the time of the 
self-reported exposures. 
 
As far as possible chronic bronchitis is concerned, grain dust (OR, 13.28: 95%CI, 2.28-
77.39), hops (OR, 7.21: 95%CI, 1.33-39.18) and malt dust (OR, 5.83: 95%CI, 1.08-31.55) 
were also significantly associated with possible chronic bronchitis (Table 14). 
 
The reporting of harmful effects of grain dust on lung function, namely the development of 
respiratory disease amongst grain workers or workers handling grain products is well 
recognized (Williams et al. 1964; Chan-Yeung et al. 1978; Yap et al 1994; Schwartz et al. 
1995; Vidal & Gonzalez-Quintela 1995; Deetz et al. 1997; Jeebhay et al. 2000;  Sigsgaard & 
Schlunssen 2004; Jeebhay et al. 2005; Sikora et al. 2008; Baatjies et al. 2009).   A few studies 
(Riddle et al. 1968; Riddle 1974; Grant et al. 1976; Ellis & Friend 1981; Heaney et al. 1997; 
Godnic-Cvar et al. 1999; Schachter et al. 2001 & Miedinger et al. 2009),  have investigated 
the respiratory health of brewery workers, particularly in relation to dusts, gasses, vapours 
and fumes.  A number of studies have recognized that, as only a small proportion of exposed 
workers develop occupational reactions, host as well as industrial factors may be associated 
with respiratory outcomes  (Chan-Yeung et al. 1978, Nicholson et al. 2005, Sikora et al 2008, 













Exposure to malt dust and other allergens may lead to the development of acute and chronic 
respiratory symptoms, accompanied by lung function and immunological changes, including 
occupational rhinitis, occupational conjunctivitis, extrinsic allergic alveolitis/grain fever, or 
occupational asthma (Sikora et al. 2008). 
 
Not all exposures cause respiratory problems only at high levels.  The level of grain dust is 
influenced by a number of factors including the type of grain handled, the extent of 
enclosure, the efficiency and upkeep of the exhaust ventilation provided at transport points,  
and work and housekeeping practices (Bernstein et al. 2006).   Although grain is normally 
emptied into the silos by means of an extractor system from base of the train carts, grain is 
not always transported to the brewery by train.  Tipper trucks are also used.  It has been 
observed by workers in this brewery, that the emptying of grain from tipper trucks generates 
far more dust than that from the train.  Annual dust monitoring in this plant has revealed 
varying exposure levels to malt dust during these past few years, which at times have been 
over the legislated recommended limit for total inhalable dust of 10 mg/m3.  It has been 
observed by workers that some malt intakes are more ‘dusty’ than others with the distribution 
of malt/grain dust dispersed all over the plant, such as on a very windy day.  Futhermore, it 
has been reported by participants that engineering control measures to contain the dust and 
limit the number of employees exposed to this dust, such as the use of an extractor system 
and curtains to enclose malt intake area, have been, at times, dysfunctional.  This has resulted 
in greater dispersion of, and over-exposure of employees, to this dust.  Subsequent enclosure, 
however, of the sides of the malt intake area with metal plates a few months ago, together 
with the re-institution of the extractor system, when in use, has had a positive impact on 
reducing the dust levels. 
 
Dust exposures in this brewery have recently reported as being below the threshold limit 
values. Occupational asthma and extrinsic allergic alveolitis may, however, occur with 
exposure to lower concentrations due to the allergic basis for these symptoms (Chan-Yeung 
et al. 1978). This implies that general particulate dust levels are a poor index of exposure to 
allergens and cannot be used as a basis for determining the risk of developing allergic 
respiratory disease.  The occupational exposure control limit for silica has been amended in 
Table 1 of the Hazardous Chemical Substances Regulations from 0.4mg/m3 to 0.1mg/mg3.  
The specific standards presently being suggested for a number of allergens include the 












by ACGIH), for ammonia, 17mg/m3, for carbon dioxide, 9000mg/m3 (although 4mg/m3 is 
suggested by ACGIH), and for sodium hydroxide, 2mg/m3.  It is to be noted that 
international variation of limits set, vary.   
 
Personal protective equipment is worn.  This, however, is not mandatory for all processes, as 
expected levels of exposure are minimal or engineering control measures, such as extractor 
fans, are in place.  It has been reported by participants, however, that ventilator systems are 
not always functional or adequate, that these may, at times, be absent, ineffective or not in 
use.   
 
In this study, in addition to environmental factors, several host-related factors were also 
identified. Among the host factors, age (OR 1.06, 95%CI, 1.02 – 1.10) and the male gender 
(OR 4.80, 95%CI 2.11 – 10.94) where associated with the experiencing of chest symptoms 
after starting at the brewery.  The male gender, the reporting of previous hospitalization for a 
lung disease, and a family history of allergy, hay fever or asthma was strongly associated 
with the respiratory symptom outcomes (Table 10). 
 
The study found a strong association between exposure and the gendered distribution of 
work.  Consistent with brewery populations in previous studies, in this study, the study 
population was predominantly male (n=195, 78%) (Table 3).  Males were, therefore, more 
likely to have adverse respiratory outcomes as they were more likely to be found in the higher 
and medium exposure groups rather than the lower exposure group.  Ninety percent (90%) of 
workers in the high exposure group were males (n=58, 23%).  Ninety percent (90%) of 
workers in the medium exposure group were male (n=116, 46%).  Only thirty-nine percent 
(39%) of workers in the low exposure group were male (n=22, 9%).  The female gender, 
mainly employed in administration, sales and marketing of the product, predominated the low 
exposure group (61% female gender) (Table 8). 
 
With regard to atopy, the association between atopy and the development of occupational 
asthma caused by high molecular weight agents is well recognized (Nicholson et al. 2005, 
Sikora et al. 2008, Baatjies et al. 2009 & Nicholson et al. 2010).  Atopic individuals 
commonly have a family history of allergy.  In this study a relatively high percentage (n=62, 
25%) of participants reported a family history of allergy, hay fever, asthma (Table 3).  This 












3.25, 95%CI, 1.60 – 6.63) and work-aggravated asthma (OR 8.16, 95%CI 1.54 – 43.1) (Table 
10).  This was unlike a study of grain workers where the proportion of individuals with atopy 
in grain workers appeared to be about the same in that working population as the general 
population (Chan-Yeung et al. 1978). The previous study of male workers in a brewery plant, 
demonstrated that atopy was not a major factor responsible for the high prevalence of chronic 
respiratory symptoms in this population (Godnic-Cvar et al. 1999).   
 
Tobacco use has been associated with 42% of chronic respiratory disease (World Heath 
Organisation 2009). Conflicting evidence is available, however, regarding the role of 
cigarette smoking as far as occupational asthma is concerned (Nicholson et al. 2010).  
Cigarette smoke has been found to increase bronchial epithelial permeability, potentially 
allowing inhaled allergens increased access to immune-competent cells and an immune 
response (Sikora et al. 2008).   According to Chan-Yeung et al. (1978), the effects of cigarette 
smoking has an additive effect on grain dust exposure and is the most important factor 
influencing the frequency of chronic bronchitis (Chan-Yeung et al. 1978).  Interestingly, 
smoking was not found to be a significant factor associated with the respiratory outcomes of 
interest in this study.  Although a substantial proportion of the workforce studied (35%) were 
smokers (n=88, 35%), the majority of smokers (n=57, 65%) reported smoking less than 10 
cigarettes per day.  Only eight percent (n=7, 8%) of participants reported having smoked 
more than 20 cigarettes per day (Table 3).   
 
In this study five percent (n=13, 5%) of workers reported a previous history of a serious lung 
problem for which the participant had to be hospitalized.  Two percent (n=5, 2%) of the 
participants reported a past history of tuberculosis for which they did not need to be 
hospitalized (Table 3).  Our study showed that previous hospitalization for a serious lung 
problem was strongly associated with adverse respiratory symptom outcomes.  These 
included asthma (OR, 5.32, 95%CI, 1.68-16.83), work-aggravated asthma (OR,17.55, 
95%CI, 3.45 – 89.15), atopic asthma (OR, 7.11, 95%CI  1.95 – 25.98) and work-related 
asthma (OR, 9.17, 95%CI 2.44 – 34.48) (Table 10).  Other studies have documented a strong 
association between respiratory infections and lung infections.  Tuberculosis and childhood 
infections has been significantly associated to all asthma outcomes and strongly linked to the 













5.3  Significance to clinical practice   
The high prevalence of work-related respiratory symptoms associated with chemical (Table 
13) and biological (Table 14) exposures in a brewery were identified.  In addition, several 
host-related factors were also associated with work-related respiratory symptoms (Table 10) .  
This study points to the need for appropriate preventative strategies to be undertaken in order 
to reduce exposures and more targeted respiratory medical surveillance of exposed workers. 
A more targeted respiratory medical surveillance of exposed workers in the long term will 
reduce the incidence of respiratory problems among brewery workers, and ensure the 
protection and promotion of the respiratory health of employees in the workplace.   
 
5.4 Limitations 
There are potential limitations of this study (Please refer to 3.11.4 page 43:  Bias) that need to 
be borne in mind when interpreting the results of this study. Selection may bias results of this 
study due to the opportunistic nature of the sample selected.  All individuals would, however, 
have had an equal chance of presenting to the clinic for their annual medical surveillance.  
There is a possibility that there may have been some exposure misclassification in grouping 
the workers as no objective measurements were done. Similarly, there were no objective tests 
done to confirm the presence of asthma, and no objective tests done, such as Xrays to confirm 
the presence of Silicosis.  There were no tests done to confirm the diagnosis.  However, the 
questionnaire instrument has been well validated in other settings to identify asthmatic 
individuals. It is acknowledged that the definition for possible allergic alveolitis may be quite 
crude and therefore lacked specificity.  Furthermore, only permanent, full time employees, 
who were generally of higher socio-economic status, and, therefore, possibly healthier than 
non-permanent employees, participated in this study.  This may have caused the ‘healthy 
worker survivor effect’.  This ‘effect’ results when workers become ill are ‘selected out’ of 
employment, through either medical disability or resignation.  This will result in reduced 
risks estimates in a cross-sectional study assessing the relationship between the exposure and 
the outcome, such as asthma (Joubert & Ehrlich 2007).  Since this study was cross-sectional 
in nature, this study may have reflected the resulting ‘survivor effects’.  Workers who had 
recently left the company or changed jobs in order to safeguard their health may also have 
contributed to the ‘healthy worker survivor effect’ observed.  Attempts were made to account 
for this latter effect by collecting data and analyzing for those who had changed their jobs on 













5.5.1 Research Objectives 
i. To describe the demographic profile of the workforce in relation to personal and 
occupational characteristics. 
 
ii. To classify the subjects into 3 exposure groups based on subjective levels of exposure to 
dusts, gases, vapors and fumes in different departments.  This was based on the principle 
investigators prior knowledge and assessment of departmental level of exposure to 
chemical and biological dusts, gases, vapours and fumes.  Prior knowledge of the 
principle investigator, to the level of exposure, was built on current risk assessments and 
level of medical surveillance to which each department was currently subjected to, at the 
brewery. Exposure levels included: 
• High exposure: Brewing (Including Utilities), Logistics. 
• Medium exposure:  Packaging, Warehouse, Laboratory (Including QAQC). 
• Low exposure:  Administration (Including Sales and Distribution). 
 
iii. To determine the prevalence of work-related respiratory symptoms associated with 
allergic respiratory outcomes (rhino-conjunctivitis, asthma, extrinsic allergic alveolitis 
and chronic bronchitis) among workers in these different exposure groups. 
 
iv. To document the relationship between work-related respiratory symptoms reported and 
potential risk factors for disease with specific reference to: 
• Host factors: Age, gender, smoking status, atopy (allergic tendency), previous family 
history (of allergy, hay fever or asthma); 
• Work-related factors:  Exposure group category (to dusts, gases, vapors or fumes) 
 
5.5.2 Presentation of results with reference to tables 
A total of two hundred and fifty-one (n=251; 61%) permanently employed brewery workers 
(n=414) were selected to participate in the survey.  The mean age of this study sample was 40 
years.  The majority of the participants were male (n=195; 78%).  The years of service in 
current jobs of participants averaged 10 years (Table 3)  Job categories varied quite 
substantially (Addendum 8).  Of interest, twenty-five percent (n=62; 25%) of participants 












of workers reported a past history of a serious lung problem for which the participant had to 
be hospitalized.  Only two percent (n=5; 2%) of participants reported a history of tuberculosis 
for which they did not need to be hospitalized (Table 3). 
 
Subjects were classified into 3 exposure groups, based on visual inspection of levels of 
exposure to dusts, gases, vapors and fumes in different departments. Exposure levels 
included: 
• High exposure: Brewing (Including Utilities), Logistics. 
• Medium exposure:  Packaging, Warehouse, Laboratory (Including QAQC). 
• Low exposure:  Administration (Including Sales and Distribution).  
 
The study population was predominantly male (n=95; 78%) with a mean age of 40 years and 
an average of 10 years employed in the current job.  Thirty-five percent (n=88; 35%) of the 
workforce were smokers, twenty-five percent (n=62; 25%) reported a family history of 
allergy, hay fever, asthma and sixteen percent (n=39; 16%) reported doctor- diagnosed 
asthma (Table 3). 
 
The more common hazardous biological agents used in the analysis and to which brewery 
workers reported to have been exposed to was kieselguhr and silica dust (n=88; 35%), and to 
malt dust (n=83; 33%) (Table 4). 
 
The most common potentially hazardous chemical agents reported included sodium 
hydroxide (n=123; 49%), carbon dioxide (n=108; 43%), ammonia (n=100; 40%), 
kieselguhr/silica dust (n=88; 35%), and malt dust (n=83; 33%) (Table 5). 
 
The common respiratory disease phenotypes included general asthma (n=39; 16%), atopic 
asthma (n=18; 7%), work-related asthma (n=15; 6%), work aggravated asthma (n=7; 3%), 
possible allergic alveolitis / grain fever (n=63; 25%) and possible chronic bronchitis (n=7; 
3%) (Table 7). 
 
Upper respiratory symptoms (n=161; 64%) were more common than lower respiratory 
symptoms (3 – 28%). Between 2% and 38% of workers reported possible work-related 












The common respiratory disease phenotypes included general asthma (n=39; 16%), atopic 
asthma (n=18; 7%), work-related asthma (n=15; 6%), work aggravated asthma (n=7; 3%), 
possible allergic alveolitis / grain fever (n=63; 25%) and possible chronic bronchitis (n=7; 
3%) (Table 7). 
 
Among the host factors, age, male gender, previous hospitalization for a lung disease and a 
family history of allergy, hay fever or asthma was strongly associated with the respiratory 
symptom outcomes (Table 10). 
 
In the adjusted multivariate logistic regression models,  hazardous chemical agents such as 
sodium hydroxide (OR, 2.27: 95%CI, 1.09-4.73) and kiesselguhr/silica (OR, 2.58: 95%CI, 
1.22-5.46) were strongly associated with work-related upper airway symptoms.  Workers in 
the high exposure group were 10 times as likely (OR, 10.45: 95%CI 3.08–35.45), compared 
to the lower exposure group, to have reported a chest problem caused by peak exposures to a 
large amount of dust, chemical, vapors, gases or fumes.  Chemicals strongly associated with  
lower respiratory symptoms in general and excessive levels of either dust, chemical, gas, 
vapor or fume causing a chest problem included sodium hydroxide (OR, 2.79: 95%CI,1.48 - 
5.28), carbon dioxide (OR, 3.92: 95%CI, 2.04 -7.56), ammonia (OR,3.69: 95%CI, 2.01 – 
6.78).  In addition, sodium hydroxide (OR, 7.28: 95%CI, 3.41-15.56), carbon dioxide (OR, 
2.93: 95%CI, 1.53-5.62) and kiesselguhr/silica (OR, 2.40: 95%CI, 1.27- 4.53) were 
significantly associated with possible allergic alveolitis.  Only sodium hydroxide 
demonstrated strong associations with possible, probable or confirmed asthma (Table 13). 
 
Among the biological agents, grain dust (OR, 2.16: 95%CI, 1.08-4.33), hops (OR, 2.05: 
95%CI, 1.07-3.93) and malt dust (OR, 2.16: 95%CI, 1.17-4.04) were strongly associated with 
possible allergic alveolitis/grain fever.  Grain dust (OR, 13.28: 95%CI, 2.28-77.39), hops 
(OR, 7.21: 95%CI, 1.33-39.18) and malt dust (OR, 5.83: 95%CI, 1.08-31.55) were also 













5.5.2.1 Conclusion and significance to clinical practice  
Brewery workers exposed to high levels of dust, chemical, gas, vapour, fumes are at 
increased risk of developing work-related respiratory symptoms and developing work-related 
asthma, chronic bronchitis and possible allergic alveolitis/grain fever. The symptoms are 
associated with exposure to once off peak exposures of dust, chemical, gas, vapour or fumes. 
Both hazardous chemical agents (sodium hydroxide, carbon dioxide, ammonia and 
kiesselguhr/silica) and biological agents (malt dust, hops and other grain dust) are implicated. 
 
The high prevalence of work-related respiratory symptoms associated with chemical and 
biological exposures in a brewery were identified.  In addition, several host-related factors 
were also identified.  This survey points to the need for appropriate preventative strategies to 
be undertaken in order to reduce exposures and more targeted respiratory medical 
surveillance of exposed workers. This, in the long term, will reduce the incidence of 
respiratory problems among brewery workers and ensure the protection and promotion of the 
respiratory health of employees in the workplace. 
 
5.5.3 Present recommendations based on results obtained 
Work-related factors can be responsible for up to 25% of adult asthma cases.  It has been 
revealed that WRA is under-diagnosed, poorly diagnosed and managed and inadequately 
compensated in South Africa (Jeebhay 2010).  It is recommended that WRA (OA + WRA),  
be considered in all adult patients with new onset or worsening asthma through the taking an 
appropriate history.  Upon a confirmed positive diagnosis it is advised the patient be 
investigated to determine the presence of WRA.  These tests should be performed prior to 
advising the patient to change his job (Jeebhay 2010). 
 
5.5.3.1. Adequate history taking to assess the probability of respiratory problems 
It is recommended that the probability of WRA and other respiratory problems should by 
assessed, based on adequate history taking (Jeebhay 2010). According to Nicholson, 
however, care should be taken that health practitioners avoid use of poorly discriminating 
factors, such as atopy, cigarette smoking or a family or personal history of asthma which may 
increase individual susceptibility to occupational asthma for some agents, as a reason to 













5.5.3.2. Confirm the diagnosis of asthma/respiratory problem 
It is recommended that a diagnosis of occupational asthma be confirmed by objective criteria 
and not on the basis of a compatible history alone.  Tests could include skin prick tests, 
specific IgE tests, spirometry.  It has been recommended that arrangements be made for 
workers who are suspected to having occupational asthma to perform serial peak flow 
measures at least four times per day for at least 3 weeks (Tarlo et al. 2008). 
 
5.5.3.3. Establish the work-relatedness of the asthma/respiratory problem 
In relation to the above, in individuals who have asthma not caused by work but subsequently 
worsens while working, the diagnosis of WEA should be considered (Tarlo et al. 2008). 
 
In individuals with suspected sensitizer-induced OA, in addition to carefully documenting the 
occupational history, additional objective tests could be performed when feasible (e.g. serial 
peak flow recordings, serial methacholine challenges, immunologic assessments, induced 
sputum testing, SICs to improve the diagnostic probability). 
 
In individuals with suspected WRA who are currently working at the job in question, the 
recording of serial measurements of peak flow as part of the diagnostic evaluation is 
suggested. A minimum of four times daily, for at least two weeks at work and two weeks off 
work should be optimally recorded. 
 
In individuals with suspected sensitizer-induced OA, working at the job in question, a 
methacholine challenge test could be performed or comparable measurements of nonspecific 
airway responsiveness be obtained during a working period.  This could be repeated this 
during a period away from work exposure to identify work-related changes. 
 
In individuals with suspected sensitizer-induced OA, perform immunological tests (skin prick 
testing or in vitro specific IgE assays) to identify sensitization to specific work allergens 
when these tests are technically reliable and available. 
 
In individuals with suspected sensitizer-induced OA, conducting an SIC is suggested when 
the diagnosis or causative agent remains equivocal, performed only in specialized facilities, 













5.5.3.4 Avoid further exposure 
The major determinant of risk for the development of occupational asthma is the level of 
exposure to its causes (Nicholson et al. 2010).  In the light of the findings of this study it is 
recommended that preventive actions be aimed at avoiding exposure (Jeebhay 2010), 
reducing occupational exposures, especially peak exposures to chemical irritants and long 
term exposures to biological agents to reduce the incidence of work-related respiratory 
disease.  This may be achieved by means of the substitution of an agent with a less toxic 
agent, ensuring adequate enclosure, efficiency and upkeep of the exhaust ventilation system, 
whether local or general, at various points, and maintaining work and housekeeping 
practicing (Bernstein et al.2006).  Reducing airborne exposure by means of substituting the 
agent with a less harmful agent, engineering and hygiene measures, including the use of 
respiratory protection and worker education and training, can prevent acute and chronic 
respiratory symptoms (Henneberger 2007).  
 
Industrial hygiene monitoring programs (for particulate dust, allergens and chemicals), with 
aim of the maintenance of respiratory health and safety of all employees, needs to ensure that 
the preventive measures are effective in reducing exposures. This would include an adequate 
personal and environmental monitoring program that accommodates peak exposures. 
 
For all individuals with WRA, attempt better control of exposures.  Remove patients with 
sensitizer-induced OA from further exposure to the causative agent in addition to providing 
optimal asthma management. 
 
In individuals with irritant-induced or WEA, it has been advised that asthma treatment be 
optimized together with reduction in exposure to relevant workplace triggers. 
 
For workers who are potentially exposed to sensitizers or uncontrolled levels of irritants, 
primary prevention through the control of exposures (eg. elimination, substitution, process 













5.5.3.5 Optimising asthma treatment 
The treatment of occupational asthma is no different to the treatment of other types of 
asthma.  It is recommended, however, that efforts be made to increase the use of inhaled 
corticosteroids early after diagnosis (Jeebhay 2010).  General measures to be taken include 
the cessation of smoking, the avoidance of common aeroallergens to which the patients may 
also be sensitized, and to prevent further exposure to high concentrations of irritants (Jeebhay 
2010). 
 
5.5.3.6 Ensure ongoing follow-up and assessment of impairment and/or disability 
Furthermore, it is recommended that a targeted respiratory medical surveillance program with 
the aim of identifying the common adverse respiratory outcomes  observed in this study 
including allergic alveolitis and grain fever, work-related asthma (work-aggravated and 
occupational asthma) and chronic bronchitis, be provided. This should be done at least 
annually, and more frequently in the first years of exposure, as the likelihood of improvement 
or resolution of symptoms or of preventing deterioration is greater in workers who have 
relatively normal lung function, and shorter duration of exposure, at the time of diagnosis 
(Nicholson et al. 2010).  Use should be made of standardised questionnaires, as well as 
objective tests such as immunological tests and lung function spirometry. 
 
5.5.3.7 Assist with worker’s compensation claim 
According to Jeebhay (2010), about one-third of workers with OA are unemployed at 6 years 
after diagnosis and are known to suffer financially.  It is recommended that impairment and 
disability evaluation is carried out as soon as asthma is stabilized and 2 years later.  
Importance is placed on the physician to support the affected workers in the application of 
workman’s compensation claims, and the reporting of the occupational disease to the 
Department of Labour (Jeebhay 2010). 
 
An individual diagnosis of OA represents a potential sentinel health event. 
 
Evaluate the workforce to identify and prevent other cases of OA in the same setting. 
 













5.6. Recommendations for future research 
Further studies are required to validate the usefulness of the ‘follow-up’ questionnaire for 
workers, to detect early affected workers. 
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Addendum 2: Memorandum of Understanding  
Memorandum Of Understanding Between S.A. Breweries And Gail Irwin 
Principal Investigator:  Gail R. Irwin    Student:  University of Cape Town 
Course:  MSc (Nursing).  Student No:  HLMGAI001 
 
Introduction and purpose of the study: The purpose of this survey is to determine the prevalence of 
respiratory problems, including asthma and allergy, as well as patterns and factors associated with these 
outcomes within the brewery setting, in order to identify groups of workers that may be potentially at risk of 
developing respiratory problems, with ultimate aim of further refinement of the medical surveillance and health 
care programme,  if indicated, in order to achieve optimal health of  employees.  
 
Sample frame and size: A sample of at least 200 workers will be drawn from currently employed permanent 
fulltime brewery workers (n = 358).  The study population will be classified into 3 exposure groups based on 
subjective levels of exposure to dusts, gasses, vapours and fumes in different departments, categorized into high, 
medium and low exposure groups.  All subjects in the high exposure group, and a proportion of workers in the 
medium and low exposure groups will be included in the study.   
 
Explanation and procedure: Those that meet certain criteria, including that of being employed at the brewery 
in a full time capacity  will be invited to participate in this study.  Participation is entirely voluntary, on an 
informed basis.  Full participation will be encouraged to ensure a 100% response rate. This will take the form of 
an interviewer-administered questionnaire (which should take no longer than 15 minutes of the subjects time) 
linked to routine annual medicals, at work, during working hours. An appointment or private phone call will be 
made if necessary.  
 
Ethical Approval: Ethics approval has been obtained from the Faculty of Health Sciences Human Research 
Ethics Committee, and adheres to the Declaration of Helsinki (Seoul version, 2008). 
 
Rights and confidentiality: All information collected during the course of this study will be kept confidential to 
the extent permitted by law.  Responses will not be linked to the participant personally and individual names 
will not be included in the analysis of the findings.  The participant may refuse to answer any question.  The 
participant may feel free to withdraw from the study at any time.  Withdrawal from the study will not result in 
any negative consequences to the participant. 
 
Risks and discomforts of the research: There are no risks from completing the questionnaire. 
 
Compensation: There is not remuneration or compensation for participation in the study.  
 
Expected benefits to the participant and others: What we hope to learn from this study is how many people 












health problems among brewery workers and assist in the identification of appropriate preventative strategies 
that may be taken in order to reduce the incidence of these problems among brewery workers, with ultimate aim 
of the protection and promotion of the respiratory health of employees in the workplace.  It is, however, 
emphasised that although the study will recommend changes, the study will not implement any changes, as the 
researcher cannot guarantee that management will act on any recommendations.   
 
Costs: Tthe study is offered at no cost to the participant.  In the event a problem is discovered and the 
participant wishes to be seen by a doctor for it, the principle investigator will recommend to the participant who 
to see should the participant not have a family doctor. However, it will be emphasized that the study cannot pay 
for these additional medical visits or treatments.  Normal protocol of the brewery will apply, however, regarding 
the diagnosis, management and reporting of occupational disease. 
 
Questions: If there are any further questions in relation to the research methods to be used in this study, Gail 
Irwin can be contacted at the following email address:  gail.r.irwin@gmail.com  
 
Consent to participate in the study: To voluntarily agree to take part in the study, the participant will be 
requested to sign a consent form.  The participant will not be giving up any of his/her legal rights by signing this 
form.  The signature will indicate that the participant has read, or had read to him/her, the entire consent form, 
including the risks and benefits, and had all questions answered.  The participant will be given a copy of thereof. 
 
Commitment of researcher to S.A. Breweries, Newlands: Gail Irwin acknowledges the commitment that all 
information collected will be held in the strictest of confidence, and only accessible to the research team.  A 
report of findings will be presented to management.  The findings will be reported in a thesis for degree 
examination purposes.  S.A. Breweries  recognise that, where appropriate, findings may be published in 
scientific literature in accordance with academic practice, but the company will have the right to see and 
comment on any manuscripts; and a period of 6 months will be allowed for the company to respond to any of 
the findings.  Good faith will be expected from the researcher to ensure the findings are interpreted objectively 
and accurately and presented as such. 
 
___________________________    ___________________________ 
Signature of Researcher      Date 
 
_______________________________    ________________________________ 
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RESPIRATORY HEALTH SURVEY WITHIN A BREWERY IN SOUTH AFRICA 
2010 
For all questions; 
1 Yes 
2 No 
3 Do not know 
Code for interviewer: 
1. gi: Gail Irwin 
A. DEMOGRAPHICS 
CODING SYSTEM FOR THE QUESTIONNAIRE 
1. Code for 'what is your date of birth'? (dob): 
1.1. Code for 'date of birth': year (dob_year) 
1.2. Code for 'date of birth': month: (dob_month) 
1.3. Code for 'date of birth': day: (dob_day) 













2.1. Code for 'today's date': year: (today_year) 
2.2. Code for 'today's date: month: (today_month) 
2.3. Code for 'today's date: day: (today-day) 
3. Code for 'Are you male or females' (gender) 
1. Male 
o. Female 
4. Code for 'Do you have a family history of allergy, hayfever or asthma?': (fam_hist) 
5. Code for smoking status: 
5.1. Code for 'Are you a non-smoker (lifelong absence from smoking cigarettes)?' (non_smok) 
5.2. Code for 'Are you an ex-smoker (ceasing of smoking more than a month before the 
survey)?' (ex_smok) 
5.3. Code for 'Are you a current smoker?' (curr_smok) 
5.4. 1 Code for number 'cigarettes smoked currently' (no_cig_smok_curr) 
1. 0 cigarettes 
2. 1-10 cigarettes 
3. 11-20 cigarettes 
4. More than 20 cigarettes 
5.4.2 Code for number of 'cigarettes smoked in the past' : (no_cig_smok_past) 
1. 0 cigarettes 
2. 1-10 cigarettes 
3. 11-20 cigarettes 













B. CHEST SYMPTOMS: 
§.o. Code for 'Have you had wheezing or whistling in your chest at any time in the last 12 
months?' (whz_whist_12mnths) 
6.1. Code for 'Have you been at all breathless when the wheezing noise was present?' 
(b'less_whz) 
6.2. Code for 'Have you had this wheezing or whistling when you did not have a cold?' 
(whz_whist_no_cold) 
7. Code for' Have you woken up with a feeling of tightness in chest at any time in last 12 
months?' (woke_tightchest) 
8. Code for 'Have you ever had an attack of shortness of breath at rest in last 12 months?' 
(sh'brth_rest) 
9. Code for 'Have you ever had an attack of shortness of breath after exercise/exertion in last 
12 months?' (sh'brth_exerc) 
10. Code for 'Have you ever had an attack of shortness of breath at night or woken at night 
by an attack of shortness of breath in last 12 months?' (sh'brth_night) 




12. Code for 'Were there changes in work processes in period preceding the onset of 
wheezing or shortness of breath?' (workproc_whz_sh'brth) 
13. Code for 'Are these chest symptoms worse, better or no different when working in our 
current job?' (whz_sh'brth_cur~ob): 
1. Worse 
2. Better 
3. No different 
14. Code for 'Do you have chest symptoms, such as wheezing, shortness breath that improve 














15. Code for 'Did a Doctor ever tell you you had Asthma' (dr_tell_asthma) 
15.1. Code for 'Have you had an attack of asthma in last 12 months?' (asthma_12mnths) 
15.2. Code for 'Are you currently taking medicine for asthma?' (med_asthma) 
15.2.1. Code for 'Have you had to increase your asthma medication while working in this job? 
(increase_med,job) 
16. Code for 'Have you ever developed fever, chills, cough, difficulty in breathing a few hours 
after exposure to a product or after a certain work activity?' (fever_chills_aft_exp) 
16.1. Code for 'Have you ever developed fever, chills, cough, difficulty in breathing a few 
hours after exposure to a product or after a certain work activity? Specify 
(fever _ chills_aft_exp_specify) 
17. Code for 'Do you cough on most days/nights for as much as three or more months in each 
of the last two years?' (cough_3mnths_2yrs) 
18. Code for 'Have you ever had any nasal allergies including hay fever, runny nose, blocked 
nose or itchy, red, watery eyes in the last 12 months?' (nas_allergy_12mnths) 
18.1. Code for 'Did you have any nasal allergies, including hay fever, runny nose, blocked 
nose or itchy, red, watery eyes in the last 12 months, that is worse with work? 
(nas_allergy_worsework) 
O. No (Not worse) 
1. Yes (Worse with work) 
18.2. Code for 'Did you have any nasal allergies including hayfever, runny nose, blocked nose, 
or itchy watery red eyes, before or after starting at the brewery, or only with a cold? 
(nas_allergy _beCafter _cold): 
O. Before starting at the brewery 
1. After starting at the brewery 
3. Only with a cold 
19. Code for 'Do you have or ever had, TB of the lungs?' (tblungs) 














20.1 Code for 'Do you or did you ever have a serious lung problem for which you needed to 
be hospitalized? Specify' (Iungproblem_hosp_specify) 
C. CURRENT WORK HISTORY: 
21. Code for 'As a permanent employee, are you employed by the brewery or by a 
contracting firm at the brewery? (perm_brew_contr): 
1. Permanently employed by the brewery 
2 Permanently employed by a contracting firm. 
22. Code for 'How long have you been working in this brewery?: (yrs_mnths_brewery): 
23. Code for 'How long have you been working in your current job?: (yrs.mnths.currjob): 
24. Code for 'In which areas/sections/departments are you currently working? 
01. Are you currently working in utilities/Logistics? (utilJog_dept_curr) 
02. Are you currently working in brewing/brewing Engineering? (brew_dept_curr) 
03. Are you currently working in packaging/packaging engineering? (pack_dept_curr) 
04. Are you currently working in warehouse? (warehouse_dept_curr) 
as. Are you currently working in the laboratory? (Iab_dept_curr) 
06. Are you currently working in admin/sales/distribution? (admin_sales_dist_dept_curr) 
07. Are you currently working in any other department? (dept_other) 
If 'yes', specify which department: (dept_other _specify) 













26. Code for 'Give a short description of your job in this section' (jobdescribel) 
D. PAST WORK HISTORY 
27. Code for 'Did you previously work in another department in the brewery?' 
(work_otherdept) 
28. Code for 'In which departmentjs did you previously work?' 
01. Did you previously work in utilities/Logistics? (utiUoLdept_prev) 
02. Did you previously work in brewing/brewing Engineering? (brew_dept_prev) 
03. Did you previously work in packaging/packaging engineering? (pack_dept_prev) 
04. Did you previously work in warehouse? (warehouse_dept_prev) 
05. Did you previously work in the laboratory? (Iab_dept_prev) 
06. Did you previously work in admin/sales/distribution? (admin_sales_dist_dept_prev) 
07. Did you previously work in any other department? (dept_other_prev) 
If 'yes', specify which department: (dept_other_prev_specify) 
29. Code for 'What was your job in this area/section?' (jobtitle2) 
30. Code for 'Give a short description of your job in this section' (jobdescribe2) 
E. EXPOSURE HISTORY 
31. Code for 'Which dust products do you come in contact with, or work with, whilst working 
in this brewery? 
31.1. Did you come in to contact with malt/malt dust?: (malt_dust) 
31.2. Did you come in to contact with grain dust?: (grain_dust) 













31.4. Did you come into contact with Kieselguhr?: (kieselguhr) 
Did you come into contact with silica?: (silica) 
31.5. Did you come in to contact with other dust?: (other_dust) 
Specify which 'other dust' you came in contact with (other_dust_specify) 
32. Code for 'Do you or did you come in contact with, any chemicals such as chemical 
cleaning/disinfectants/sterilizing agents (e.g. caustic soda, sterilant, make-up fluid, solvents 
etc.?: (contact_chem) 
If yes, specify which chemicals: (contact_chemicals_specify) 
33. Code for 'do you/did you come in contact with, any gases, refrigerant/cooling gases, 
liquids?: (contact....llases) 
If yes, specify which gases: (contact....llases_specify) 
34. Code for 'Do you come in contact with vapours/fumes? (contact_vap_fumes) 
If yes, specify which vapours or fumes: (contact_vap_fumes_specify) 
35. Code for 'Has there been an instant when you inhaled a large amount of vapour, dust, gas 
or fumes in any of these jobs that resulted in you developing a tight chest, wheeze or cough, 
within the next 24 hours? (large_amnt_symptoms_24hrs) 
If yes, specify which vapours, dusts, gases or fumes: (large_amnt_symptoms_24hrs_specify) 
36. Code for 'Do you come in contact with other ego moulds/mildew? (mould_mildew) 
If yes, specify which, moulds or mildew? (mould_mildew_specify) 
37. Code for 'Do you come in contact with birds, pests, insects (e.g. cockroaches)? 
(bi rds _pests _i nsects) 
If yes, specify which birds, pests, insects (birds_pests_insects_specify) 
38. Code for "Do you/did you use any personal protective equipment on a regular basis 
(almost every day) while doing your job? (ppe) 
38.1. Code for 'Do you use safety glasses?': (sgl) 
38.2. Code for 'Do you use safety goggles?' : (sgg) 













38.4. Code for 'Do you use mask(s} ?': (msk) 
38.5. Code for 'Do you use a face shield?': (fs) 
38.6. Code for 'Do you use a respirator?': (resp) 
38.7. Code for 'Do you use any other form of personal protective equipment?': (other) 
Specify which form of other personal protective equipment: (other_specify) 
39. Code for 'Did you ever have to change your job because you had a chest problem? 
(chnge_chestprob ): 
INTERVIEW 
40. Code for 'Type of interview': 
40.1. Code for 'Was it a face to face interview'?' (face_interv) 
40.2. Code for 'Was it a telephonic interview?' (teUnterv) 












Addendum 4a:  ECRS Request 
___________________________________________________________________________ 
 
School of Health and Rehabilitation Sciences 
Faculty of Health Sciences 
Divisions of Communications Sciences and Disorders, 
Nursing and Midwifery, Occupational Therapy, 
Physiotherapy  
 
F45 Old Main Building, Groote Schuur Hospital,  
Observatory 7925 




12 May, 2010 
 
Dear Professor Peter Burney and Dr. Deborah Jarvis, 
 
Re: The European Community Respiratory Health Survey 11:  Screening Questionnaire 
 
I am a Masters student at University of Cape Town, and currently wishing to conduct a study, for my thesis, on 
‘Work-related allergy and asthma and their associated risk factors, among brewery workers in the Western 
Cape, South Africa”. 
 
My Supervisor is Professor Doris Khalil, School of Health and Rehabilitation Sciences, University of Cape 
Town.  My Co-Supervisor is Professor Mohamed Jeebhay, Centre for Occupational and Environmental Health 
Research, School of Public Health and Family Medicine, University of Cape Town. 
 
I have found this tool very useful and request permission to replicate the tool for this small scale study.  It would 
be my intention for each participant to answer a standard questionnaire, a modified version of the ECRHS 11 
questionnaire, modified for local conditions, and specifically designed for the investigation of asthma and 
allergy, acute and chronic work-related and non work-related respiratory symptoms and conditions, 
environmental exposure, subjective categorization of exposure including host risk factors, use of personal 
protective equipment, past medical history, past work history, workers description of job in a specific work area, 
dietary factors and domestic activities. 
 
I will be very grateful if you could kindly acknowledge your willingness to permit the use of a modified version 







Student Number:  HLMgai001 
















Gail Irwin <gail.r.irwin@grnail.com> 
ECRHS questionnaire 
Jarvis. De bbie l <d.jarviS@irnperial.ac.u k> Tue. Jun 15. 2il10 at 11:13 AM 
To: "gail.r.ifwin@gmail.com" <gail.r.i"";n@gmail.corn> 
Dear Gail 
Peter Burney and I are more than happy fo< you to use the ECRHS quest ionnaire in you r projed ~ sounds very inte rest ing and I wish you luck with you r work 
AJ I we ask is that you adrnO'o'<1e<ige the sou rce of the quest ionnaire whe n you publ ish you r work 
Best wi shes 
Debbie 
Dr Debbi e Ja"'; s MBBS MRCP MD FFPHM 
E-MAIL d ja"';s@imperi al j!C Il k 
POSTAl. ADDRESS 
Respirat"'Y Epidemiology and Publ ic Hea lth Group 
Emmanue l Kaye Bu ilding 
Manresa Road 
Nmiona l Heart and Lung Inst itute 
Imperi al Coll ege 
London SW 3 &l.R 
Phonen~' 
office +44 (0) ~07 35~ BPI x 3510 
secretary (Hilary Barton) + 44 (0) 207 352 8121 x 3506 












Addendum 5: English Consent Form 
 
 
ENGLISH CONSENT FORM 
 
Title of research project 
Respiratory health survey of brewery workers in a South African brewery. 
 
Purpose of the research 
The University of Cape Town (UCT) is conducting this study in order to determine the 
prevalence of chest problems among brewery workers. This study is going to be done by 
Sister Gail Irwin (Course:  MSc Nursing) under the supervision of Prof. Doris Khalil, School 
of Health and Rehabilitation Sciences, UCT, and Prof Mohamed Jeebhay, Centre for 
Occupational and Environmental Health Research , UCT, who are both independent of the 
company.  Due to the fact that you meet certain criteria, you have been selected to participate 
in this study.  It is hoped that this study will provide greater insight into the risk factors for 
respiratory health problems among brewery workers and identify appropriate preventative 
strategies to be implemented in order to reduce the incidence of these problems among 
brewery workers. 
 
Description of the research project 
 If you agree to participate you will be asked to complete a questionnaire, which will take  
approximately 10 minutes, during your working time.  A member of our research team, Sister 
Gail Irwin, will interview you in privacy in order to complete the questionnaire.  You will be 
asked questions about any breathing or chest problems, allergy and work history. 
 
Rights and confidentiality of information collected: 
Your name will not appear in any reports in this study.  The records of the questionnaires will 
be kept completely confidential, and will be seen only be members of the study team. 
 
Risks and discomforts of the research: 
There are no risks from completing the questionnaire. 














Expected benefits to you and to others 
What we will learn from this study is how many people suffer from chest problems.  We will 
also be able to identify groups of workers that may be potentially at risk of developing chest 
problems, which will be useful in further refinement of the medical surveillance and health 
care programme of this brewery, where appropriate, in order to protect and promote the 
health of all employees.  
 
Costs to you resulting from participation in the study 
The study is offered at no cost to you. In the event a problem is discovered and you wish to 
be seen by a doctor for it, we can recommend to you who to see should you not have a family 
doctor. However, the study cannot pay for these additional medical visits or treatments. 
 
Contact persons: 
You may contact one of the following persons for answers to further questions about the 
research, your rights, or any problem you may feel is related to the study. 
 
University of Cape Town Researchers (Study team): 
Prof. Doris Khalil, Telephone No:  (021) 406-6164 
Prof. Mohamed Jeebhay, Telephone No. (021) 406-6309 
Sister Gail Irwin, Telephone No. (021) 658 7230 (email: gail.r.irwin@gmail.com) 
 
 
















ENGLISH CONSENT FORM 
 
STUDY/SURVEY NO. ______________ 
 
Consent of the participant 
I have read the information given above, or it has been read to me.  I understand the meaning 
of this information.  Sister Gail Irwin has offered to answer any questions concerning the 
study.  
 
By signing this form, I hereby consent to participate in the study. I also understand that I am 
free to withdraw from the study at any time without penalty or any negative consequences. 
 
Documentation of the consent 
One copy of this signed document will be kept together with our research records for this 














UNIVERSITY OF CAPE TOWN 
OCCUPATONAL ALLERGY AND ASTHMA AND ASSOCIATED RISK FACTORS 













Addendum 6: Questionnaire 
118 
RESPIRATORY HEALTH SURVEY IN BREWERY WORKERS - 2010 
Allocated number 1-3 
A. DEMOGRAPHICS 
YEAR MONTH DAY 
1. What is your date of birth? OJ OJ OJ 04-09 
YEAR MONTH DAY 
2. What is today's date? I I IOJOJ 1().15 
3. Are you male or female? Male Female 
4. Do you have a family history of allergy, hayfever or asthma? 
5. What is your smoking status? 
5.1. Are you a non-smoker (lifelong abstinence from smoking 
cigarettes) 
5.2. Are you an ex-smoker (ceasing of smoking more than a 
month before the survey)? 










5.4. How many cigarettes/ day do you smoke at present/ did you smoke in past? 
o cigarettes? 21 
1-10 cigarettes? 22 
11-20 cigarettes? 23 
More than 20 cigarettes? 24 
B. CHEST SYMPTOMS 
NO YES 6. Have you had wheezing or whistling in your chest at any time 
in the last 12 months? DD25 
IF 'NO' GO TO QUESTION 7, IF 'YES', 
6.1. Have you been at all breathless when the wheezing noise 
was present? 
6.2. Have you had this wheezing or whistling when you did 
not have a cold? 
7. Have you woken up with a feeling of tightness in your chest at 
any time in the last 12 months? 
8. Have you ever had an attack of shortness of breath at rest 


























RESPIRATORY HEALTH SURVEY IN BREWERY WORKERS - 2010 
9. Have you ever had an attack of shortness of breath after 
exercise/ exertion in the last 12 months? 
NO YES 
DD30 
10. Have you ever had an attack of shortness of breath at night or woken NO YES 
at night by an attack of shortness of breath in the last 12 months? D D 31 
IF 'NO' TO ABOVE QUESTIONS GO TO QUESTION 15, IF 'YES': 
11. Did you have these chest symptoms before or after starting this job? 
BEFORE AFTER 
12. Were there changes in work processes in the period preceding the 




13. Are these chest symptoms (wheezing; shortness of breath) worse, better or no 
14. 




Do you have chest symptoms, such as wheezing, shortness of breath 
that improve during extended times away from work, such as 
weekends or holidays? 
15. Did a Doctor ever tell you that you have asthma? 
If 'NO' GO TO QUESTION 16. IF 'YES, 
15.1. Have you had an attack of asthma, in last 12 months? 
15.2. Are you currently taking any medicine (including inhalers, 
aerosols or tablets) for asthma (self- or doctor-diagnosed asthma)? 
IF 'NO' GO TO QUESTION 16. IF 'YES, 
15.2.1. Have you had to increase your asthma medicine while 











16. Have you ever developed fever, chills, cough, difficulty in breathing NO YES 
a few hours after exposure to a product or after a certain work activityD D 42 
17. Do you cough on most days/nights for as much as three or more 















RESPIRATORY HEALTH SURVEY IN BREWERY WORKERS - 2010 
NO YES 18. Have you ever had any nasal allergies including hay fever, runny 
nose, blocked nose or itchy, watery, red eyes in the last 12 months? 00 44 
IF 'NO' GO TO QUESTION 19. IF 'YES, 
NO YES 18.1. Did you have any nasal allergies including hay fever, runny 
nose, blocked nose or itchy, watery, red eyes in the last 12 
months that is worse with work? 
DO 45 
18.2. Did you have any nasal allergies including hayfever, runny nose, blocked 
nose, or itchy watery red eyes, before or after starting at the brewery, or 
only with a cold 
Before starting at brewery? 
After starting at brewery? 
Only with a cold? 







20. Do you or did you ever have a serious lung problem for which you NO YES 
needed to be hospitalised? 0 0 50 
If yes. what was this condition? Specify __________ _ 
C. CURRENT WORK HISTORY 
Brew Cont 21. As a permanent employee, are you employed by the brewery 
or by a contracting firm at the brewery? 00 51 
YEARS MONTHS 
22. How long have you been working in this brewery? I DO DO 52·55 
YEARS MONTHS 
23. How long have you been working in your current job? I DO DO 56-59 
24. In which areas/sections/departments are you currently working? 
NO YES 
24.1. Utilities/Logistics? DO 60 
NO YES 
24.2. Brewing/Brewing Engineering? DO 61 
NO YES 
24.3. Packaging/Packaging Engineering? DO 62 
NO YES 
















RESPIRATORY HEALTH SURVEY IN BREWERY WORKERS - 2010 
NO YES 
24.5. Laboratory? DD64 
NO YES 
24.6. Administration/Sales/Distribution? DD65 
NO YES 
24.7. Other? DD66 
Specify ______________ ________ _ 
25. What is your job in this area/section? 
26. Give a short description of your job in this section. 
D. PAST WORK HISTORY 
~7. Did you previously work in another department in this brewery? 
IF 'NO' GO TO QUESTION 31, IF 'YES', 
28. In which department/s did you previously work? 
28.1. Utilities/ Logistics? 
28.2. Brewing/ Brewing Engineering? 





















Specify ____________________________ ___ 













RESPIRATORY HEALTH SURVEY IN BREWERY WORKERS - 2010 
30. Give a short description of your job in this section. 
E. EXPOSURE HISTORY 
31. Which of the following dust products do you/did you come in contact with, 
or work with whilst working in this brewery? 
NO YES 
31.1. Malt/ malt dust? DD 75 
NO YES 
31.2. Grain dust? DD 76 
NO YES 
31.3. Hops? DD" 
NO YES 
31.4. Kieselguhr/ Silica? DD 78 
NO YES 
31.5. Other dust(e.g. lucilite, activated carbon, calcium sulphate dust,D D 79 
calcium chloride dust. 
Specify: 
32. Do you / Oid you come in contact with any chemical cleaning! 
disinfectants I sterilising agents (e.g caustic soda, sterilant make-up 
fluid, solvents etc.? 
NO YES 
DDso 
Specify: ___ ____ ____ ____________ _ _ 
33. Do you/ Did you come in contact with any gases (e.g N, CO, C02); 
Use any refrigerant, or cooling gases, liquids (eg. Ammonia) 
NO YES 
D D 81 
Specify ______________________ _ 
34. Do you come in contact with vapours/fumes? NO YES 
DD 82 
Specify ______________________ _ 
35. Has there been an instant when you inhaled a large amount of vapour, NO YES 
dust, gas or fumes in any of these jobs that resulted in you D D 83 
developing a tight chest, wheeze or cough, within the next 24 hours? 












RESPIRATORY HEALTH SURVEY IN BREWERY WORKERS - 2010 
36. Do you come in contact with other: e.g moulds/mildew, NO YES 
0084 
Specify ________________________ _ 
37. Do you come in contact birds, pests, insects (e.g. cockroaches) NO YES 
00 85 
Specify _ _ ______________________ _ 
38. Do youl did you use any personal protective equipment on a 
regular basis (almost every day) while doing your job? 
IF 'NO' GO TO QUESTION 39, IF 'YES', 
NO YES 
00 86 
38.1 Which of the following protective equipment do you/ did you use on a 
regular basis, meaning wearing of protective equipment on a daily basis? 
NO YES 
38.1.1 Safety glasses? 0 0 87 
NO YES 
38.1.2 Safety goggles? 0 0 88 
NO YES 
38.1.3 Coverall/overall? 0 0 89 
NO YES 
38.1.4 Mask? 0 0 90 
NO YES 
38.1.5 Face shield? 0 0 91 
NO YES 
38.1.6 Respirator? D D 92 
NO YES 
38.1.7 Other? 0 0 93 
SpffUy ______________________________________ _ 




Spffify _____________________________________________ _ 
40. Type of interview: 
NO YES 
40.1. Face to face interview? 00 95 
NO YES 
40.2. Telephone Interview? 00 96 






















































































Addendum 8: Operational Definitions of Respiratory Symptoms 
 
1. OPERATIONAL DEFINITION OF RESPIRATORY SYMPTOMS 
Respiratory Symptom Definition 
Demographics/History:  
2. Male Answer ‘male’ to “Are you a male or female?” 
3. Female Answer ‘female’ to “Are you a male or female?” 
4. Family history  Positive answer to:  Do you have a family history (Immediate 
blood relatives) of allergy, hayfever,  asthma? 
5.1.  Non-smoker Positive answer (lifelong abstinence form smoking cigarettes) 
to question 5.1:  Are you a non-smoker? 
5.2. Ex-smoker Positive answer (Ceasing of smoking for more than a month 
before survey) to question 5.2:   Are you an ex-smoker? 
5.3. Current smoker 
 
Positive answer (Smoking cigarette/s within the past month of 
survey) to question 5.3:  Are you a current smoker?   
19. TB of lungs Positive answer to question 19:  Do you have, or ever had TB 
(Tuberculosis) of lungs? 
20. Hospitalized for 
serious lung problem 
Positive answer to question 20:  Do you, or did you ever have a 
serious lung problem for which you needed to be hospitalized? 
Respiratory symptoms:  
Wheeze: Querie 
phenotype of asthma: 
 
6. Wheeze or whistling in 
chest:   
 
6.1  Wheeze or whistling 
in chest and 
breathlessness:   
 
6.2. Wheeze or whistling 
in chest when you did not 





Positive answer to question 6:  Have you had wheezing or 
whistling in your chest at any time in the last 12 months? 
 
Positive answers to questions 6 and 6.1 :  Have you been at all 
breathless when the wheezing noise was present? 
 
Positive answers to questions 6 and 6.2:  Have you had this 





8. Attack of shortness of 
breath:  
 





Positive answer to: Have you had an attack of shortness of 
breath at rest in the last 12 months? 
 














15.1. Attack of asthma: 
 
15.2. Use of asthma 
medication: 
Have you had an attack of asthma in the last 12 months (This 
leads on from Dr-diagnosed asthma) 
Are you currently taking any medication for asthma? (This 




1.  Wheeze and 
breathlessness  
 
2.  Feeling of tight chest  
 
3.  Attack of shortness of 
breath at rest  
 
4.  Attack of shortness of 
breath after exercise  
 
5.  Woken by attack of 
shortness of breath  
 
6.   Ever asthma? (Only 
can be yes to question 15: 
   
7.  Attack of asthma  
 
 





(Yes to question 6.0 and 6.1) 
 
 
( Yes to question 7) 
 
 
(Yes to question 8) 
 
 
(Yes to question 9) 
 
 
(Yes to question 10) 
 
 
(Yes to question 15: ‘Did a Doctor ever tell you had Asthma 
?’) 
(Yes to question 15.1: Have you had an attack of Asthma in the 
last 12 months?) 
 
(Yes to question 15.2: Are you currently taking any medicine 
for asthma?)  
Possible Occupational 
asthma 
11. Chest symptoms after 
starting this job: 
 
12. Changes in work 
processes preceding onset 
of symptoms 
 
13. Chest symptoms 






Positive answer to question 11: “after”  Did you have chest 
symptoms before or after you started  this job; 
 
Positive answer to question 12: Were there changes in work 
processes preceding onset of symptoms of wheezing, shortness 
of breath, tight chest? 
 
Answer  “worse”  to question 13:  Are these chest symptoms 
worse, better or no different when working in current job? 














14.  Chest symptoms that  
improve during extended 
times away from work? 
 
15.2.1 Increase in 
medicine while working in 
the job 
Answer yes to question 14:  Do your chest symptoms improve 




Positive answer to question 15.2.1:  Have you had to increase 





11.  Chest symptoms 
before  starting  this job: 
 
12.  Changes in work  
processes preceding  
onset of symptoms 
 
13. Chest symptoms 
worse when working in 
current job 
 
15.2.1 Increase in 
medicine while working in 





Positive answer to question 11: “before”  Did you have chest 
symptoms before or after you started  this job; 
 
Positive answer to question 12:  Were there changes in work 
processes preceding onset of symptoms of wheezing, shortness 
of breath, tight chest? 
 
Answer  “worse”  to question 13:  Are these chest symptoms 
worse, better or no different when working in current job? 
 
Positive answer to question 15.2.1:  Have you had to increase 





16.  Development of fever, 








Positive answer to question 16:  Have you ever developed 
fever, chills, cough, difficulty in breathing a few hours after 




17. Coughing on most 
days nights for three, more 









Positive answer to question 17:  Do you cough most 
days/nights for as much as three or more months in each of the 















18.  Nasal allergies 
including hay fever, runny 
nose, blocked  nose or 






Positive answer to question18:  Have you ever had any nasal 
allergies including hayfever, runny nose, blocked nose or itchy, 




 18.1.  Development of 
Nasal allergies last 12 
months that is worse with 
work 
 
18.2. Nasal symptoms 
after starting this job 






Positive answer to question 18.1:  Did you have any nasal 
allergies including hay fever, runny nose, blocked nose, itchy, 
red, watery eyes in the last 12 months that is worse with work? 
 
 
Answer “after” starting at the brewery to question 18.2:  Did 
you have nasal allergies including hayfever, runny nose or 
blocked nose or itchy, watery, red eyes, before or after starting 
this job (starting at the brewery)? 
 
21. Permanent employee Positive answer to question 23: The fact that the employee 
works on a full time, permanent basis for the brewery, and not 














Addendum 9: Self-Reported Exposure to Particulate Dust 
Dust source specification dust_code n 
Air hoses/blowers: Dust generated by blowers, air hoses 1 6 
Boiler/soot dust: Chimney soot; Smoke when boiler starts up 2 2 
Dust from crates, cases, trays, machines, and/or generated by processes 3 36 
Diesel dust: Back end, from hysters, trucks, scrubber, from ground, from smoke, from tyres; Black dust 5 38 
Dried yeast dust 6 2 
Energy-saving dust: Dust created due to energy-saving: Ventilation/blowers switched off 7 1 
Glass dust: Bottle washer, EBI (empty bottle inspection), glass crusher; depallitiser, glass under machines, re-cycle 8 5 
Label dust: Fibres/paper dust from labels 9 2 
Laboratory analysis dust: Media that is made up to do analysis 10 1 
Lucilite 11 20 
Metal dust: Drilling, grinding of various materials 13 2 
Plastic dust: Plastic dust when cutting plastic; plastic dust from intake bottles that go into filler 17 2 
PVPP; Polychlor (Additives in beer processing) 18 2 
Rail dust: Black soot 19 1 
Recycling depot dust: Where contractors sit: Where all dirt, food, filtering close to where work: Dusty and odour 21 1 
Sawdust 22 1 
Activated Carbon 24 28 
Calcium Sulphate and Calcium Chloride Dust 25 33 
Sulphur/Sulphur Dioxide 26 3 
Malt/malt dust 27 12 
Grain dust 28 9 
Hops 29 11 
Kieselguhr 30 10 












Addendum 10:  Self-Reported Exposure to Hazardous Chemical Agents 
Number CHEMICALS SPECIFIED chem_code 
123 Caustic 3 
108 Carbon Dioxide 1 
100 Ammonia 2 
55 Sterilant (Hydrogen Peroxide Acqueous Solution) 4 
48 Carbon Monoxide 5 
30 Welding, soldering and cutting 6 
25 Make-up fluid 7 
23 Chlorine Dioxide 8 
20 Lactic Acid 9 
17 Sulphurs (Sulphur; Sulphuric Acid; Sulphur Dioxide) 10 
15 Solvents 11 
15 Various chemicals: General 12 
13 Various chemicals: Laboratory/QESH 13 
10 Nitrogen 14 
9 Diesel 15 
6 Glue chemicals: Casin-based, milk-based or Gemkem 16 
5 Soap, soap powder, liquid soap for cleaning the machines; 17 
5 Hydrox (Hydrogen Peroxide based) 18 
5 Methanol 19 
5 Nitric Acid 20 
5 Various chemicals used by cleaners 21 
4 Chemical cleaner used for cleaning floors and used by scrubber 22 
4 Hydrogen peroxide 23 
4 Synthetic Air 24 
3 HCL 25 
3 Methylated spirits 26 
3 Tapoxi-reactive; 27 
3 Hydrogen 28 
3 Hydrogen 29 
3 Liqueous Petroleum Gas 30 
2 Acid AC 30 31 
2 Battery gas and acid 32 
2 Detergent (EP3) 33 
2 Ethanol 34 
2 Sodium chloride 35 
2 Xonia 36 
2 Printing machine fumes 37 
1 Acid AC 10 38 
1 AC101 (Caustic-based) 39 
1 Acetone 40 












1 Acetic Acid 42 
1 Alcohol 43 
1 Beroxole 44 
1 Biosperse 45 
1 Brewbite 46 
1 Brew Plus 47 
1 Calcium sulphate 48 
1 Carbol 49 
1 Degreaser liquid 50 
1 Enviro-serve 51 
1 Fedta 52 
1 HD2 lubricating grease and oil and soap for washing belts 53 
1 Hydrolic oil 54 
1 Iodine 55 
1 Iso-octane 56 
1 Media 58 
1 Phostoxin: Bag of Phostoxin in malt container 59 
1 PWC: 60 
1 Sodium sulphide 61 
1 Various chemicals: Packaging 62 
1 Various chemicals: Brewing 63 
1 Topactive DES etc; 64 
1 Battery Acid 65 
1 Paint fumes 66 
1 Running Reds 67 













Addendum 11:  Self-Reported Exposure to Gases, Vapours and Fumes 
 
Coding: Self-Reported Exposure to Gases, Vapours, fumes 
 
Ammonia plus Hydrox (no. 12) 




















Printing machine fumes 
Running reds 
Sulphur (Sulphur/Sulphuric Acid/Sulphur dioxide) 
Synthetic air 
Welding, soldering, cutting 
Various and including/excluding lab chemicals 
 
